ROW_ID,ROW_VERSION,id,name,assay,createdBy,type,currentVersion,parentId,benefactorId,projectId,dataFileHandleId,dataFileSizeBytes,dataFileMD5Hex,consortium,dataSubtype,dataType,diagnosis,fileFormat,fundingAgency,individualID,nf1Genotype,nf2Genotype,species,resourceType,isMultiSpecimen,isMultiIndividual,studyId,specimenID,sex,age,readPair,reportMilestone,accessType,accessTeam,cellType,modelOf,compoundName,experimentalCondition,modelSystemName,isXenograft,transplantationType,createdOn,Filename,dissociationMethod,eTag,entityId,initiative,isCellLine,libraryPrep,libraryPreparationMethod,modelSystemStrainNomenclature,nucleicAcidSource,organ,platform,readLength,runType,study,timePointUnit,tissue,transplantationDonorTissue,transplantationRecipientSpecies,transplantationRecipientTissue,etag,modifiedOn,modifiedBy,experimentId,tumorType,readStrandOrigin
25791488,2,syn25791488,CUDC-907_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065924,302888,3ee8d1d49c3052b86e7f4a576b466c3e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,CUDC-907,,,,1.62E+12,,,b2ad9ee3-baeb-45aa-b7f9-c79d7eb89063,syn25791488,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c83a1717-a7b4-49ef-acc3-a8052cb43133,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791489,2,syn25791489,Dacarbazine_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065928,327900,9aa54423adf7e04ee25c1300de04b6cb,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Dacarbazine,,,,1.62E+12,,,511b2466-01eb-44b5-9a3d-870e70683242,syn25791489,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7d529a9f-e77c-4ae6-9abe-6eb39ecf32ea,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791490,2,syn25791490,Digoxin_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065930,628231,18176ccf33e40c4be110baebfea84bd3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Digoxin,,,,1.62E+12,,,efe03921-9c1f-43c2-95ea-f9b9599e9ed3,syn25791490,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ac214c0d-2272-48f9-b8a0-f9d158b4b3c7,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791491,2,syn25791491,Doxorubicin_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065934,449581,f8677b0938d057c9c12cf1c2d13fe5e5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Doxorubicin,,,,1.62E+12,,,4f3785ab-2e4f-418b-a91c-a2653408c7f1,syn25791491,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,69af4eb1-0133-4bea-a8d6-6bf71b365fe0,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791492,2,syn25791492,Ifosfamide_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065938,337734,086b527bc4a27ac45b25c5e9f8f0a1c9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Ifosfamide,,,,1.62E+12,,,776f86e7-24cd-4b0e-9a58-ffcebcff7961,syn25791492,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,73a9d4c9-1621-4a9f-b415-9f65787cd395,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791493,2,syn25791493,PD901_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065940,287228,68d39baf793dc462a589915b921f6b17,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Mirdametinib,,,,1.62E+12,,,46c3cd08-72ac-4c5b-956c-bd662e9a402c,syn25791493,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6dbfbdc8-707b-4550-acc8-4753818883a9,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791494,2,syn25791494,Ribociclib_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065942,338316,c27d1c645823337806681ad3b773fb81,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Ribociclib,,,,1.62E+12,,,174ec58f-bf22-43c8-a8e4-e19bbdd538e8,syn25791494,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,51147559-0e32-4cda-a500-546480e751fb,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791495,2,syn25791495,Sapanisertib_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065944,307075,b378db738a36d57c9eb3d1d5055ea84f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Sapanisertib,,,,1.62E+12,,,a0bc4ef6-fff4-4208-ad21-a5316d86a8e0,syn25791495,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3750c8a4-4ef7-43e1-ae26-21c43a495b4d,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791497,2,syn25791497,Selumetinib_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065946,396405,ec76c3b3241d1c9b8eddee4bc7c2da34,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Selumetinib,,,,1.62E+12,,,de991454-43e7-4b06-8aeb-b205e93f95a5,syn25791497,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,938dc227-f3a1-4eb3-a984-111e83fce9b8,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791498,2,syn25791498,Sirolimus_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065950,764052,c9870cfce1980b88a0d023076c175abd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Sirolimus,,,,1.62E+12,,,ed6f8674-4898-4285-8101-ad75a2ad6d73,syn25791498,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,139ce4bb-6d9d-426a-9056-75544c70b5cd,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791499,2,syn25791499,Trametinib_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79066652,380418,891ce3e0a606294f930aa0d9fbef8cf5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Trametinib,,,,1.62E+12,,,83cd5e5b-d63d-4918-8e55-86635a607468,syn25791499,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,70e48ec7-cedf-48eb-afe7-7d90445646db,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791500,2,syn25791500,Vorinostat_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79067454,284823,1623fb6dc2739a16c010cce27dcc129a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Vorinostat,,,,1.62E+12,,,28665ede-b1a4-4d31-af62-59ac5b0f2373,syn25791500,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,256f999b-8db3-49af-89d2-488d06772c64,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791501,2,syn25791501,Carboplatin_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065914,310571,2ea9745ada5e9f69e00f344dadae58c8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Carboplatin,JH-2-031-MIC,,,1.62E+12,,,c12b3f9b-51c5-4dc8-a8ad-cc814630a0f7,syn25791501,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0d389279-f2e1-4eee-9a2d-12f25988002e,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791502,2,syn25791502,Cerdulatinib_JHU_2_031.csv,3D microtissue viability,3418059,file,2,syn25791480,syn21984813,syn21984813,79065917,376105,1455954bdc2b0bac030734938a6c1118,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,12,,,,,microtissue,,,Cerdulatinib,,,,1.62E+12,,,f11f3020-7469-4ecf-a0ae-cc020f4ec956,syn25791502,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e522f57a-a405-4e0d-9d6b-2866e27a693a,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791506,2,syn25791506,CUDC-907_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061874,980762,9125e37ea28a68d8bd675223fcc88974,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,CUDC-907,,,,1.62E+12,,,ea7032fd-852a-4fba-829a-33425745ab4e,syn25791506,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4dd73641-37da-42da-bfe1-34c8aa08f6ef,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791508,2,syn25791508,Dacarbazine_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061876,885537,a55c1aed0c04148dc48670bdb29552b5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Dacarbazine,,,,1.62E+12,,,e0082839-b4a8-4ad4-9c90-de3cb883eea1,syn25791508,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,31d7c943-e12a-4f61-83d6-228557b78916,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791509,2,syn25791509,Digoxin_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061878,1715824,c7c5993d765290b8468eb13038f10dd9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Digoxin,,,,1.62E+12,,,aab5df48-4d53-45da-8118-eae5619678a9,syn25791509,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9536ad6d-5273-4ccc-bb10-324ce781cc25,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791510,2,syn25791510,Doxorubicin_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061880,1180555,8df79b49fa3635156502d5a79ac2c21e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Doxorubicin,,,,1.62E+12,,,7249c472-6751-4565-b531-2ed1cb448d4f,syn25791510,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b77ec09e-820c-4156-bbcd-f5da1fba66f9,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791511,2,syn25791511,Ifosfamide_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061884,684986,9c5b75566e76ed3e05191535b3ac2d9b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Ifosfamide,,,,1.62E+12,,,fa4816ec-ea5d-4a59-9d86-84650ff779a0,syn25791511,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c89d5ea1-e9f7-4722-b8e2-5810077c4f57,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791512,2,syn25791512,Palbociclib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061886,996579,8097321b440b4e9d26025e86be03be58,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Palbociclib,,,,1.62E+12,,,f33e3188-2b2c-46ec-bd2f-4c54aa73ce7b,syn25791512,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,744c7f86-1978-4476-893f-5f0e8ebb53dd,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791513,2,syn25791513,PD901_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061888,945850,aebcdda077d21a5a2c3c7997f751f42f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Mirdametinib,,,,1.62E+12,,,73adf4f8-cd01-4b7b-a288-9e54d3adfa38,syn25791513,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3bbd32f0-6534-41e0-a455-c6392a3cdbf2,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791515,2,syn25791515,Sapanisertib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061890,679607,c67645b92c2ca73647578fb76006cd92,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Sapanisertib,,,,1.62E+12,,,d76cef94-9c8a-4626-b866-0dbfe95c4292,syn25791515,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,28a18592-cc0a-48e8-b428-bc41b8f6f4bc,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791516,2,syn25791516,Selumetinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061892,722148,30bbe448df9232bf7ce1105fe9e050d2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Selumetinib,,,,1.62E+12,,,01c6bd97-fc9e-4705-8dee-3c1ed42f07c2,syn25791516,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e8cc2063-9433-4e23-9e06-d17e3666bb5d,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791517,2,syn25791517,Sirolimus_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79062214,1777957,4263aa545caa1a7bd0e423316297c14e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Sirolimus,,,,1.62E+12,,,bd023672-b976-402e-9328-de0143139516,syn25791517,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6401c6b8-8d37-4f20-ad93-338742403563,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791519,2,syn25791519,Trametinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79062998,1132478,64f285f6d52de37e856134a1d6358b54,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Trametinib,,,,1.62E+12,,,70e431a4-698b-42c9-9da8-eabd422c95bc,syn25791519,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d83286e9-11c3-442f-a256-8cb15d1915d9,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791520,2,syn25791520,Vorinostat_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79063800,854923,5d13c09710bddec2bc09911c5403a4a0,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Vorinostat,,,,1.62E+12,,,2c32ffbe-3438-411e-abe4-29a7e37340e3,syn25791520,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3050ff2c-7490-44d0-bc3f-be9a7b71de87,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791521,2,syn25791521,Carboplatin_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061868,699831,b1e65d72396121a2b6e221e4611bc22d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Carboplatin,,,,1.62E+12,,,a69b566c-2b4b-4036-bd3e-475fcb2be0d2,syn25791521,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,47db7438-b59c-45ee-af6c-70754ec6d787,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25791522,2,syn25791522,Cerdulatinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25791505,syn21984813,syn21984813,79061871,962258,dc42750690966116359fb50264721901,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Cerdulatinib,,,,1.62E+12,,,5c1bf6ea-0635-40f3-aaab-6608b56fcfc7,syn25791522,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ab65e6c0-a68e-4895-be57-ca4c01bc5504,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837065,2,syn25837065,Ifosfamide_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769525,710595,fed243328dda1a098d27fd8a6633170e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Ifosfamide,,,,1.62E+12,,,6756d6f1-7264-4977-b49f-4d3ec73c5a69,syn25837065,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8c5d132c-f4b8-47cb-80bc-461109e1199d,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837066,2,syn25837066,Irinotecan_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769531,1211272,2f9ae8832f7291467512337b7b08ad0a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Irinotecan,,,,1.62E+12,,,6314f4ba-6634-4144-b428-1164ff5c1d40,syn25837066,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6bed50cc-921c-46e2-9dec-3ba6b64e7254,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837067,2,syn25837067,Mirdametinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769533,1240479,32c9b2e065fad22a824a5e04636f15ea,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Mirdametinib,,,,1.62E+12,,,7e83bfa1-e6a8-4832-a6cb-ed3f201eaaeb,syn25837067,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,97f0ea34-43be-4cd0-9419-eeb5b12bd5a4,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837068,2,syn25837068,Olaparib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769535,199770,8eb77b21fda72802eec32b5685460adc,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Olaparib,,,,1.62E+12,,,a8ba42f1-281b-4575-9ea8-46bcece180e7,syn25837068,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,bc05099b-fbaf-44f9-9fc6-a20efa7e8022,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837069,2,syn25837069,Ribociclib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769541,1475897,7790ebcedbe9170d05e913c119b06299,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Ribociclib,,,,1.62E+12,,,051bc716-92e5-4c4e-b89e-53c14986f781,syn25837069,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5470e955-a4bb-4f19-b34f-073531dcdece,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837070,2,syn25837070,Ripretinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769543,1265809,05b34fface07784d27df95633058048b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Ripretinib,,,,1.62E+12,,,c51ef6cd-8860-4edf-824a-ddc7fb08e0e6,syn25837070,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,59f1642c-be8e-4b59-8839-2a9931fd23ca,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837071,2,syn25837071,Sapanisertib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769547,1191593,dd0955b78e266c88818ee5afdc8be9c1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Sapanisertib,,,,1.62E+12,,,efe70fa2-5476-4c80-ace7-8c622fa12c18,syn25837071,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,cfffcd19-63f9-4a99-86a8-4b5f2d23a488,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837072,2,syn25837072,Selumetinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769553,1088026,30f0a5992f29b64871d68b70d079bc3d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Selumetinib,,,,1.62E+12,,,0c9c256c-6718-4382-899e-167f1d82267f,syn25837072,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c3f23074-18e9-4518-9699-ebf3185cc030,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837073,2,syn25837073,SHP 099_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769555,1064881,42980e37c66809e4865e2dd55fe320fd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,SHP099,,,,1.62E+12,,,3835ddc2-4b8b-4893-be4f-2ce591875813,syn25837073,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,399205a4-34d9-44c3-90f8-93ae8f9e9bdc,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837074,2,syn25837074,Sirolimus_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769557,2036136,395f476b8c3f93135d410f4bb65893be,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Sirolimus,,,,1.62E+12,,,b82ebe55-915e-42d9-9c6f-5193978b7560,syn25837074,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a9549561-0f97-46b6-bff8-aeb4b45bb73e,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837076,2,syn25837076,Trabectedin_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769559,1218221,f6228629b8bb7c4ed9725ed1c3996f92,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Trabectedin,,,,1.62E+12,,,5492f37f-8446-4302-a3b1-d5efc9bb9c25,syn25837076,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,558621b8-4778-4a15-8b1c-1053550281fe,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837077,2,syn25837077,Trametinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769561,1395428,037e3e12b603eb24d0d92b15b93c5aab,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Trametinib,,,,1.62E+12,,,2b6cb85e-8740-4c92-959f-b9e5a2e35291,syn25837077,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,dc40e474-4321-4225-a20c-feacd32bc37c,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837078,2,syn25837078,Verteporfin_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769569,2269476,f87757de75775507e8cfc8a6eadc8be7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Verteporfin,,,,1.62E+12,,,6acadee8-acf8-4552-bdaa-3657a45163b3,syn25837078,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,dbd3522e-503c-47bc-903b-d5dca20dda24,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837079,2,syn25837079,Vorinostat_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769571,1246294,229205c468327c96b501b6a2b2158983,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Vorinostat,,,,1.62E+12,,,fea9c0ec-ba4f-4b7b-bb10-767d59d63306,syn25837079,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ec50927b-6908-4ce2-974f-9bc8503a5f1e,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837080,2,syn25837080,Bortezomib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769449,392946,feed4540eef1829a0e11d4e43565dae3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Bortezomib,,,,1.62E+12,,,784f54af-2a4d-4ada-b712-567ec6928d03,syn25837080,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0a877850-bf96-42e1-b71c-eaa465ac6f73,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837081,2,syn25837081,Brigatinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769457,1111660,4e1ca1503f4c46b9cb6fda3777514449,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Brigatinib,,,,1.62E+12,,,0d6fc411-85a3-4873-a369-033f61479563,syn25837081,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,35fd5014-b9d3-4aa8-aa41-a42e8eb7f525,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837082,2,syn25837082,Cabozantinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769459,1302673,d92db6d10165c92b2216717991430f9f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Cabozantinib,,,,1.62E+12,,,e01f6dac-9744-49af-a8e3-0e738b0737dc,syn25837082,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ca1be0c4-ad05-4da8-8684-3d785546fa8e,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837083,2,syn25837083,Carboplatin_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769465,1042528,e97a6cf34f28d9176d3fc5db0dcb816b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Carboplatin,,,,1.62E+12,,,5f483d4e-210a-4fa7-a1ec-99c28f5d63ec,syn25837083,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,07edc85b-fdb2-48e1-92a5-2d7e5a07823b,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837084,2,syn25837084,Cerdulatinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769467,1239902,1bc8091afed11fe8f08002e34de07fa7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Cerdulatinib,,,,1.62E+12,,,595fa7d1-f527-46dc-939a-f08b29bdef2d,syn25837084,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,fb2b4e21-e4c7-457c-b863-5fc8e8f254b0,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837085,2,syn25837085,CUDC-907_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769473,1431990,b6307bd0a6f146b06aadc1ddaa8cc2a9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,CUDC-907,,,,1.62E+12,,,2ef55eed-cd29-44cd-a3dd-e3ce6cab1493,syn25837085,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a8b52429-940b-4314-87a3-6de2c7286509,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837086,2,syn25837086,Dacarbazine_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769477,1095922,34ba24be80f8c5443d2d74e6264f10e1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Dacarbazine,,,,1.62E+12,,,c2c005e0-1fe4-4cba-81d5-d881db39ce6c,syn25837086,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3b86467a-0863-4480-a08f-057223b522cc,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837087,2,syn25837087,Digoxin_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769483,2541631,4a21b7f06f632b6690d51f70039df0ea,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Digoxin,,,,1.62E+12,,,bf8cca57-3824-4a6a-bfdd-c6160e78385d,syn25837087,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,efc01072-78c7-44f7-be0d-2c12cf4891a0,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837088,2,syn25837088,Doxorubicin_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769490,1695684,0387f189935ab2222590422cfefe8efa,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Doxorubicin,,,,1.62E+12,,,318dc7ff-7bb6-4390-8740-24da53387d2d,syn25837088,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,af00ffbb-14b6-4df8-afdb-fe408cf05a01,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837089,2,syn25837089,Epirubicin_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769497,1645762,e5928a42be15924fbc1c4d59f94b6943,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Epirubicin,,,,1.62E+12,,,282841f0-16b8-4a6f-8a67-fe1c85a31a5f,syn25837089,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,43cfd9d2-a956-4299-81b9-272f0631974f,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837090,2,syn25837090,Eribulin_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769503,467119,246ca1a9e182e7553596a2e261318412,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Eribulin,,,,1.62E+12,,,7ac3e3bd-0851-439d-8d32-104031c232b3,syn25837090,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4a556495-d020-4984-a2e2-03d29a08d31d,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837091,2,syn25837091,Erlotinib_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769511,1503864,28c56d7f2255f8f7cc699ea101ed3b95,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Erlotinib,,,,1.62E+12,,,55f5701a-5bd2-49b6-831b-7bf4a996f59f,syn25837091,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,47cd3d2b-284a-4fc6-aa1e-a6aad1230257,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837093,2,syn25837093,Etoposide_T18_MN2.csv,3D microtissue viability,3418059,file,2,syn25837063,syn21984813,syn21984813,78769519,1266791,ccf5fe99cf29997b6ee30ede37def11f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,67,,,,,microtissue,,,Etoposide,,,,1.62E+12,,,be0de9ac-27be-4539-a3e3-9c9a9896aa4f,syn25837093,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5cccb126-2cc9-42b5-994a-637f23666bcf,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837095,2,syn25837095,CUDC-907JHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806744,805803,ada521e258e282e67ddea6665cda776f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,CUDC-907,JH-2-103-CL,,,1.62E+12,,,2a511bad-e769-4f5d-bdd8-0bd6cfe55feb,syn25837095,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,198bf75f-8cb4-4fa2-87f4-410f62bbf838,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837096,2,syn25837096,DacarbazineJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806748,648983,fed52b78d69776560610b0a3531ccb41,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Dacarbazine,JH-2-103-CL,,,1.62E+12,,,bc937093-cc36-476e-ab33-6ac9735981f1,syn25837096,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,742548e5-30cd-49cd-a609-bef9065746fd,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837097,2,syn25837097,DigoxinJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806754,1083205,7851865e125e2980d3a23696ca51a695,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Digoxin,JH-2-103-CL,,,1.62E+12,,,767ed681-e384-458a-94bd-58c4bcae2a8b,syn25837097,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,458225e7-70ee-491d-a3b0-99697286db55,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837098,2,syn25837098,DoxorubicinJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806756,921065,a82bb6380c1f2952e147e1e701c27d40,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Doxorubicin,JH-2-103-CL,,,1.62E+12,,,e5fddb32-089f-445d-906f-6efab2c3cb73,syn25837098,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,9402766f-0d7b-4b0a-91e5-cc632c5f5d05,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837099,2,syn25837099,EpirubicinJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806760,896690,f2c2ea9c0a558386cd01b8a8c95f567d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Epirubicin,JH-2-103-CL,,,1.62E+12,,,ae759ea0-6be1-4508-8b8b-3bd828b58ca6,syn25837099,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,aaeb202f-a8ed-4637-8cbc-db24cf4c243e,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837100,2,syn25837100,EribulinJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806766,1286842,d2538185a32fd54795f2cef1342ed1c6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Eribulin,JH-2-103-CL,,,1.62E+12,,,5a910dad-40cc-460a-88ca-184a9e6180ac,syn25837100,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,3e5147ad-c526-4cb7-adcb-b1904d33b7ec,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837101,2,syn25837101,ErlotinibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806768,838255,d811fb199680f5decf248989bcb2d73f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Erlotinib,JH-2-103-CL,,,1.62E+12,,,8849f95d-e5a3-4f2f-bec8-abcc4fa2f310,syn25837101,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,63d7578d-d33f-4f35-bbcb-80af7a529045,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837102,2,syn25837102,EtoposideJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806772,1280035,5101328bc6ce411106a8f5a6b01bd752,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Etoposide,JH-2-103-CL,,,1.62E+12,,,61bd7671-f4bd-48aa-a52f-50d15af70358,syn25837102,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,dcc7bf5a-b2a0-4d6d-ab10-b2c8c13af39d,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837103,2,syn25837103,IfosfamideJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806775,529981,4296d2789e3db21218e6b68562c86a73,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Ifosfamide,JH-2-103-CL,,,1.62E+12,,,7f48bbc0-53c0-4afa-bb49-dd2a7a7a4fd3,syn25837103,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,8d39c53d-ae7d-4efe-a3ce-b000e4b5ff2b,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837104,2,syn25837104,IrinotecanJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806779,957890,1434c33e18c87186248b82bbdacccc2d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Irinotecan,JH-2-103-CL,,,1.62E+12,,,bcf2c138-db6a-46e9-86da-9d21598e92c5,syn25837104,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,4e160e5c-e698-4aba-962a-08ba7639ee17,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837105,2,syn25837105,MirdametinibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806781,563218,96b9e54a29669446440b6aa7862d480b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Mirdametinib,JH-2-103-CL,,,1.62E+12,,,19e3cef1-f316-4f96-b466-de30351d09c0,syn25837105,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,166ddd8d-e60d-44ab-a377-c49e4e146392,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837106,2,syn25837106,OlaparibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806783,1027809,fc7a8a271a3f4167907e1e7543183089,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Olaparib,JH-2-103-CL,,,1.62E+12,,,9c80e103-e7b6-4df0-8ca0-5e3998bdaf37,syn25837106,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,6ad9d072-3d6a-40bf-a0d9-bf0d50a5796f,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837107,2,syn25837107,RibociclibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806785,741172,4b9f8129902153975f836b40549fb2b5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Ribociclib,JH-2-103-CL,,,1.62E+12,,,177b8f66-4179-4a92-9834-6c1cb4a7982d,syn25837107,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,19511539-0ec4-4e59-ac5a-068c526faf1f,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837108,2,syn25837108,RipretinibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806794,888617,46546597cfd418a2765e6c3fab9020cd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Ripretinib,JH-2-103-CL,,,1.62E+12,,,560ea490-e841-49fd-8855-deee823fa756,syn25837108,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,05c7e280-795d-4e30-bf24-a97e917682ec,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837109,2,syn25837109,SapanisertibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806818,757213,ad691d624ad529e4813377407ed79b9c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Sapanisertib,JH-2-103-CL,,,1.62E+12,,,999c3257-3fe0-4ad3-95db-927705cf69c1,syn25837109,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,9e7b1673-d05f-4a55-b633-e3115e214fa5,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837110,2,syn25837110,SelumetinibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806823,749469,077e6af8b3501e78b6304f6acb0e97a2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Selumetinib,JH-2-103-CL,,,1.62E+12,,,2aa7655b-019f-4fd8-a0a1-8a1ccc5467b3,syn25837110,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,8665f53f-be4b-415a-b9cb-5736c348b544,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837111,2,syn25837111,SHP 099JHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806828,822029,904224de02920a95ee9e8005ac1aa29b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,SHP099,JH-2-103-CL,,,1.62E+12,,,7eaa18c7-78d8-4ec9-bd81-752a724698c4,syn25837111,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,926bd798-b7d4-4c20-ba14-fc6b97f45762,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837112,2,syn25837112,SirolimusJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806830,1237458,aef03689ade3bc4c0af64b73acf8c865,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Sirolimus,JH-2-103-CL,,,1.62E+12,,,cdcf8c01-31d7-4d84-882c-e8fd45325771,syn25837112,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,2c025529-2873-4ca5-877b-099c9a183311,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837113,2,syn25837113,TrabectedinJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806833,1838953,cc17b6be0ce5b7359ce14027caa4edd4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Trabectedin,JH-2-103-CL,,,1.62E+12,,,338c0970-10bc-409b-8915-13e1682cac8f,syn25837113,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,b6a9db4a-578a-42b6-a402-4d2563de1300,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837114,2,syn25837114,TrametinibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806839,781236,2023d439dc14e370364f5688886986d6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Trametinib,JH-2-103-CL,,,1.62E+12,,,401c28e8-0185-45bc-9d43-bb98d29969c4,syn25837114,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,425c594b-b29a-451f-85b5-ab586342dcd6,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837115,2,syn25837115,VerteporfinJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806841,1079504,d6d75f25779b45da13d06d570f3211fd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Verteporfin,JH-2-103-CL,,,1.62E+12,,,1bd0bf33-6335-4094-927e-b8a33ddec4ea,syn25837115,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,ce2942d6-2f15-45d5-8435-7a851edbcab6,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837116,2,syn25837116,VorinostatJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806843,620985,03d78d1628dcc6375ee0ec7bc43155c3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Vorinostat,JH-2-103-CL,,,1.62E+12,,,553f288a-4d12-4d0f-9730-b399bf7211ce,syn25837116,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,695e65c6-bcee-4ee6-8a9f-15c19f597e40,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837117,2,syn25837117,BortezomibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806727,650300,dceb8b8695946e5c6abce3884cec0bef,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Bortezomib,JH-2-103-CL,,,1.62E+12,,,7b89bd37-0e34-4a45-8315-d24071b17d3c,syn25837117,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,711bd430-0af4-4831-8d73-a7ca5da32032,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837118,2,syn25837118,BrigatinibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806733,963183,05453ccc698691ffb8dea3357dc12252,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Brigatinib,JH-2-103-CL,,,1.62E+12,,,d81764b8-85a8-4fd9-beb1-15dc9c27e068,syn25837118,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,ca0cbaee-ac86-4cd2-b67f-30d733b40d85,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837119,2,syn25837119,CabozantinibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806737,810623,cd5aea4c33ce91d4ead733d8afe52350,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Cabozantinib,JH-2-103-CL,,,1.62E+12,,,7ec643db-4f6e-4808-8d34-e47bc1ab7b9e,syn25837119,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,69ff5d0a-3522-4127-a8bf-349581b64dcb,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837120,2,syn25837120,CarboplatinJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806739,627120,6a5d62327dadac6d3bc4dd8229fa61d4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Carboplatin,JH-2-103-CL,,,1.62E+12,,,7f0cfe96-7c10-47e6-8bdb-3fa5cca20724,syn25837120,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,40767d25-6af9-4ce7-8ebe-984537d08303,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837121,2,syn25837121,CerdulatinibJHU_2_103_CL_210406.csv,3D microtissue viability,3418059,file,2,syn25837094,syn21984813,syn21984813,78806741,946110,045b23e45a569c5c6d36b9dbc7f610e8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,unknown,,,,,,microtissue,,,Cerdulatinib,JH-2-103-CL,,,1.62E+12,,,6127a211-79c4-4dd5-9099-85616ea3979c,syn25837121,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,92689365-8c26-4e3e-bada-49f9e2bad0c6,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837123,2,syn25837123,DigoxinJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847740,1079640,0c9d4b81e295f01310c832512109ff4a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Digoxin,JHU 2-002-CL,,,1.62E+12,,,0e1b2c57-e8cb-47b2-8a0c-e00978b4a5e7,syn25837123,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,8172924b-4a9f-4e77-96b0-73bcc1d10967,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837124,2,syn25837124,DoxorubicinJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847744,976315,0acc12ca3e1cebd56e5796e29ed9b3c9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Doxorubicin,JHU 2-002-CL,,,1.62E+12,,,ca891e34-5c11-4285-8f75-4dc2053caf34,syn25837124,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,80ba5195-d869-4b7c-8847-4017744c3629,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837125,2,syn25837125,EpirubicinJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847748,1300932,d34b9a731e493a3c0e31f3c4d2c2c04c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Epirubicin,JHU 2-002-CL,,,1.62E+12,,,8bf308e6-043d-49c0-a2bf-7241d827c7f1,syn25837125,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,f23fa6fd-c050-4755-9e07-cab307223169,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837126,2,syn25837126,EribulinJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847756,1354525,0a391514fcf47e6519a4e828b2fd3c4f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Eribulin,JHU 2-002-CL,,,1.62E+12,,,12b2cf02-9988-43e5-a0d4-fad469e765df,syn25837126,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,1fa3ed49-90aa-444c-9c65-0315a35f559b,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837127,2,syn25837127,ErlotinibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847760,879800,ae57e30e2e6694432319b46a0200e265,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Erlotinib,JHU 2-002-CL,,,1.62E+12,,,c5a50779-6d0c-4585-a728-7b91ffcc351f,syn25837127,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,fa1e8ec6-1ce3-4a16-9c6b-7009ac937817,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837128,2,syn25837128,EtoposideJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847763,1529039,fb1c9da73d820a48ffa4d8ede16e5b45,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Etoposide,JHU 2-002-CL,,,1.62E+12,,,dc7c9944-791a-494b-8f5b-d0d568d1b4b1,syn25837128,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,61ff316e-87d8-42f8-bc76-69b19bbf0f2c,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837129,2,syn25837129,IfosfamideJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847766,666789,9f0a48ebea8f953fec5bd2bb5507d1ea,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Ifosfamide,JHU 2-002-CL,,,1.62E+12,,,191f7526-29c8-4f61-bb0e-bf5019b458f7,syn25837129,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,7316b1bc-acc6-4f5e-a2d1-35fa3218c551,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837130,2,syn25837130,IrinotecanJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847768,1003596,80ce193843d5b1f7476cb809db54d241,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Irinotecan,JHU 2-002-CL,,,1.62E+12,,,91754d72-e518-4761-8a58-efc16922aed6,syn25837130,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,370b8eee-5bb8-4b45-ad41-876482178bb4,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837131,2,syn25837131,MirdametinibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847773,899397,afb414ec6414af589eda52820794c953,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Mirdametinib,JHU 2-002-CL,,,1.62E+12,,,14e6164b-f43a-45b4-aa2f-7f28b0fbdd09,syn25837131,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,569159c1-90dd-4ffd-9aaf-b5294a498776,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837132,2,syn25837132,OlaparibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847775,816629,e3222b6447e653757a933f18cc73afba,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Olaparib,JHU 2-002-CL,,,1.62E+12,,,50c29843-2106-4ba9-8c15-dcc4b590fd96,syn25837132,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,980f6e0a-539b-40ce-911a-70beb4d3686b,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837133,2,syn25837133,RibociclibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847781,789748,bdec4a69361d36641e916f575b9939ea,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Ribociclib,JHU 2-002-CL,,,1.62E+12,,,34b33ef8-c0a2-40e4-9484-ea6bb7776459,syn25837133,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,5ab2e662-dbce-4e96-90d8-1ce465acdec2,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837134,2,syn25837134,RipretinibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847785,899524,ec6d36c0812b0a07b946b2cf2d362d0c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Ripretinib,JHU 2-002-CL,,,1.62E+12,,,f8094d74-9b9f-419d-be3a-888b6be1ee0e,syn25837134,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,cbda59ca-e711-4192-bacd-e2bb2da09bb9,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837135,2,syn25837135,SapanisertibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847787,877341,90c3a4e89e6d201e905ca1ed90b9f7c3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Sapanisertib,JHU 2-002-CL,,,1.62E+12,,,a12a266a-d767-4cf5-b6cb-a3da6c9ab143,syn25837135,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,d2534197-1c8b-4013-afd3-822840d95078,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837136,2,syn25837136,SelumetinibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847789,1100279,050e84b96368fa3211ba3dfe3a763973,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Selumetinib,JHU 2-002-CL,,,1.62E+12,,,a6712125-78c9-43da-9308-e58d9237797a,syn25837136,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,32e32d17-b87d-4811-b6e6-a4497c367c0e,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837137,2,syn25837137,SHP 099JHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847793,612211,e304a31e34f259ebc8cb6583b46c1264,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,SHP099,JHU 2-002-CL,,,1.62E+12,,,bd3ba443-aaa4-4f03-832e-597feee405ad,syn25837137,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,52fbc5f8-aba4-480e-bafd-4241512dff3c,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837138,2,syn25837138,SirolimusJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847795,1762661,47e9f1fa3e78bb8e20c8af8efcd882c4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Sirolimus,JHU 2-002-CL,,,1.62E+12,,,5b403985-78ce-4ee4-9b91-67a23a07a26c,syn25837138,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,4eb71c99-3bce-47e0-ae6d-60342ac09886,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837139,2,syn25837139,TrabectedinJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847797,1365901,a0825e97d9ebc8ca1e29b163a93872c7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Trabectedin,JHU 2-002-CL,,,1.62E+12,,,08e17536-bfb4-4923-bc3a-8fe6f829d567,syn25837139,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,2e4cc10a-29b9-4347-8967-2fa2d8e7e158,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837140,2,syn25837140,TrametinibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847801,1315726,3c28ef2c43fba2668903fea9f0c5448c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Trametinib,JHU 2-002-CL,,,1.62E+12,,,0636ad08-c57a-4bb4-9548-f3e0a5d79924,syn25837140,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,2e0298e1-04c4-4946-873a-7af5a67f28fb,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837141,2,syn25837141,VerteporfinJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847803,1073728,080057142352bacf8a1fb616685621b4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Verteporfin,JHU 2-002-CL,,,1.62E+12,,,1fb92ed1-c170-4a1f-8ed0-49841bc7c0fc,syn25837141,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,c8264191-d085-4fe5-8588-e591e4579cc6,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837142,2,syn25837142,VorinostatJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847809,554790,f7a514ed7d5bdc6e7614931f2f81915c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Vorinostat,JHU 2-002-CL,,,1.62E+12,,,9e704684-33c4-4fcf-bb2d-7d611b784eda,syn25837142,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,a10c5eb4-3a38-44df-8238-0c6d6c46011d,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837143,2,syn25837143,BortezomibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847714,799455,c7182e71a488afaf9632297195d8c4bc,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Bortezomib,JHU 2-002-CL,,,1.62E+12,,,4ed3ffb9-3a4b-4757-b49f-ba13405b9335,syn25837143,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,e8d8eb22-1600-498e-9ebd-ddf40285ec3e,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837144,2,syn25837144,BrigatinibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847716,1025980,fa82dca2a15739463700c5dbb94431a7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Brigatinib,JHU 2-002-CL,,,1.62E+12,,,a5d95b2f-0e99-4ab2-9624-1aa47f08a856,syn25837144,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,2ab6475d-86ad-4139-9870-558a16f96ea2,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837145,2,syn25837145,CabozantinibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847720,1194750,4b798432e77e0a5682eacd4d052475ee,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Cabozantinib,JHU 2-002-CL,,,1.62E+12,,,446ebe73-94c8-42f5-a007-74fc895105c0,syn25837145,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,fd3888ef-49f8-463d-88b6-1d0420161a1a,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837146,2,syn25837146,CarboplatinJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847727,1052641,d777156e5ea8c86c35db6aa7eac79627,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Carboplatin,JHU 2-002-CL,,,1.62E+12,,,109ab73f-6d54-4bac-8068-51ff7aaff4c1,syn25837146,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,3564cae2-5c03-4b0e-bd35-d4589fcf2968,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837147,2,syn25837147,CerdulatinibJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847730,808984,d3f931299a3f026aa2cc2d8f9610cc32,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Cerdulatinib,JHU 2-002-CL,,,1.62E+12,,,41bf3137-17fe-42d6-a2d5-8696577a2c01,syn25837147,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,36640cd5-6384-4dba-8bcd-6cba9f43aa56,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837148,2,syn25837148,CUDC-907JHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847733,888598,0a9e2062b5bf13020dc702f9d4ed5a22,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,CUDC-907,JHU 2-002-CL,,,1.62E+12,,,b15dfb3d-8976-49f0-931b-3308946d5572,syn25837148,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,3417ac40-e831-4d97-8922-b9264532c203,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837149,2,syn25837149,DacarbazineJHU_2_002_CL_210413.csv,3D microtissue viability,3418059,file,2,syn25837122,syn21984813,syn21984813,78847738,881530,856bf60adf9bd8fbc5e7fc631f0f3559,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,9,,,,,microtissue,,,Dacarbazine,JHU 2-002-CL,,,1.62E+12,,,076e8cf0-b823-4604-b336-30e1bd32390a,syn25837149,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,1a2f57aa-7080-4f1e-8e0c-18682dfa2300,1.65E+12,3434950,JH-2-002-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837152,2,syn25837152,OlaparibWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848148,487298,7200ba7be61ee589b2ec04af1859a349,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Olaparib,,,,1.62E+12,,,ac0b1b6a-7fda-4dd7-913a-b5f5d735f461,syn25837152,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4e22f3c6-1a14-4616-9607-46a19aebacb6,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837153,2,syn25837153,RibociclibWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848150,592680,a8737b2d2ccdc425b4ae2d38790f5e63,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Ribociclib,,,,1.62E+12,,,fd944cae-cc6b-42c6-bb7a-31d3ee5f2922,syn25837153,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b334197f-8656-40c1-be55-c33b19562f90,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837154,2,syn25837154,SelumetinibWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848153,501778,a18c6b7686d09c3d1e9793a01d9b8ae7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Selumetinib,,,,1.62E+12,,,b31cc74e-ef8c-4e3e-a2ef-b4ff001c1731,syn25837154,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,36751353-bf0c-4eb0-9916-263e8ccbb03e,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837155,2,syn25837155,SHP099WU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848160,416617,2c6ad1c7d6cc6b8c0e9d2daab6d10678,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,SHP099,,,,1.62E+12,,,9ac5f7c8-279c-48fa-bbe8-6ae82edba87a,syn25837155,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e00b1028-2df6-407f-ba1f-ca216abb5417,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837156,2,syn25837156,TrabectedinWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848162,829901,b9b8c5ce66b6874e4ab78be76e61c665,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Trabectedin,,,,1.62E+12,,,d0fea953-5991-483a-9505-f8f1562cbef8,syn25837156,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,fcbc9772-2c6c-4d93-85f9-358fa4f6da9b,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837157,2,syn25837157,TrametinibWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848168,374454,25ac232f7425c5b292c1d80237ec4e63,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Trametinib,,,,1.62E+12,,,2df36ffc-c5af-4fb3-90bd-6b81593bca08,syn25837157,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,399e9887-bd51-4d41-8fd4-6461c93040fa,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837158,2,syn25837158,VorinostatWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848170,327017,d225eb5690f2a7ce4c2867a0771a61aa,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Vorinostat,,,,1.62E+12,,,cb7973e2-0fed-42dc-8787-3b736be47482,syn25837158,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,26713b4a-dbd4-4534-abb4-05fd3855bd49,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837159,2,syn25837159,BortezomibWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848121,572091,e5650791cd8fb2aa3685eca07545b975,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Bortezomib,,,,1.62E+12,,,f8cfa8c0-cdc5-421d-944c-7f7ce6d64cf2,syn25837159,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,541055fb-f3fa-4e7a-9ee9-23f832fdab8d,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837160,2,syn25837160,BrigatinibWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848126,513460,46f4589888f3ce92a4e4eb98ccb172d2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Brigatinib,,,,1.62E+12,,,12f3928d-9ab8-4dcf-816a-24310a3c2262,syn25837160,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,adcb74a6-02a0-491b-b524-c5a581356138,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837161,2,syn25837161,CUDC-907WU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848129,554966,51a840150af56664b7968e881c7cd310,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,CUDC-907,,,,1.62E+12,,,78fe9719-ac7d-4348-8597-c58e5d5cf8a3,syn25837161,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e73713da-0a85-4b6e-a3da-8996bb9db53e,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837162,2,syn25837162,DacarbazineWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848135,377196,cd34dc750b6ab578c4e82a13db4c78c7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Dacarbazine,,,,1.62E+12,,,fe5b4679-4ac5-487d-b6bf-5b588bbfd32b,syn25837162,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,50caa1a0-5836-4d5c-8703-40027fe2ef96,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837163,2,syn25837163,DoxorubicinWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848141,747894,92a8b6871e5d886875a02a007ac7054c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Doxorubicin,,,,1.62E+12,,,e8443c37-5caf-4c12-9640-58337fe8440f,syn25837163,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,948208e6-1f92-4b34-9b78-6eafa2c06ccb,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837164,2,syn25837164,EribulinWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848143,782259,b8490070aeb70808a176650448b1d494,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Eribulin,,,,1.62E+12,,,0eeb091b-bc03-46cd-9cab-847c997a7320,syn25837164,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,453cab30-addf-4133-8e23-0e9eb37a310f,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837165,2,syn25837165,IfosfamideWU_356_210428.csv,3D microtissue viability,3418059,file,2,syn25837151,syn21984813,syn21984813,78848145,317641,e8b3f0b6c98f9a4f40f60c4b2ceb2566,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,27,,,,,microtissue,,,Ifosfamide,,,,1.62E+12,,,ec742cfd-b4a2-4dca-978b-fdde6abce5be,syn25837165,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,37a00de8-4218-4c43-8329-672f3dc19a8d,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837177,2,syn25837177,DoxorubicinMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847873,1253710,e5a9134c2ff991907b8ba48e68a180d1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Doxorubicin,,,,1.62E+12,,,8b879181-ecb3-4e08-91d9-1efebfe69f7e,syn25837177,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c92d70fd-a9af-405e-9f55-b9199a50b31a,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837178,2,syn25837178,EpirubicinMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847875,849286,85c3373fe0946fa3f4d066be722283ca,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Epirubicin,,,,1.62E+12,,,3bee8975-e4e8-4a7a-b038-775973780b7a,syn25837178,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,984b55d2-f73a-4314-b51b-60c4ad8fd07e,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837179,2,syn25837179,EribulinMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847880,1153000,3ecefe37d08dae35c5184b073a38b636,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Eribulin,,,,1.62E+12,,,1aed7843-7dca-452e-a6b8-6c2f0f3e73c1,syn25837179,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,dde435e1-08ff-4eed-a93f-93294fcbb0c9,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837180,2,syn25837180,ErlotinibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847883,823469,7722292f6df60ecbef8f55d6f9fa7b8f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Erlotinib,,,,1.62E+12,,,4e1cac24-ea77-48bb-8c3c-6502d30e81f5,syn25837180,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7eff88c7-6162-4b42-8640-28a68355812e,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837181,2,syn25837181,EtoposideMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847885,1091386,344f62872ee185d58682b69307776037,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Etoposide,,,,1.62E+12,,,374de86b-53a7-4ad4-b069-9c7f43d0bdf0,syn25837181,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,90d267bc-2201-41e5-b676-7ba322f67d0a,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837182,2,syn25837182,IfosfamideMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847887,673117,a36fdd87adcb97cacda6c12ab0158e43,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Ifosfamide,,,,1.62E+12,,,86ba1a19-225f-4576-bd6b-4eea0ac82238,syn25837182,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,14322df4-0f94-4ea3-bd99-a84fa89c5264,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837183,2,syn25837183,IrinotecanMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847889,1087024,e993108cca77c054787bd9dcc6401fb3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Irinotecan,,,,1.62E+12,,,f396b3de-495e-4ab7-bc07-80dabceb19e8,syn25837183,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3c318176-796a-4881-9184-bebb7cc79642,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837184,2,syn25837184,MirdametinibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847891,929445,4ba99f98f5717e8434f4c6981c295528,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Mirdametinib,,,,1.62E+12,,,2c0760d1-f02a-40d3-9648-d148427b875c,syn25837184,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,501b0159-e1ba-4dc8-b151-53305dc7740c,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837185,2,syn25837185,OlaparibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847893,580938,9841962764d83a91fd8a0b846e18da65,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Olaparib,,,,1.62E+12,,,accc40e7-c91a-4836-bdd6-02c66535037c,syn25837185,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0def1ffd-57fa-48b0-b0b1-c49ca93a7403,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837186,2,syn25837186,RibociclibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847903,1077357,0ea67581504581d01bdac596f82e4ce3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Ribociclib,,,,1.62E+12,,,9e33bda9-b4fc-421a-9fa9-a1194c493b99,syn25837186,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e066e20e-b79b-4297-9a01-633f11ff0e79,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837187,2,syn25837187,RipretinibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847919,841401,f618c554d9e560a2cf381101c79d4dc4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Ripretinib,,,,1.62E+12,,,a9a6cd0a-e8aa-4e64-9257-b70c5fbc89b7,syn25837187,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3fdf6134-967a-479a-b381-85848a6cea3b,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837188,2,syn25837188,SapanisertibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847932,777780,93c92345d4a3e2031374e2be3d177a75,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Sapanisertib,,,,1.62E+12,,,54e0c1e1-4930-4d31-85ed-8d02fbd6e6bc,syn25837188,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,996b1e3e-f8ac-487c-8eb5-9cc1cdf0e744,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837189,2,syn25837189,SelumetinibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847944,1071064,697e75ef2100f89aed8214ac16fd9fb9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Selumetinib,,,,1.62E+12,,,b54cde32-5c3e-4dbe-8a1d-aa3416ab46a9,syn25837189,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,84e4318c-ebc5-45ce-b1e1-ba6a53881fb6,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837190,2,syn25837190,SHP 099MN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847956,543010,650c46fb3cc2e2e7211283fd74e8d605,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,SHP099,,,,1.62E+12,,,256827b5-6443-4fc8-baea-9181c79408af,syn25837190,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6204f50d-d5fb-45ce-9877-90b158443637,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837191,2,syn25837191,SirolimusMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847974,1462771,6d89dbab5f0141cf192c55502971345b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Sirolimus,,,,1.62E+12,,,9675187f-c501-4f99-b136-3a09e2d9bce6,syn25837191,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6c85e8f3-1d7c-4e22-a539-97523f4b3799,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837192,2,syn25837192,TrabectedinMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847987,948286,5604397a0a315de16e50ce666f3e42a1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Trabectedin,,,,1.62E+12,,,ba35315f-9069-4449-a113-1b9cd7906e8b,syn25837192,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,fecc8787-a2d2-40d7-ad75-e09855ea4a04,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837193,2,syn25837193,TrametinibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847997,951330,5845d755154015b61a25276b504f6750,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Trametinib,,,,1.62E+12,,,80f5255c-7a64-43b7-a566-ba8dff289f33,syn25837193,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,61cf3b50-6403-4024-ae8d-72ef7e36aac1,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837194,2,syn25837194,VerteporfinMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847999,1152271,4693cce6fdaf29c1ae815623d9df3f63,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Verteporfin,,,,1.62E+12,,,55415888-aebd-4ff3-9371-717510dec307,syn25837194,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,30ac7e98-39db-4248-b63b-65405836e605,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837195,2,syn25837195,VorinostatMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78848001,786769,5f953a8371a22c3de0973763027fe6a5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Vorinostat,,,,1.62E+12,,,29b06912-db23-4272-a1c9-3b49bf9e3c86,syn25837195,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,09679f83-2ae4-4ef9-9d57-e50b6e8ee3cd,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837196,2,syn25837196,BortezomibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847853,634256,0bae9335b8be5c9ba0ba1e35880a4b0a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Bortezomib,,,,1.62E+12,,,7ab07663-defe-431a-85ca-086ad5a2646a,syn25837196,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9a5c795d-fd85-49dc-b8b6-3ca242ab29a7,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837197,2,syn25837197,BrigatinibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847857,1006882,9941bcb400ba33bdb196292f95d4aba0,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Brigatinib,,,,1.62E+12,,,f4ffde17-0314-4b1e-9afa-07671609bff2,syn25837197,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c3b0df85-81f7-49ee-bbdb-4bd31e44e3ca,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837198,2,syn25837198,CabozantinibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847861,632648,f82e6dc13eca7a1dd76516becca69bc1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Cabozantinib,,,,1.62E+12,,,14886e7e-a01a-418f-a671-99364eeb09c3,syn25837198,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2203574e-54b4-4533-b833-7d016fdc7431,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837199,2,syn25837199,CarboplatinMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847863,818083,2af5e92606311f45340beec427e7cbd7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Carboplatin,,,,1.62E+12,,,9a7bbe2d-fb30-426a-ae7d-a4f49da27560,syn25837199,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2ef90cef-ea40-43da-b4a6-faec88dbe95b,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837200,2,syn25837200,CerdulatinibMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847865,1064527,07018c3b1bf7773869d2074785d738db,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Cerdulatinib,,,,1.62E+12,,,9b6d869f-a90a-4aed-8bf3-94b23fe220d0,syn25837200,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,77515160-538a-47a9-a24d-ab4fac3a1c77,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837201,2,syn25837201,CUDC-907MN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847867,1276530,900182cac444cdfb9a530fd00e49729f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,CUDC-907,,,,1.62E+12,,,40e7812e-af78-40b5-9e0b-4cf1ad1a02b7,syn25837201,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,39f08d37-9e73-4dc4-8543-2b564964e079,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837202,2,syn25837202,DacarbazineMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847869,667487,1d191e5e5e48dc9fe08ce6ffa751cb00,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Dacarbazine,,,,1.62E+12,,,36f7ea13-a7b1-4598-b1c9-c7eedd899bb0,syn25837202,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8a6cfa9c-7dd8-4876-bf3f-c335c2c5a0eb,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837203,2,syn25837203,DigoxinMN3_002_210420.csv,3D microtissue viability,3418059,file,2,syn25837175,syn21984813,syn21984813,78847871,1426271,a298b6ddc6a9e958ada62e46d339a353,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-002-MIC,Male,21,,,,,microtissue,,,Digoxin,,,,1.62E+12,,,ec54664b-2310-4498-9fb7-121181f6353e,syn25837203,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a9ab1ce8-a087-4dca-a229-d20b8ad5e93e,1.65E+12,3434950,MN-3-002-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837207,2,syn25837207,RipretinibJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848081,595385,30b0c21741e56778653ac3e9a32fcb6e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Ripretinib,JH-2-079-CL,,,1.62E+12,,,a6b9e829-acda-41b8-9113-6eafe99faf33,syn25837207,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,83bfe21f-04e5-44c8-9183-7aea83ca3262,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837208,2,syn25837208,SapanisertibJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848083,361558,e094f800eff0b7d3b64349e90d8aac71,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Sapanisertib,JH-2-079-CL,,,1.62E+12,,,8653d94d-251f-450f-a9ce-af9c3229af26,syn25837208,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,549f480c-7a65-493c-8992-804479001689,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837209,2,syn25837209,SirolimusJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848089,960537,2cf54f85d5456a38c4c32a126294201f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Sirolimus,JH-2-079-CL,,,1.62E+12,,,8b71a481-1833-4d04-9bd5-e7f6b96431b6,syn25837209,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,85f08ec7-8b0b-4a61-bf99-b12352c51e6e,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837210,2,syn25837210,VerteporfinJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848091,645840,e3b24b0149eb8b1415c67ecbb4e627b2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Verteporfin,JH-2-079-CL,,,1.62E+12,,,558c69e8-0c11-4bca-b02b-bffd048b0f73,syn25837210,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,9c5bc571-b729-4bcd-9f0b-65c594c99a80,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837211,2,syn25837211,CabozantinibJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848032,411833,a080af7940964d5f7be85d0c2d48f7dd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Cabozantinib,JH-2-079-CL,,,1.62E+12,,,bd3388bf-e320-47ef-9fc5-b45cfe279388,syn25837211,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,2bc14f68-5ba8-466e-8365-5d3d3bafb557,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837212,2,syn25837212,CarboplatinJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848042,416287,c8efe29ddfcc013f2fba3925dd38c659,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Carboplatin,JH-2-079-CL,,,1.62E+12,,,8c8ffc13-73ef-487c-ab02-02cd92f095ef,syn25837212,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,afe65410-de7f-429f-b33b-448b5dceb2ca,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837213,2,syn25837213,CerdulatinibJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848049,487972,2b41032e252499fc916b6d6de64a6f91,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Cerdulatinib,JH-2-079-CL,,,1.62E+12,,,9c464d0f-659a-42a6-a303-cd596a691b9b,syn25837213,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,afaeb20b-e21e-4e52-952e-f7c623f49226,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837214,2,syn25837214,DigoxinJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848051,779898,9bdd481ee20268ee3f3fac9f4d5e8984,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Digoxin,JH-2-079-CL,,,1.62E+12,,,261e16d1-84d1-4b3e-a953-772099f3624a,syn25837214,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,63b05b46-13f5-46cd-885f-7fd87d2bf30d,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837215,2,syn25837215,EpirubicinJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848057,611740,35bd347a19a0cfd8c0a9d58dff16f81f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Epirubicin,JH-2-079-CL,,,1.62E+12,,,d55820f9-a3ee-4eea-b915-2f741c4f8062,syn25837215,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,390d58db-a7ec-4ce9-95db-4ead4229171e,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837216,2,syn25837216,ErlotinibJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848061,435132,14abce5e9c16ac4abc4ccdf3535321c0,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Erlotinib,JH-2-079-CL,,,1.62E+12,,,ee73163a-7358-4563-bf26-a999512f15c8,syn25837216,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,991f18d3-8ff7-4d7e-95e6-2e6a0cd84d46,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837217,2,syn25837217,EtoposideJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848063,585184,d19de0b54041838b3d4e45fb2d7c360f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Etoposide,JH-2-079-CL,,,1.62E+12,,,0c678acd-508b-4bbc-9767-f9e047cb7c4b,syn25837217,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,62bb0c81-08ed-4605-a53a-79bf20fcf8db,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837218,2,syn25837218,IrinotecanJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848069,628214,56f3fee1b7d5b7239dff61f188d04b2a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Irinotecan,JH-2-079-CL,,,1.62E+12,,,6aa17932-39b0-41bf-8705-f9a819b29714,syn25837218,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,7ff78688-7d1d-4272-8e9d-f0288e5633de,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837219,2,syn25837219,MirdametinibJHU_2_079_CL_210428.csv,3D microtissue viability,3418059,file,2,syn25837206,syn21984813,syn21984813,78848075,372793,9f1427b71e8baed19fac58a53e620fd3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Mirdametinib,JH-2-079-CL,,,1.62E+12,,,91ad45a2-74d0-4b69-b633-00689a2108fb,syn25837219,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,4f3c331e-57d1-44b8-92c1-59bd13321c43,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837221,2,syn25837221,DacarbazineJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848307,422577,eac0668b90b54e042f6d0f19bbdb7398,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Dacarbazine,JH-2-079-CL,,,1.62E+12,,,8039f8c5-4130-4f4d-a107-5b4864212374,syn25837221,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,e4b201e2-83f4-410d-aa9e-974114e93ca6,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837222,2,syn25837222,DigoxinJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848315,771715,9812f0ef1339ee3e604d37122d181cf6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Digoxin,JH-2-079-CL,,,1.62E+12,,,a3b230f7-11e2-46c8-b18d-5a32a3ad6ca9,syn25837222,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,58bb2250-aa48-4aa3-b9cb-341a05842bb4,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837223,2,syn25837223,DoxorubicinJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848324,569049,aa2c2a4be8b6481a86e3a93c31407823,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Doxorubicin,JH-2-079-CL,,,1.62E+12,,,0118a3ac-a6ec-459a-aa63-a49b4d2a835f,syn25837223,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,89a4d68c-dca4-4ae1-a69f-7e1d98d1af81,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837224,2,syn25837224,EpirubicinJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848330,760727,c1b6d29bb20590bb385089b2608a56c8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Epirubicin,JH-2-079-CL,,,1.62E+12,,,ed5b1f72-0bbe-4e6f-b79a-5163a237d0ae,syn25837224,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,c57b50de-d7cc-41b0-9cd8-abf091a03f8a,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837225,2,syn25837225,EribulinJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848336,744920,a12afd6b93d57685d1b8220bab30f4fc,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Eribulin,JH-2-079-CL,,,1.62E+12,,,a20ffd91-b0dd-47aa-8b1f-ac329c364a53,syn25837225,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,d1ec2b6c-8d17-4224-83b1-83d6ac4fcb1c,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837226,2,syn25837226,ErlotinibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848338,454084,8d2aa75c64472f82ff4ef9643e3c4aaf,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Erlotinib,JH-2-079-CL,,,1.62E+12,,,c37f8ca0-09fa-4176-909e-f27f83b5a27f,syn25837226,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,bf96dbbf-7aed-43f8-be44-a427714b5b75,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837227,2,syn25837227,EtoposideJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848340,699163,b1039dd5fc3ee2dc9f52a810e5408d60,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Etoposide,JH-2-079-CL,,,1.62E+12,,,8c537f99-9cb1-4483-b598-1500a498fc80,syn25837227,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,5a9db599-0fea-4baa-a5a0-f6790ce28ccb,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837228,2,syn25837228,IfosfamideJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848342,336786,72bd915fcbd4ad8382c9a2d5799b0d34,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Ifosfamide,JH-2-079-CL,,,1.62E+12,,,90087c24-0a63-4b76-a606-b51424884e91,syn25837228,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,f786c919-770e-4d66-85c6-123e8b160824,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837229,2,syn25837229,IrinotecanJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848344,651188,187ceca7aebe710744c4f4991501283f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Irinotecan,JH-2-079-CL,,,1.62E+12,,,15734950-178c-49c8-9695-e8d7c877975c,syn25837229,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,1adbe70d-01db-4ac8-a261-3fde881649d0,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837230,2,syn25837230,MirdametinibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848346,596251,c6b86ec7003c29a922e7bc6ac2c34b22,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Mirdametinib,JH-2-079-CL,,,1.62E+12,,,3d3e8ad3-d1ac-4a41-b518-2cdaaa3a982d,syn25837230,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,1422302a-4614-4da3-9d05-e53f53631da5,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837231,2,syn25837231,OlaparibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848352,577409,b493b5387cd0f8d4a043cb3cb2e9398f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Olaparib,JH-2-079-CL,,,1.62E+12,,,471b9f71-b2a0-4de7-bb34-c96faa97aef5,syn25837231,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,ee02848b-c1b0-46f4-9646-4c9c5b3b0087,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837232,2,syn25837232,RibociclibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848354,624695,b98a8dccf5558ee1457d22856e397dc0,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Ribociclib,JH-2-079-CL,,,1.62E+12,,,a629bfd0-92fd-4643-9eaf-bd3530bcef9c,syn25837232,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,784644f2-d8b7-455b-b9c6-8ad48635892e,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837233,2,syn25837233,RipretinibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848356,598842,99fba2f9a954fa48c1f65ec8c8db009c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Ripretinib,JH-2-079-CL,,,1.62E+12,,,6c55c16f-daa4-4a35-bd7e-7c98ff08a431,syn25837233,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,0705ff53-8a4d-4897-b23b-9d70df503ba5,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837234,2,syn25837234,SapanisertibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848358,725392,4b14216c5823a45d2d6684da2dbc8847,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Sapanisertib,JH-2-079-CL,,,1.62E+12,,,0096fc12-779a-43df-9162-3d5e19c861fd,syn25837234,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,87399f2a-33fb-4aaf-b721-ac1fa803c0aa,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837235,2,syn25837235,SelumetinibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848360,446887,cce43fb25f9fa3a092a9742f9d80073a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Selumetinib,JH-2-079-CL,,,1.62E+12,,,54d38378-bc4e-4fb1-b88a-8788c28126aa,syn25837235,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,ee4e4ea9-90c3-48c3-90a2-d1e48c0e5036,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837236,2,syn25837236,SHP099JHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848366,460293,acb458316725233d7d8e1f548ee79eaa,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,SHP099,JH-2-079-CL,,,1.62E+12,,,20ef403a-8c40-4cc2-a11a-3668059e9947,syn25837236,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,b00e671a-8a33-4217-b8f1-37afec088a13,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837237,2,syn25837237,SirolimusJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848370,1045098,4cfa2e051b8a81164e1ce4fa9f0aafc6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Sirolimus,JH-2-079-CL,,,1.62E+12,,,946cfabe-aafd-4301-ae16-50cb47151b1e,syn25837237,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,726abe64-14f6-4305-8de1-82b2a2a5711d,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837238,2,syn25837238,TrabectedinJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848372,614408,5eabd689e990e50ed9a46b674a16ba17,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Trabectedin,JH-2-079-CL,,,1.62E+12,,,456078c0-d1b7-4917-a0ee-fe52fd585463,syn25837238,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,5baec740-3092-4a07-b3b6-6a8e0447ad6e,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837239,2,syn25837239,TrametinibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848374,383293,3dd596dd64ad815385b48455b3044bcd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Trametinib,JH-2-079-CL,,,1.62E+12,,,cf4e2f36-6ee5-4677-8466-66e6428fbcbc,syn25837239,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,46cc77e4-ebdb-499d-8d7f-9351cbf2037a,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837240,2,syn25837240,VerteporfinJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848380,913092,88495f5f84250152a4973daa332730f4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Verteporfin,JH-2-079-CL,,,1.62E+12,,,8bab62ad-6922-4018-b35d-392b0a68061d,syn25837240,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,36959b26-ee92-4fdd-b2ce-19f92e707cb6,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837241,2,syn25837241,VorinostatJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848382,581909,853c6d6c4717f53829722969f0d6c1af,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Vorinostat,JH-2-079-CL,,,1.62E+12,,,ecd2cee7-2ba3-4f31-aa67-e44387be2b49,syn25837241,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,a93a023c-2dd0-4385-ae4c-3bf5dc967f7e,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837242,2,syn25837242,BortezomibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848269,540353,68d4f1a8d16058eadf356c03fcab6212,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Bortezomib,JH-2-079-CL,,,1.62E+12,,,7e9cc8a0-52a5-4f32-83f8-9d4ad30c9420,syn25837242,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,89f4f637-cc19-4138-a711-4f74bb96be39,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837243,2,syn25837243,BrigatinibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848275,660325,83b495dcd4e979d3cc17ed151eca0f14,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Brigatinib,JH-2-079-CL,,,1.62E+12,,,465d79cb-5fee-402f-b9ce-7df7673f995a,syn25837243,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,bc3a6d61-f1a9-4346-9867-833c0b7fd9ad,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837244,2,syn25837244,CabozantinibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848280,563881,f19b14406a69afe361d95333d7d96ce4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Cabozantinib,JH-2-079-CL,,,1.62E+12,,,0e9f833f-e120-4e81-a76e-c86944ddc6ce,syn25837244,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,493b3050-2e55-4068-8e8b-daffd12bdabc,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837245,2,syn25837245,CarboplatinJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848288,378500,03262c68d87010a42d2c8986e9c9cda3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Carboplatin,JH-2-079-CL,,,1.62E+12,,,c9689e9a-6dd3-4b38-8313-9b058ef6540d,syn25837245,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,088c92fe-d374-49f7-a71d-be43c2dcd5e8,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837246,2,syn25837246,CerdulatinibJHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848295,630446,003039c4684c8635a43d56f1dbb4f895,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,Cerdulatinib,JH-2-079-CL,,,1.62E+12,,,c0b39c3b-6fc0-45e8-854b-e2b4bfcc88fb,syn25837246,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,9a16ece4-874a-4306-9b10-0dd4921316ab,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837247,2,syn25837247,CUDC-907JHU_2_079_CL_210505.csv,3D microtissue viability,3418059,file,2,syn25837220,syn21984813,syn21984813,78848301,438090,51f0b13bb2a0e570607a34f5da8cb83e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,18,,,,,microtissue,,,CUDC-907,JH-2-079-CL,,,1.62E+12,,,c08deaef-02a5-4fbc-a5c7-c51a47fe2bed,syn25837247,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,752c6a94-7469-4c68-a1eb-11f743b0c54b,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837249,2,syn25837249,CUDC-907MN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848434,658590,bf987d9f5120ec9fd68349e6769e9c08,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,CUDC-907,,,,1.62E+12,,,96fea892-635c-45f1-9cbb-d69f71eac664,syn25837249,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6121c636-fde8-4b39-8330-16ce260bf3b6,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837250,2,syn25837250,DacarbazineMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848440,461482,2fe44ce8ba95facffc4ff16f53fb9bad,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Dacarbazine,,,,1.62E+12,,,7045bed4-065c-4dac-81af-7a490a674ed7,syn25837250,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8f74ccf5-dda7-4546-9949-8ce31b9eb67d,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837251,2,syn25837251,DigoxinMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848446,634349,1a8d4636f759b8e46ee8168d184c905a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Digoxin,,,,1.62E+12,,,46e06b19-1020-4645-8ae6-f00d54ab3fcd,syn25837251,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d1724ffb-8e29-4f1a-b876-b4585cbd5c01,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837252,2,syn25837252,DoxorubicinMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848453,1057529,4d8b3cf0f8a06018f2f8c7a1dcb43718,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Doxorubicin,,,,1.62E+12,,,385709f6-a03e-48b7-b3ab-cc8f99790f34,syn25837252,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,75fc9914-f811-4978-9b12-017b317ad470,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837253,2,syn25837253,EpirubicinMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848462,783201,4cb8f0d6c9770ea062cc78f904029611,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Epirubicin,,,,1.62E+12,,,9f4954c0-591b-4e0c-a063-4223927999dd,syn25837253,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,bdb226a8-c9dd-4310-a2e4-f78d245c6e5e,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837254,2,syn25837254,EribulinMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848470,863804,c01ce384519798bb6ea0f812c8c870cc,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Eribulin,,,,1.62E+12,,,47166a48-75e3-4e64-a433-5b044c508d65,syn25837254,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6053b7b2-ad1f-4684-8986-51c415a58bca,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837255,2,syn25837255,ErlotinibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848478,526771,e9176da6614a5a4b38d7d455d250f5b6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Erlotinib,,,,1.62E+12,,,393670fe-3215-4d87-8c52-64461c2b0449,syn25837255,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0e23de53-b743-4abe-8674-2780825db269,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837256,2,syn25837256,EtoposideMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848486,860548,1582c774c8ee3afcdf610545f134cd41,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Etoposide,,,,1.62E+12,,,23e692ec-d938-4f0c-a675-fa3558950a05,syn25837256,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5e943ce3-dad5-4276-994b-817f87fc1875,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837257,2,syn25837257,IfosfamideMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848488,425409,0845c9871c2773bd8a2e9de4ba8f0f49,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Ifosfamide,,,,1.62E+12,,,9c477a16-59e1-4635-af2f-5b2173d0855e,syn25837257,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,abfb03f6-1125-4795-9c98-e5b2c7e888cb,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837258,2,syn25837258,IrinotecanMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848491,688240,a39a7d748cf93890d3e3344e13ec30fe,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Irinotecan,,,,1.62E+12,,,6d1d7f78-19d6-4e44-bdda-909fa7e55a2f,syn25837258,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,df9377e0-3052-4519-b273-4248692de212,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837259,2,syn25837259,MirdametinibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848496,546155,165b38da388443218bd7cfc626ea156b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Mirdametinib,,,,1.62E+12,,,c34becc9-f287-4b37-bd5e-f916c4451d9d,syn25837259,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,206cad2b-3ce9-4cec-a383-fa7621894a6b,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837260,2,syn25837260,OlaparibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848498,644960,3f25e8338d41636b1d25e8a1b5c19110,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Olaparib,,,,1.62E+12,,,3f385e9c-4d80-4bc9-8e81-df664231c932,syn25837260,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a6ac928e-d0fb-40db-a9f7-0b6fed426164,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837261,2,syn25837261,RibociclibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848500,388722,eb3b558ad6d739ea9c1ce67c650f888d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Ribociclib,,,,1.62E+12,,,ab3cdba7-15cc-43d6-bff9-5d52c51d3836,syn25837261,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2da487cb-d34f-4440-bb00-9a4d905f8967,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837262,2,syn25837262,RipretinibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848502,553552,a76975b930bd6d67f7a8dfc305fcf60c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Ripretinib,,,,1.62E+12,,,96d178f8-5f46-4a40-9bc0-a48625ae405c,syn25837262,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3db89eb3-421d-4c61-9261-a0ca623a6b1a,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837263,2,syn25837263,SapanisertibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848504,139121,6332406d9713201c2f19439a43c87808,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Sapanisertib,,,,1.62E+12,,,5a189cce-c70a-488e-8eb0-5739bf9b6b53,syn25837263,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8acae39f-d750-432b-aab9-c32987cf3773,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837264,2,syn25837264,SelumetinibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848512,567440,e9d6ada479b29b0380fc58978ac60193,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Selumetinib,,,,1.62E+12,,,bc279839-61e0-44e7-898c-49218097a861,syn25837264,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2167fd82-c2db-4683-b319-784d71dcc779,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837265,2,syn25837265,SHP099MN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848514,1575733,de1b19b819b88471d1538c15445b5353,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,SHP099,,,,1.62E+12,,,ef845e49-dcb5-4a46-a25c-c3496163bbcc,syn25837265,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ac3b565b-cca4-4b87-9636-fef097e396a7,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837266,2,syn25837266,SirolimusMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848518,952209,039b95cbee020a55b88a038c7473f5d7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Sirolimus,,,,1.62E+12,,,1e742f44-d59f-4ad9-b19a-bfaa6d661664,syn25837266,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,56d2cb29-cbef-4328-92b9-5326293bba6a,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837267,2,syn25837267,TrabectedinMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848520,809571,bb2a13a1916851c3507378bc3c2c32ed,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Trabectedin,,,,1.62E+12,,,f44b4ad5-875c-4b54-b423-173ea02ad572,syn25837267,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9734109e-dc4b-4f6d-ba44-db4523cb5d09,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837268,2,syn25837268,TrametinibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848522,1092710,60bb0578ee27b916fa079578d510e559,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Trametinib,,,,1.62E+12,,,f0f39acd-55e6-4a37-88a0-5aa61faf35ba,syn25837268,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1cab0153-2203-4edc-b703-ddb70dc47b17,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837269,2,syn25837269,VerteporfinMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848526,490076,c18f1c93d14bf8fd9a7a9e0d002b4481,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Verteporfin,,,,1.62E+12,,,1eff1a14-3174-42be-8459-f0149572e0a5,syn25837269,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4c6336c1-f489-4fbe-aef3-d83641742148,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837270,2,syn25837270,VorinostatMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848528,354139,f9b0e5162be9fde4333c6b785c5b4083,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Vorinostat,,,,1.62E+12,,,6d8a7d17-24ac-4d32-959a-67327daadee2,syn25837270,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,682f2e45-6f15-4cb4-9350-116c498b2cb8,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837271,2,syn25837271,BortezomibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848414,801913,2ebd991c5841796c109a0cf6193092a2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Bortezomib,,,,1.62E+12,,,3d31fc64-cd8d-4957-be08-f415381b3d00,syn25837271,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d261f7b0-7f74-4446-b5a0-0555dca046d9,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837272,2,syn25837272,BrigatinibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848416,649490,a8a71a2dcc170a71b703af2a10b1e08c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Brigatinib,,,,1.62E+12,,,e53b7b18-a47d-441b-85af-8b71163026bb,syn25837272,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,833a14d9-2b94-43f9-8804-c8f30d150dec,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837273,2,syn25837273,CabozantinibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848418,597625,01fda0a62f62d4fff9873690fa44466b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Cabozantinib,,,,1.62E+12,,,0127203f-96f8-4a92-9b53-2f1221d45014,syn25837273,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,935064dc-a3b5-4718-a41b-77834532c215,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837274,2,syn25837274,CarboplatinMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848420,117761,601aeb3b39ac019403338477794afea9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Carboplatin,,,,1.62E+12,,,9c843aef-c9f2-4bb2-b687-3a5b5ba58c61,syn25837274,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d9fc5359-2328-4288-9cd1-59b715b2f52b,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25837275,2,syn25837275,CerdulatinibMN1_210512.csv,3D microtissue viability,3418059,file,2,syn25837248,syn21984813,syn21984813,78848428,251977,27b5307af75ecddc568e9c9b248f5b6c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,22,,,,,microtissue,,,Cerdulatinib,,,,1.62E+12,,,48fa13e1-e834-4bb8-b6da-2d86bff200ce,syn25837275,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9edf1b4d-ced5-4389-b9cb-de82a974d84a,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958789,1,syn25958789,DacarbazineMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848568,209246,52e8ab92e2eed42355b64765bdac9b1a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Dacarbazine,,,,1.63E+12,,,1474b30e-69b4-4b90-bbcf-3eed4c52994b,syn25958789,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,abbe1152-1b3a-4b96-96f8-4471a8328ec6,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958790,1,syn25958790,DigoxinMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848570,679485,731af0b7440e9ce8cd45e56a73277535,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,f62fb6cf-39c4-4b37-9b13-11db073d3b8c,syn25958790,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e311d72c-354e-465e-a0ce-6721b2a5960c,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958791,1,syn25958791,DoxorubicinMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848571,358353,7908f9a3f92c9aff8c02c9e4775c4424,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Doxorubicin,,,,1.63E+12,,,cc7b4efa-7bf9-4dcc-a7b1-28e5e9ad39f5,syn25958791,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,fce010af-f8d0-4103-ad9c-27245f35124d,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958792,1,syn25958792,EpirubicinMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848575,472574,cfe16f7f34de29a588d221ba8277e4e2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Epirubicin,,,,1.63E+12,,,22b88914-8448-48db-a19b-cfa50e5f4e0f,syn25958792,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,41917702-c1ca-4687-902b-3c949f8e1459,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958793,1,syn25958793,EribulinMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848580,649500,6a93f99f39e83e2cee0698ee6306b8e9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Eribulin,,,,1.63E+12,,,16961767-ee9a-4b0a-9024-b52ae729e106,syn25958793,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1b978a9a-2022-4cbb-bdbf-a4f5f78daa9a,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958794,1,syn25958794,ErlotinibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848581,374975,1383bb2c292ee568f31a0ba99662a443,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Erlotinib,,,,1.63E+12,,,9c1beb1a-5d2c-40b2-802d-af4e3ab7d7dd,syn25958794,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7f77782a-977a-4fef-8232-40f9997e220a,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958795,1,syn25958795,EtoposideMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848584,593605,be310efd8fd25463ca74a5010e2a2d68,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Etoposide,,,,1.63E+12,,,e5a75fe5-1b87-48ec-be6c-bea73a260990,syn25958795,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,87240eb7-f245-4256-80bb-0bb7176b2449,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958796,1,syn25958796,IfosfamideMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848586,425851,14d6737c2b44e573b96f82794dc9f214,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Ifosfamide,,,,1.63E+12,,,419ece91-86e6-434d-89c6-1c9271a8309c,syn25958796,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f7401b58-f6c0-44a6-9fd3-c07ab5e44f23,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958797,1,syn25958797,IrinotecanMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848588,381636,5269af8ca403edebac14190b8a8c4f59,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Irinotecan,,,,1.63E+12,,,e8c305f6-5871-4434-a398-4786da378752,syn25958797,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e07dca10-78f7-4445-968b-8668b4c6f884,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958798,1,syn25958798,MirdametinibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848590,399843,a431fb086f26f5001d097bcada21ca93,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,cc77fa77-f7e2-4d82-a761-4779743cb023,syn25958798,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9739b85c-7fda-4b6a-a967-5c1e82dd8d0c,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958799,1,syn25958799,OlaparibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848591,431224,be165e4f4fa6fc0ea0c9dd9a9464a253,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,4eff143d-c8f2-492f-bfc9-fe0f8b446b10,syn25958799,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,be3c02c2-e0e7-4881-a21a-ecf1caf4b852,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958801,1,syn25958801,RibociclibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848594,328643,f1c3e11484d4af46e92f4d4cb90e067f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,2872a5b2-85e5-4b08-9fad-6302098369a3,syn25958801,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,94dc9305-773b-4b3c-8e1b-53a6d746800c,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958802,1,syn25958802,RipretinibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848597,458911,358e82e89eb402a526adb081b316d9ad,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Ripretinib,,,,1.63E+12,,,25f3be2f-f1d9-420d-b7e0-5232fd9b5017,syn25958802,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6e88b601-e6b5-4417-9dc2-0b813b8644d9,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958803,1,syn25958803,SapanisertibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848598,266611,69cde02210b3035c0ef4bcd899fe69fe,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Sapanisertib,,,,1.63E+12,,,cd4944cc-a583-4a97-ab0e-59c6fef3586f,syn25958803,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0fdd4a68-d462-493b-83c5-40798ed771da,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958804,1,syn25958804,SelumetinibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848601,347028,3f7e06a3fb977bcaf89d510f330f61e0,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,e17fa35b-a9bd-4efc-8a11-30f850d0381d,syn25958804,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,cdc5fdbe-4427-4612-ad5d-cd0215591e44,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958805,1,syn25958805,SHP099MN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848603,342467,a6e1db0cc81dac74b75f172d53256103,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,3f28f678-5983-420f-bfb2-a0d6e4d76208,syn25958805,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8011276d-53b2-4ecc-af3a-5a6c815fd761,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958806,1,syn25958806,SirolimusMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848605,618222,c370d4e756740eaf46986897569afa13,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Sirolimus,,,,1.63E+12,,,ab7a6459-6d0a-4119-b3ae-95f201986fed,syn25958806,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,295105f2-16a7-4c55-89b2-e23841bc262b,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958807,1,syn25958807,TrabectedinMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848607,590908,431f65ee99444addfd023fd47a7dfde2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,94851b08-7abc-4bbf-949a-8474029d474e,syn25958807,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,66a9fae4-8650-4b59-b864-bc4dc0df3ac8,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958808,1,syn25958808,TrametinibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848609,335528,b248f9168b664ad36e01842200ea2efe,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,79558c46-f7c2-450d-94d1-b889633e3d12,syn25958808,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,52032e39-dbf3-43c3-af18-53eb8d534357,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958809,1,syn25958809,VerteporfinMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848611,665049,c510ea5ba5eca02d3a79d679d9069c9d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Verteporfin,,,,1.63E+12,,,a253251d-1517-49f1-ae63-971a965bdbb7,syn25958809,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ea729922-cf0f-4afd-acfa-178a590dc5a9,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958810,1,syn25958810,VorinostatMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848613,273608,4e2313d63a48a9711c77e1a3cd52477b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,3f570ff6-cf22-4a2e-80d1-a351e78684fa,syn25958810,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e2c3f40c-8b70-45d4-8ee2-1ac38d219fdb,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958811,1,syn25958811,BortezomibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848614,457495,766fab5a852f935a2734260ca60019f7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Bortezomib,,,,1.63E+12,,,165a5267-6552-497d-a99b-c2238a4d8fa2,syn25958811,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c7bdb7a1-0ffc-430e-87a1-1bb3bda47b96,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958812,1,syn25958812,BrigatinibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848617,434658,7307e3613a1ea6dd9f36b577afc320b2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Brigatinib,,,,1.63E+12,,,ad965ffa-3c1a-445b-bef7-5495f8748878,syn25958812,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,fcaec507-172e-4040-b521-9254f4c81569,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958813,1,syn25958813,CabozantinibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848618,355105,dc4712dc929c8efbcba75442ea02b413,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Cabozantinib,,,,1.63E+12,,,f9ed8ee4-d570-48c7-9798-238fc0d68380,syn25958813,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a84a9c81-b63a-46a8-9554-d967d2255574,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958814,1,syn25958814,CarboplatinMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848620,266897,c7570cc3eb34ca63075e4d2c5c24946f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Carboplatin,,,,1.63E+12,,,4c2ec39c-275b-4fda-8823-774924f7078a,syn25958814,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,eb9fef05-79a0-4cb4-ab4b-d1038b53e73f,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958815,1,syn25958815,CerdulatinibMN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848622,450380,b49c69574c1156604f5b4745f9706153,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Cerdulatinib,,,,1.63E+12,,,c21a4c0c-1ade-4292-884a-3c55030685ce,syn25958815,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,891e16ff-86ec-46e7-90ce-c4e86720332a,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958816,1,syn25958816,CUDC907MN3_001_210519.csv,3D microtissue viability,3418059,file,1,syn25958788,syn21984813,syn21984813,78848624,320065,3a8c612ec8199ff8389e66950474a57a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,CUDC907,,,,1.63E+12,,,22ec3408-187e-4d25-87be-778f3f828315,syn25958816,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ca18139c-9eb9-4c98-ad46-8f0db700a00b,1.65E+12,3434950,MN-3-001-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958818,1,syn25958818,CarboplatinMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848633,538718,8c815640dcc581dd7408c04734fcdc8f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Carboplatin,,,,1.63E+12,,,dad42942-b3bd-4303-aba5-97f7dd525789,syn25958818,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,707df87d-ad9d-49a0-bfdc-e3db1f139b51,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958819,1,syn25958819,CerdulatinibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848634,901639,37941e1577578b8324f6898dec93fc05,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Cerdulatinib,,,,1.63E+12,,,5c269a82-da99-41d3-bf28-4a1ddd4ddac2,syn25958819,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0976e8d5-a206-4de5-a36c-332a71447b28,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958820,1,syn25958820,CUDC907MN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848636,918528,8e68a62534d27a152777be675f1eb730,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,CUDC907,,,,1.63E+12,,,a2bcd461-f54f-44b3-816b-7ca3c2749ea3,syn25958820,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1c429e31-38fd-4427-a698-ca60bb09460f,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958821,1,syn25958821,DacarbazineMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848638,658542,25a6c1d8b0c3c544b3fef5a4eab24ce4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Dacarbazine,,,,1.63E+12,,,285f3aec-b519-468b-b1d2-2e0911e8b453,syn25958821,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,047cd7cc-3b04-40be-b5cd-25dedc42cfb6,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958822,1,syn25958822,DigoxinMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848641,1584100,0625120ef03e2b7170a7bd6681e4f846,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,0a9b5095-10a9-44e1-924a-ef8d21055000,syn25958822,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c7e965b3-f048-4ea9-89c9-2b569db7caa3,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958823,1,syn25958823,DoxorubicinMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848643,996597,de6f5a935dde95a25684b97e6998d521,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Doxorubicin,,,,1.63E+12,,,2d9f68d1-7f66-4ae9-b581-51857b6c4b3a,syn25958823,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,50b775b7-750b-4bd5-ab9a-468856023a3f,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958824,1,syn25958824,EpirubicinMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848646,910877,f26fc238a4d1006a09952c713a467ea4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Epirubicin,,,,1.63E+12,,,84c8665c-1ee4-4310-aa14-54eba9a7cb9e,syn25958824,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1e81b482-917f-40a7-9d12-435024e87b1f,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958825,1,syn25958825,EribulinMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848649,1174677,f1d9a91c5126b945f3eb497e0c28cfdf,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Eribulin,,,,1.63E+12,,,5e6eea20-4e43-4917-afdf-cea1bbaf5f50,syn25958825,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,af4158f3-21a6-45cf-8bbe-3e9b894cf13c,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958826,1,syn25958826,ErlotinibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848651,674436,e23bbf9ceaf04e5a90e9d9b7d0fa7a4c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Erlotinib,,,,1.63E+12,,,5eac2d5b-35eb-49dc-8cbe-d0ffbc3030ed,syn25958826,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0211f7c5-b7c3-4d77-915a-1892e5a310c0,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958827,1,syn25958827,EtoposideMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848652,1046667,baa66d9fc50d7f44ac93997467301b30,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Etoposide,,,,1.63E+12,,,a1bc2178-0d76-4d58-b9c9-221e46cc6e70,syn25958827,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,403a78de-5d7d-4e5f-ae8b-14bf2a7bad0f,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958828,1,syn25958828,IfosfamideMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848657,705374,7e47b0dca573887e5b6228e55bb1062f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Ifosfamide,,,,1.63E+12,,,fcf872e0-be81-491f-a287-bd391d729aee,syn25958828,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6fe1fea0-98ba-4d50-ab14-e5e358c8b3a2,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958829,1,syn25958829,IrinotecanMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848659,878210,61e93a9dd93f72d08371183cdf768283,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Irinotecan,,,,1.63E+12,,,d5b13c3e-4377-45e5-baba-bad733a70b67,syn25958829,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b9555de0-836f-4b57-8f82-27de16cc24cb,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958830,1,syn25958830,MirdametinibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848660,770692,0442ab3c0ba63ad480f96dab26dff9e8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,12216270-77db-4e50-9a61-95f14cfe5612,syn25958830,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,97b5d504-b352-410c-869e-f733b492a7e3,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958831,1,syn25958831,OlaparibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848665,906952,271aaa1e877424d3b3c9fb290abdd313,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,908aaac7-397f-4b94-b25d-eacabe27a205,syn25958831,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9a8e4a52-889d-4e5b-81a7-6425fcc0ffd3,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958832,1,syn25958832,RibociclibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848669,827214,0dc94f40e0da57c9829cba3fe140a342,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,2ad98d71-89e9-4239-801b-966f6518b109,syn25958832,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9a74d3f4-d5e4-42f8-9022-38c44d949a6e,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958833,1,syn25958833,RipretinibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848671,1023642,48982539e6e8ef49e410506869d5ae27,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Ripretinib,,,,1.63E+12,,,a739972b-f391-4945-bb7d-f8f34ef8058b,syn25958833,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5858184a-7b6a-4c2d-9821-764e58299071,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958834,1,syn25958834,SapanisertibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848674,458095,f4641a4fac1c453a0c96705e5aded529,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Sapanisertib,,,,1.63E+12,,,8e6475df-fe98-46db-aee8-114536467469,syn25958834,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4bab28e9-96cb-4271-9df7-89b183f17a51,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958835,1,syn25958835,SelumetinibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848676,846378,7096f7d3b90428fd89a0443a8002cccd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,ad10808f-ef36-455f-b51f-7631f14d4f31,syn25958835,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9c5048d1-1dab-48ae-8213-a94d786ba9e7,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958836,1,syn25958836,SHP099MN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848679,454271,5bd8e1eadae4676438c0051cfdeaecaa,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,dc19e94d-a4d3-4ccb-b0e0-54083b18f027,syn25958836,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,42ab4025-4483-4a12-bbee-7258c386b216,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958837,1,syn25958837,SirolimusMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848681,1282640,37f56f69e8fd37103cb88a4176de27ce,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Sirolimus,,,,1.63E+12,,,1264a49a-521c-4c44-9613-bb4b8713aa8b,syn25958837,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1d53bd60-8672-498e-b595-18307935702e,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958838,1,syn25958838,TrabectedinMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848683,1232901,d3c01d047319d881d63bf2e8ebb871c4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,ca65d9e3-1c29-44da-bac5-fa8c719c7920,syn25958838,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ed0bec48-dad2-46c5-9b38-565984b480ba,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958839,1,syn25958839,TrametinibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848685,973221,38447fb2db8c4f53eb0ddd2dea0894d9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,4f937448-35b1-4f1c-8d90-7a1177d9df09,syn25958839,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8755ad38-3d32-4d81-b6fa-2803aae8efa6,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958840,1,syn25958840,VerteporfinMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848687,1311730,6c0e1b77fceb1fa8c37573f84f72b9cc,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Verteporfin,,,,1.63E+12,,,f8e6e8e8-f5b6-4fb5-af0d-0964ba9187db,syn25958840,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0ed4b9ee-45f7-4b72-b391-b284ade1a82d,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958841,1,syn25958841,VorinostatMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848689,681943,4fc54584e331de5476e45f18a35b1e14,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,ff311053-a18f-4e1d-8bd4-886386553d4a,syn25958841,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,cb3ef8a0-896d-4fe9-8dfa-3dfa50bed8e4,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958842,1,syn25958842,BortezomibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848691,597501,da4be8657bf12adf06c96e486887a98f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Bortezomib,,,,1.63E+12,,,6851a711-f67a-42f1-9e21-61cbe9cbe7c7,syn25958842,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,dcb01f8f-85b1-4107-8d70-6a25fdb4402e,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958843,1,syn25958843,BrigatinibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848692,630988,660263087b2fba705a378a12ae8cc21e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Brigatinib,,,,1.63E+12,,,b88cc7c2-d9cd-4244-91f4-a78d763e4679,syn25958843,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2dd01207-db99-42fa-b14c-25a3c7eb5141,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25958844,1,syn25958844,CabozantinibMN2_210526.csv,3D microtissue viability,3418059,file,1,syn25958817,syn21984813,syn21984813,78848693,863074,bc51a7441c65309370acd96305d82ca3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Cabozantinib,,,,1.63E+12,,,022e1e5b-c6da-4e6b-b14d-732382fde5e3,syn25958844,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1914a68e-162f-4a88-a144-48945352fb52,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981457,1,syn25981457,DacarbazineJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067965,413826,80b6907c7609774571dfea4245bdff1f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Dacarbazine,JH-2-002-CL,,,1.63E+12,,,25d11953-cd57-4876-8634-858c91ab6981,syn25981457,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,134b1169-d57c-441a-a95f-e717a2863522,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981458,1,syn25981458,DoxorubicinJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067967,657307,430f930efc586d30ecd71630fd85c6aa,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Doxorubicin,JH-2-002-CL,,,1.63E+12,,,4b3aa29d-c5c4-4cd3-9883-d3e97b90571d,syn25981458,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,2e8ea980-080b-4b3d-8785-db610352a256,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981459,1,syn25981459,EpirubicinJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067969,618922,bd2e10936029cb172197f426a176d878,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Epirubicin,JH-2-002-CL,,,1.63E+12,,,1ed10ce3-1c86-4407-b054-3560f99866fe,syn25981459,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,12625176-c75d-4891-b7e7-014239d11925,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981460,1,syn25981460,EribulinJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067970,692372,e711e3c0f0e3d13d181e8712c5be4ddb,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Eribulin,JH-2-002-CL,,,1.63E+12,,,2e120e3e-a851-4b21-9643-78e67497f575,syn25981460,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,38c71722-bbfe-4bef-b2c8-1ec03ebf088e,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981461,1,syn25981461,IfosfamideJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067973,425571,8bbca81017b4ce1c54481038dde2b5f6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Ifosfamide,JH-2-002-CL,,,1.63E+12,,,10cf6503-e62e-4ae1-bf49-92ceb13ff3a2,syn25981461,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,997ece98-0176-433a-97c7-2084af0c721a,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981462,1,syn25981462,IrinotecanJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067975,445711,fbf6eefeb040d941c69274d6ac241c67,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Irinotecan,JH-2-002-CL,,,1.63E+12,,,cabe5315-71d6-4677-bb2e-3fe4664b94a5,syn25981462,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,b4ad8b7b-f9af-46f4-92f9-2536ee436813,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981463,1,syn25981463,OlaparibJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067977,573185,9fc2b00113bbbbc8cf874fc3dd4d7943,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Olaparib,JH-2-002-CL,,,1.63E+12,,,4c1d544a-54e7-439b-ba60-a2d91fe9e593,syn25981463,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,84364686-e9eb-4b68-9373-61a8d330d43b,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981464,1,syn25981464,RibociclibJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067979,539258,78ef0d7e934219fd4e5972de91dd8402,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Ribociclib,JH-2-002-CL,,,1.63E+12,,,0445e937-960f-4dd2-889b-89c3bc9105fc,syn25981464,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,6add32d8-2c6f-4041-a7bd-d352adad8852,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981465,1,syn25981465,SapanisertibJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067981,493858,1a353837e80f3e184420990dd2e4d368,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Sapanisertib,JH-2-002-CL,,,1.63E+12,,,8dbd3b6b-cef4-4829-91f9-d1f1069ce188,syn25981465,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,4319471b-68ef-4534-9736-446bb7b7a2cf,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981466,1,syn25981466,SelumetinibJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067983,396967,69af31f3b996ac43de9db176d50db188,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Selumetinib,JH-2-002-CL,,,1.63E+12,,,5ee95dd9-aafa-45f6-ac73-e030fdba9e2b,syn25981466,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,c7eba2e7-2a40-45da-afe7-0c6950885110,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981467,1,syn25981467,SHP099JHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067985,434677,f36adceb6370063e2979ada89cd08f31,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,SHP099,JH-2-002-CL,,,1.63E+12,,,cbad3bfa-9c61-4151-b0c4-7fdc092b5cf3,syn25981467,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,a0050a64-87b5-45bc-8d4d-b7232c793810,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981468,1,syn25981468,TrabectedinJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067987,558268,c2276ae5a3bbba692dd2a349a7de79a9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Trabectedin,JH-2-002-CL,,,1.63E+12,,,7134e945-712a-4354-86b7-19e84dfed2d6,syn25981468,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,21843ac9-adba-42ef-9e8f-1a2daef52585,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981469,1,syn25981469,TrametinibJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067988,523467,fc8ec123c74c9e63dbdbd711fdfa5aaa,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Trametinib,JH-2-002-CL,,,1.63E+12,,,885dc4a4-a920-4409-9a56-eb38a7cce3c1,syn25981469,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,b9e3e6fb-e234-483c-917b-6eeaf8d20aa2,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981470,1,syn25981470,VerteporfinJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067991,1154411,4feced709b2e1f5633b411222285d068,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Verteporfin,JH-2-002-CL,,,1.63E+12,,,8159fca6-f3d0-43d1-ad4c-9331febdef9d,syn25981470,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,c35e6a31-6abb-41de-9ae1-a233c8aff37b,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981471,1,syn25981471,VorinostatJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067992,441736,9981d54b29dc411ce982d7203fb42ae4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Vorinostat,JH-2-002-CL,,,1.63E+12,,,f8bb1043-f408-440b-9149-409a741cbb42,syn25981471,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,2256effa-a337-49ea-9f68-c634081c9e9f,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981472,1,syn25981472,BortezomibJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067995,690039,6429224f5cc9c7eb6bf609fadf3ba7ff,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Bortezomib,JH-2-002-CL,,,1.63E+12,,,4c5f35b4-67be-4a68-b6cd-cd337fbefd11,syn25981472,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,3df15bb2-30e7-4e23-9a7a-38ff456d1c66,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981473,1,syn25981473,BrigatinibJHU_002_210609.csv,3D microtissue viability,3418059,file,1,syn25981456,syn21984813,syn21984813,79067996,671836,64fce279abbce082a527088dc9a411ee,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Brigatinib,JH-2-002-CL,,,1.63E+12,,,f7687d37-d50a-45fe-af55-ce0e5454ea3f,syn25981473,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,b8c5a51d-0d1e-489a-a671-8684649cfef3,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981476,1,syn25981476,CarboplatinJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068003,475736,e0985b1b9b130a44e01a02f1f6b296af,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Carboplatin,,,,1.63E+12,,,b01f9f50-1b82-4592-b00d-d5373bb59128,syn25981476,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,571cb0d7-082d-42b8-91e9-66281541a1c7,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981477,1,syn25981477,CerdulatinibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068005,458752,e0ae3b7520c4c5ddff7039a0453e4e59,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Cerdulatinib,,,,1.63E+12,,,0552a668-16dc-4072-8fce-353990ee4fdd,syn25981477,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7fb72af5-205e-4202-8edf-d45bdbdbbb4f,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981478,1,syn25981478,CUDC907JHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068007,678690,51ffcb45415c5d906043db48b0436ab6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,CUDC907,,,,1.63E+12,,,56fc1aa9-0b3f-4b63-8493-8bffb96cd8e2,syn25981478,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d4fa5d1d-4681-4f03-9678-bd6499a91708,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981479,1,syn25981479,DacarbazineJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068009,469038,e89633ede3175aa6085fc47e9eae8ed1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Dacarbazine,,,,1.63E+12,,,228db74c-6746-423c-94da-294a781dadac,syn25981479,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,07249c41-c90a-413f-82a2-233f997cc576,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981480,1,syn25981480,DigoxinJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068011,958370,eccae100d87b6196c2addb719f28148d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,fb31adf0-3e13-465c-8f0c-00e0bdfb76c5,syn25981480,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,407c9da7-48df-4f96-ac09-7efae8e58e47,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981481,1,syn25981481,DoxorubicinJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068013,746364,c953804e4cceed6266ea887b80518561,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Doxorubicin,,,,1.63E+12,,,92420dd9-da2f-489f-ba65-c72472f6094e,syn25981481,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3487216e-49ed-420f-a3ee-08b3cb614a10,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981482,1,syn25981482,EpirubicinJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068015,731671,7d1fc05d9a50aa14b8e4e5bb251d4a9f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Epirubicin,,,,1.63E+12,,,7a7a9c95-d10a-4833-9c2a-06a8d36e599f,syn25981482,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,969b63d9-8189-43ac-9688-977bc2a53fe2,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981483,1,syn25981483,EribulinJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068018,1098746,95c818586df45e284f665e5960e75b12,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Eribulin,,,,1.63E+12,,,fd67c191-c01f-4c5a-97ba-ebff60119f02,syn25981483,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,901f7650-cdbc-412e-b54b-40be4c557084,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981484,1,syn25981484,ErlotinibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068020,575350,ad5a837b63102ba2a61506812a74b951,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Erlotinib,,,,1.63E+12,,,492e4d77-dffb-4f26-aaca-9d1e6d82732d,syn25981484,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9a94458d-98a9-4203-8caa-c80883a1d08d,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981485,1,syn25981485,EtoposideJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068022,761990,f673bb504c6e3e8fb41ce3de4b1f463f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Etoposide,,,,1.63E+12,,,784be8ba-2949-42d6-a725-a8d01bd8c7cd,syn25981485,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f24ee574-00e4-4fc9-b8e3-d6e00796be47,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981486,1,syn25981486,IfosfamideJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068024,497893,208d1278257b8d14e22c11efee1d2b6d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Ifosfamide,,,,1.63E+12,,,7fdd9945-6472-4947-810a-06c42e81007d,syn25981486,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2837ca01-9cb3-460b-874c-6712918c4e7a,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981487,1,syn25981487,IrinotecanJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068026,722506,4e7be9de98e4df627b018f8e0d00f0b6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Irinotecan,,,,1.63E+12,,,47cc5803-a1ed-49a5-870d-072bc9dc91de,syn25981487,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,906d5f08-f7c3-417e-b8c9-137561a4f40d,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981488,1,syn25981488,MirdametinibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068028,652653,129d0d9c8f086bb77c3e868d4df94dcf,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,7bc3ab1b-7b8c-49ee-82c0-671409b081eb,syn25981488,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a3c6fe0e-5b19-4768-af77-765af3332adf,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981489,1,syn25981489,OlaparibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068030,704368,e5d7a996e62569baf573b9c9d808c9bb,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,3f5b5ec8-bfcf-41cf-9ac4-8404d4b59d8c,syn25981489,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,530a1310-0473-40c5-9352-920d7f005671,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981490,1,syn25981490,RibociclibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068032,703810,b8a6140bcb9229cf198043c3f8b22e13,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,e3952c07-ccdd-4d07-a8f5-34ff2ff5a462,syn25981490,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7b7b12dc-0b9c-41a1-9978-7ed6fa966d69,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981491,1,syn25981491,RipretinibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068034,818981,a3fc86cbf6c07b3e116236c61632fe77,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Ripretinib,,,,1.63E+12,,,69a89d59-1b98-4081-addb-16bf9f38bb90,syn25981491,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d0fc1246-e15b-4882-9a5a-b22fa132030d,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981492,1,syn25981492,SapanisertibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068036,515952,bcb52f629906c704e7493877ec7fdf3e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Sapanisertib,,,,1.63E+12,,,435d85bd-374f-4c20-b68d-a8e70d3a448a,syn25981492,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,52a4a553-4e44-4ca0-8990-d7b3891731ce,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981493,1,syn25981493,SelumetinibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068038,642124,bd510cdbb7d0ddfd4290fb70bb69dafc,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,a9eb7490-4ba4-4961-a290-79e7d6b115ce,syn25981493,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4cc5d6e6-4f35-45df-a8ac-b306f71382d3,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981494,1,syn25981494,SHP099JHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068040,541109,87521970e147dafb00d989118abf5c28,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,ed920392-157e-436d-b22c-9d6da5317071,syn25981494,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,70a90775-869c-4f00-b200-9983c5ad6454,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981495,1,syn25981495,SirolimusJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068042,1095695,b6d99fc9d5b26c4aff8bfdad59424b6f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Sirolimus,,,,1.63E+12,,,effa1aad-0529-4f93-8f6b-aae63abfc648,syn25981495,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6c3bcb2a-c6e4-47b3-a84b-2deb3a08b417,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981496,1,syn25981496,TrabectedinJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068044,955143,be33ea0c8b8f234792d9b97fdf3c7242,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,f2de6b5d-cea6-4cad-b9f2-210795524c0f,syn25981496,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6434d9ae-614e-4026-9dfd-888673f59a33,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981497,1,syn25981497,TrametinibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068047,677354,3e496f835aa2c5f7bf425b0443087897,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,9e5b22b9-2430-4446-823a-1b26616b662e,syn25981497,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,24433deb-db87-4630-8405-ddd8eea73b7b,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981498,1,syn25981498,VerteporfinJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068050,1059879,64eac79bfef4f092ce1c759ae823c684,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Verteporfin,,,,1.63E+12,,,6da17f2c-e2dd-4a08-862c-f323de85e90d,syn25981498,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,55e912f7-9317-4671-ac21-97aa7e2ce454,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981499,1,syn25981499,VorinostatJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068052,475149,73c78c3603050da8b5bb5168ac4bbd20,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,e57773ef-5042-454d-8951-e579ed01b352,syn25981499,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,dce642cf-646a-4e43-8183-e4c98be7db92,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981500,1,syn25981500,BortezomibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068054,633936,7d6f2e5027114026519f2f57c3ee6c5a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-MIC,Male,,,,,,microtissue,,,Bortezomib,,,,1.63E+12,,,7dab19ae-93cb-4194-a8a8-f76760239c58,syn25981500,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7b3c1a0b-38cb-4867-825e-ace4ba02450c,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981501,1,syn25981501,BrigatinibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068055,655118,cc2c91e7677479ce0ecf1ca8d2e2c967,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Brigatinib,,,,1.63E+12,,,c720a2fd-ec34-45dc-9b96-6e80a63ff3c5,syn25981501,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,04f8f0bb-3265-4a52-8310-e254f5da717f,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981502,1,syn25981502,CabozantinibJHU_002_210616.csv,3D microtissue viability,3418059,file,1,syn25981474,syn21984813,syn21984813,79068058,655685,2b6e2dd2c23ee1abafd9c74aaea68d83,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Cabozantinib,,,,1.63E+12,,,2ea29ef4-dcba-44a7-a17a-b05e7f0b13e4,syn25981502,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,834ecaf2-8c61-4480-ae66-9a55add557ec,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981505,1,syn25981505,CarboplatinWU_268_210609.csv,3D microtissue viability,3418059,file,1,syn25981504,syn21984813,syn21984813,79068062,528615,7a69a4925179abdb25d278474f6ef3d5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,Carboplatin,,,,1.63E+12,,,cd13ff65-19d2-4517-89ed-00393f3ef7a1,syn25981505,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2f3313ca-7b00-4b4f-a640-2de075f2ff10,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981506,1,syn25981506,CerdulatinibWU_268_210609.csv,3D microtissue viability,3418059,file,1,syn25981504,syn21984813,syn21984813,79068064,657524,bf94e7e88d8f60b1f1c7b3e719b67741,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,Cerdulatinib,,,,1.63E+12,,,6380754d-30e8-4252-92ec-2ff475b35d6a,syn25981506,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,66d06f57-e345-4c05-a8ee-354990c2dcfc,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981507,1,syn25981507,CUDC907WU_268_210609.csv,3D microtissue viability,3418059,file,1,syn25981504,syn21984813,syn21984813,79068066,931020,3a9928edfcfad61d39e7ff7386cf60fd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,CUDC907,,,,1.63E+12,,,77094658-0d12-4453-8cd4-3b80a90c6686,syn25981507,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7dd13233-b591-4278-b950-c8dc9cf86548,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981508,1,syn25981508,DigoxinWU_268_210609.csv,3D microtissue viability,3418059,file,1,syn25981504,syn21984813,syn21984813,79068067,1068225,107a952091e6b679007ea9d7ed983d47,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,a3476d8e-7a29-4530-9f46-4312b1499df2,syn25981508,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,bde49655-b657-4d8e-bf18-ab19f5ece25c,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981509,1,syn25981509,ErlotinibWU_268_210609.csv,3D microtissue viability,3418059,file,1,syn25981504,syn21984813,syn21984813,79068070,754095,ab9e74d08d6d52b4a54978659344134a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,Erlotinib,,,,1.63E+12,,,85e2ab55-16b6-471f-b20f-38ccf3e6d784,syn25981509,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f33e3db6-b487-4725-9c37-b4c48d9911c3,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981510,1,syn25981510,EtoposideWU_268_210609.csv,3D microtissue viability,3418059,file,1,syn25981504,syn21984813,syn21984813,79068072,398633,85cd1e65b83cd43f90bb7779cee1aa8c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,Etoposide,,,,1.63E+12,,,7141db61-2d23-414d-8af6-f720f8108535,syn25981510,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,93d0084a-de91-4bf4-84e4-81a7a9e81126,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981511,1,syn25981511,MirdametinibWU_268_210609.csv,3D microtissue viability,3418059,file,1,syn25981504,syn21984813,syn21984813,79068074,227839,73d694da00788cd64ff5ef2738699448,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,1a970988-c82b-4899-a9be-9ffb902a18ce,syn25981511,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,90ed14e0-d3ac-4853-bb92-cc44156bcdf9,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981512,1,syn25981512,RipretinibWU_268_210609.csv,3D microtissue viability,3418059,file,1,syn25981504,syn21984813,syn21984813,79068078,680867,2a78a22fba90765386435007f9d1c653,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,Ripretinib,,,,1.63E+12,,,960d477e-719d-46e0-bb90-31536bcdd520,syn25981512,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,80f53bee-8eea-4799-bfce-177591559e69,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981513,1,syn25981513,SirolimusWU_268_210609.csv,3D microtissue viability,3418059,file,1,syn25981504,syn21984813,syn21984813,79068080,456939,1a7cf07a350e56484a11256fce1dd685,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,Sirolimus,,,,1.63E+12,,,ded824c6-e277-4be2-a87e-a7bd565ff0d5,syn25981513,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,cb229ca5-eb1f-4d9c-9681-fcfd57174b3f,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981514,1,syn25981514,CabozantinibWU_268_210609.csv,3D microtissue viability,3418059,file,1,syn25981504,syn21984813,syn21984813,79068082,723220,63513a9311e85d395982b26c4fb0b0f4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,Cabozantinib,,,,1.63E+12,,,15f894b3-bb77-4932-b22b-c01babb9f9b3,syn25981514,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2e6cdbcd-ba16-4276-9e7a-7717c9b9d3b8,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981516,1,syn25981516,CUDC907WU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068084,706027,dea2f346a8681c53639a43d3d244c289,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,CUDC907,,,,1.63E+12,,,95059e61-a907-4f3a-aca2-31af51cbae0a,syn25981516,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a4c0d5b9-7bf7-471b-b22b-3786c7421ac6,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981517,1,syn25981517,DacarbazineWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068088,469530,1cf0eadf11e1058ab6d581af7317352a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Dacarbazine,,,,1.63E+12,,,5764a0f2-b6c6-40dc-adf2-f4eb287286e2,syn25981517,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,316df5e4-8d2c-4d2c-b88f-0af06df2ea31,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981518,1,syn25981518,DigoxinWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068091,1017945,96a8dd9bfda24ca97ef6abb59b48ad78,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,6ebbfdb9-90dc-41ae-a65a-8205e0a69843,syn25981518,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,409ad591-7548-4495-9260-0bf5a2e721b9,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981519,1,syn25981519,DoxorubicinWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068094,619801,ae8581d5492850c99322d84603fcd71d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Doxorubicin,,,,1.63E+12,,,69c86de9-c2a5-48b2-b189-e94064927dd8,syn25981519,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5e8ab377-613e-424c-8b9c-8e97dac12c76,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981520,1,syn25981520,EpirubicinWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068096,691784,c82bfff1e04204dbc845e08ce4eb215c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Epirubicin,,,,1.63E+12,,,bf3d31e8-7347-46dd-a5a0-658b7a24e98b,syn25981520,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,01607f0a-16ea-437c-aa21-c377d85442c7,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981521,1,syn25981521,EribulinWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068098,709880,67e6ed7c2d619a6b34e6c994cd5b729b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Eribulin,,,,1.63E+12,,,7acf1f91-14f9-40b7-a053-a0220a26556a,syn25981521,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9155da7b-2c0b-404a-b664-70a2afba6e44,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981522,1,syn25981522,ErlotinibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068100,584759,3627de4c1ff4f2e68d959f78a41cf928,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Erlotinib,,,,1.63E+12,,,a0a1a52b-4157-4645-89f6-66be4ce8ac24,syn25981522,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b1bdadb4-9c89-437a-98ed-ea23d591a9c2,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981523,1,syn25981523,EtoposideWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068102,771166,653557daf28b2fd2c93aa585f36b3da5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Etoposide,,,,1.63E+12,,,ec77dd16-8478-46ff-9d4e-3fa70bd7486d,syn25981523,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8396d09f-7105-41f6-ac76-4778108f2afa,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981524,1,syn25981524,IfosfamideWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068103,366293,194ac9e7d91ad45b0c2c71cdbf11d7fc,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Ifosfamide,,,,1.63E+12,,,29ebaa9e-71db-467c-9e05-b3f3b1e483f9,syn25981524,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,fc388985-5381-4c01-9e2a-5f893ae57320,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981525,1,syn25981525,IrinotecanWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068105,647632,701912e052c5214eec3ece4b32812dc8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Irinotecan,,,,1.63E+12,,,cc9fd6ff-abd1-4cf5-a4f2-751fed620163,syn25981525,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b847aa95-a20b-46cd-b1f0-8b44e3ad6385,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981526,1,syn25981526,MirdametinibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068107,539590,d7df12cb327951ca7240ff7e5ecda7e3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,1bc27a27-7d08-473a-8557-7079d56c343d,syn25981526,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,34ae9679-e732-41a6-aaa9-d36dbecfff5a,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981527,1,syn25981527,OlaparibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068110,501569,663d83080675cf3cd4d65731e0154517,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,84dbf078-48f4-4005-ba0f-5b4504ee97aa,syn25981527,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5df1b808-3d2a-4c5a-bc52-7ac3afc6ce54,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981528,1,syn25981528,RibociclibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068112,601633,de7b69c442ef436152422e32a0f4b617,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,c729f5fb-6f9f-4ed4-86f1-20ddd6f57f4b,syn25981528,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6bbdf4ab-9df8-4146-9d65-58f3755a321b,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981529,1,syn25981529,RipretinibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068114,537454,c67b37f8c5c376f48f6ee86369273ee0,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Ripretinib,,,,1.63E+12,,,550a92ab-7576-47e0-ad6c-0a94c7ac0eaa,syn25981529,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b137425b-3192-4739-96a9-4b5921da4f37,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981530,1,syn25981530,SapanisertibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068115,494103,63bd83f053cc9c92017fcbb1e5377899,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Sapanisertib,,,,1.63E+12,,,21511906-3415-49eb-95cc-3c886b04d932,syn25981530,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9fff835c-3a97-40aa-8b1c-567aac493003,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981531,1,syn25981531,SelumetinibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068117,446174,a9c8e3220cce473c857830bd8046ff0b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,0603977c-86fc-41a2-86ea-d14f16d83a89,syn25981531,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,98925915-d673-4f3c-bf64-56ac083b1ca6,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981532,1,syn25981532,SHP099WU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068119,444186,30bc8a8b7a13055842421513f7b9ff67,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,2a7bc517-8c4c-4ac3-9176-13d4bc800cfe,syn25981532,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ac31b154-88be-4aa8-8051-bb40b957125d,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981533,1,syn25981533,SirolimusWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068122,945872,e714707a06854a1510445b2433bcb9dc,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Sirolimus,,,,1.63E+12,,,1521eefb-7f57-4b09-a2de-7eccfbd0f355,syn25981533,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f7c467d0-0da3-48f4-8191-2635d50bd693,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981534,1,syn25981534,TrabectedinWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068123,707610,37b4f8677f9f4800def49894840f47d4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,a93e3112-250e-43d7-8cf1-8305d955ff94,syn25981534,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,af0d93a6-1161-40cc-8ea5-2ac98b08ae7d,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981535,1,syn25981535,TrametinibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068125,684552,9e54ea5f0c4a372c90f3f33ba205cf18,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,f96da1bb-6753-4fce-8ed7-88424c3721b3,syn25981535,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7bf581d4-ee4b-4b60-b864-b36921da20fd,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981536,1,syn25981536,VerteporfinWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068128,1122150,775568bfa2d303e6833111574d28db02,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Verteporfin,,,,1.63E+12,,,225968d0-73f5-429f-8bce-a852c489d272,syn25981536,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,27e37656-11d5-40fa-96f3-7977603496f1,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981537,1,syn25981537,VorinostatWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068130,521123,620bd011d21acf5c3cead6d0d284c9f5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,5d86b4f4-b16f-44d7-bfd6-c52838a90b21,syn25981537,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c347e435-0c71-4304-8fa3-edc401d15b62,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981538,1,syn25981538,BortezomibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068131,630954,4803c68831036fb4ccd60890ca9bfc70,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Bortezomib,,,,1.63E+12,,,ecf19052-0ec0-4c57-8f06-6cdb9b289c31,syn25981538,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b91ec71e-9d0f-43b5-896e-5d1e88db87c0,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981539,1,syn25981539,BrigatinibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068134,751357,ddeaaea84ab50bed586822c8d7041aad,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Brigatinib,,,,1.63E+12,,,d739b0cf-5c79-4c8b-9530-197ab0034724,syn25981539,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f1e89525-11ab-485c-8af5-0851176e922d,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981540,1,syn25981540,CabozantinibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068135,729366,bd8b9a285b16029446986f03195a1d52,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Cabozantinib,,,,1.63E+12,,,bf5d63d2-1ae2-4842-b2a7-18e040d64296,syn25981540,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,cd8acb56-b554-4088-b025-92ffd3d3f343,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981541,1,syn25981541,CarboplatinWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068138,513848,8ec3c97ab00ccac62d7727059c064d1f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Carboplatin,,,,1.63E+12,,,163e229c-a7d0-43c9-950e-7decd1ff6764,syn25981541,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,20442462-3b66-403f-96d6-9b89a9026b6f,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
25981542,1,syn25981542,CerdulatinibWU_225_210602.csv,3D microtissue viability,3418059,file,1,syn25981515,syn21984813,syn21984813,79068139,632201,e559afc254893c7cdd050e874d2d5f99,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Cerdulatinib,,,,1.63E+12,,,ed004e76-66d8-471a-b9da-f435e0662f34,syn25981542,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4bdf1ab0-976d-4627-8fb5-063233c96ab2,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001025,1,syn26001025,Ribociclib_WU_356_210428_combo.csv,3D microtissue viability,3418059,file,1,syn26001024,syn21984813,syn21984813,79532534,592680,a8737b2d2ccdc425b4ae2d38790f5e63,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,7ffddee0-d58b-4286-8e04-427ce133d582,syn26001025,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,23683f7a-220d-42ec-95a4-67c9fc77eba6,1.65E+12,3434950,WU-356-MIC-combos_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001027,1,syn26001027,Selumetinib_WU_356_210428_combo.csv,3D microtissue viability,3418059,file,1,syn26001024,syn21984813,syn21984813,79532537,501778,a18c6b7686d09c3d1e9793a01d9b8ae7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,20187423-df62-4b2b-8d72-dd40a4978afe,syn26001027,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7731606c-b8b2-44d2-aa1d-7ffd22e7481d,1.65E+12,3434950,WU-356-MIC-combos_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001030,1,syn26001030,SHP099_WU_356_210428_combo.csv,3D microtissue viability,3418059,file,1,syn26001024,syn21984813,syn21984813,79532546,416617,2c6ad1c7d6cc6b8c0e9d2daab6d10678,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,e1ec04b0-8371-4c31-81f4-98762761c651,syn26001030,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4b93e023-98d4-40f0-b502-b30d19716c8a,1.65E+12,3434950,WU-356-MIC-combos_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001032,1,syn26001032,Trabectedin_WU_356_210428_combo.csv,3D microtissue viability,3418059,file,1,syn26001024,syn21984813,syn21984813,79532550,829901,b9b8c5ce66b6874e4ab78be76e61c665,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,886f826f-b47d-4e40-8741-799bcdaf3bac,syn26001032,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c2c0df1b-b3f5-4e7b-b7d9-85014881a05e,1.65E+12,3434950,WU-356-MIC-combos_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001034,1,syn26001034,Trametinib_WU_356_210428_combo.csv,3D microtissue viability,3418059,file,1,syn26001024,syn21984813,syn21984813,79532554,374454,25ac232f7425c5b292c1d80237ec4e63,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,14c7084f-9193-4c84-9098-606f8a6c0f31,syn26001034,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2daf0940-47e2-4c4a-8ffb-cf5b9803c55a,1.65E+12,3434950,WU-356-MIC-combos_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001035,1,syn26001035,Vorinostat_WU_356_210428_combo.csv,3D microtissue viability,3418059,file,1,syn26001024,syn21984813,syn21984813,79532556,327017,d225eb5690f2a7ce4c2867a0771a61aa,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,3d9f20d1-1656-4aec-b411-d662f49ead21,syn26001035,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4bb9343e-c1cc-49d0-821d-a181a4a848b5,1.65E+12,3434950,WU-356-MIC-combos_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001036,1,syn26001036,Olaparib_WU_356_210428_combo.csv,3D microtissue viability,3418059,file,1,syn26001024,syn21984813,syn21984813,79532558,487298,7200ba7be61ee589b2ec04af1859a349,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,322a9959-a3f8-4c23-b933-7a74ea720cab,syn26001036,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2f640eca-85ce-4390-a85d-ddf9785e7cc4,1.65E+12,3434950,WU-356-MIC-combos_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001039,1,syn26001039,SHP099_JHU_2_079_CL_210505_combo.csv,3D microtissue viability,3418059,file,1,syn26001037,syn21984813,syn21984813,79532567,466107,b86bc72f6c31dfcb7e781cd64b00ee76,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Male,,,,,,microtissue,,,SHP099,JH-2-079-CL,,,1.63E+12,,,cc94889e-397c-48cd-b2d8-fd4fc598306b,syn26001039,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,3373759a-ccab-4669-9468-82853934dd87,1.65E+12,3434950,JH-2-079-CL-MIC-combos_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001042,1,syn26001042,Trabectedin_JHU_2_079_CL_210505_combo.csv,3D microtissue viability,3418059,file,1,syn26001037,syn21984813,syn21984813,79532572,618845,688217b0cd00083a216d26139c8c5566,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Male,,,,,,microtissue,,,Trabectedin,JH-2-079-CL,,,1.63E+12,,,13a4064e-0973-4469-bc7e-d968b6d5bd4f,syn26001042,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,64dcde01-eee6-4fce-b15f-0691fb4bb4e0,1.65E+12,3434950,JH-2-079-CL-MIC-combos_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001045,1,syn26001045,Trametinib_JHU_2_079_CL_210505_combo.csv,3D microtissue viability,3418059,file,1,syn26001037,syn21984813,syn21984813,79532583,387136,277c66047ee1e1528479de54ba545cba,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Male,,,,,,microtissue,,,Trametinib,JH-2-079-CL,,,1.63E+12,,,8a686182-3f82-49df-b5f3-39f4246908ec,syn26001045,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,70fb1bb9-dcab-4c1a-89ba-429e4ea2bd47,1.65E+12,3434950,JH-2-079-CL-MIC-combos_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001047,1,syn26001047,Vorinostat_JHU_2_079_CL_210505_combo.csv,3D microtissue viability,3418059,file,1,syn26001037,syn21984813,syn21984813,79532588,589181,7f1e2ada2d8a7759539171ef5527015b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Male,,,,,,microtissue,,,Vorinostat,JH-2-079-CL,,,1.63E+12,,,1a5e7ca5-cf3c-4c65-9ba6-0d82f0e059ee,syn26001047,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,b35d3a94-88ed-4e6b-8eb2-000aa8fe5c08,1.65E+12,3434950,JH-2-079-CL-MIC-combos_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001048,1,syn26001048,Mirdametinib_JHU_2_079_CL_210505_combo.csv,3D microtissue viability,3418059,file,1,syn26001037,syn21984813,syn21984813,79532590,603064,d249063289d33e08c2c1e103e7108395,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Male,,,,,,microtissue,,,Mirdametinib,JH-2-079-CL,,,1.63E+12,,,67b0a409-1ffc-4cbc-b616-029e3b42880c,syn26001048,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,294413d0-efd2-4663-b4fe-f402e1eaec7c,1.65E+12,3434950,JH-2-079-CL-MIC-combos_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001049,1,syn26001049,Olaparib_JHU_2_079_CL_210505_combo.csv,3D microtissue viability,3418059,file,1,syn26001037,syn21984813,syn21984813,79532592,583637,088491a408c91545f18e8127f3f9bcc6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Male,,,,,,microtissue,,,Olaparib,JH-2-079-CL,,,1.63E+12,,,fba2f7f2-6c00-45f7-bf03-3ee5f45bdecc,syn26001049,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,dedcfc63-6149-451c-a9d9-b1b017723dee,1.65E+12,3434950,JH-2-079-CL-MIC-combos_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001050,1,syn26001050,Ribociclib_JHU_2_079_CL_210505_combo.csv,3D microtissue viability,3418059,file,1,syn26001037,syn21984813,syn21984813,79532596,631121,68099ab69bbd09ecc9161bed43dcd2ad,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Male,,,,,,microtissue,,,Ribociclib,JH-2-079-CL,,,1.63E+12,,,1a74a051-aa5b-416b-aac2-ed5361806a80,syn26001050,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,e53800c5-2943-429d-813b-0237a2dc0e6a,1.65E+12,3434950,JH-2-079-CL-MIC-combos_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001051,1,syn26001051,Selumetinib_JHU_2_079_CL_210505_combo.csv,3D microtissue viability,3418059,file,1,syn26001037,syn21984813,syn21984813,79532598,451972,84602c02b664e8b92693cc6fbc555665,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Male,,,,,,microtissue,,,Selumetinib,JH-2-079-CL,,,1.63E+12,,,0f792f01-f3bb-4bbe-8eb5-e65f921d6ada,syn26001051,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,1ce18a95-b7ee-439c-9f64-77351f1a2d0e,1.65E+12,3434950,JH-2-079-CL-MIC-combos_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001053,1,syn26001053,SHP099_MN1_210512_combo.csv,3D microtissue viability,3418059,file,1,syn26001052,syn21984813,syn21984813,79532610,1575733,de1b19b819b88471d1538c15445b5353,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,9a94f161-dfd4-40bd-9173-910b635a922d,syn26001053,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1ec3d01d-b440-48e6-b5cb-86ad53e07030,1.65E+12,3434950,MN-1-MIC-combos_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001057,1,syn26001057,Trabectedin_MN1_210512_combo.csv,3D microtissue viability,3418059,file,1,syn26001052,syn21984813,syn21984813,79532618,809571,bb2a13a1916851c3507378bc3c2c32ed,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,01edc3a9-725e-45d5-9808-546064440959,syn26001057,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ac581e7a-bb70-4962-b8b9-5a5ef3bc6643,1.65E+12,3434950,MN-1-MIC-combos_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001059,1,syn26001059,Trametinib_MN1_210512_combo.csv,3D microtissue viability,3418059,file,1,syn26001052,syn21984813,syn21984813,79532623,1092710,60bb0578ee27b916fa079578d510e559,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,c9c25dd5-7567-44f6-a187-b0a4e0489f38,syn26001059,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,936023d2-425e-42c5-95cb-36181aeaec99,1.65E+12,3434950,MN-1-MIC-combos_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001061,1,syn26001061,Vorinostat_MN1_210512_combo.csv,3D microtissue viability,3418059,file,1,syn26001052,syn21984813,syn21984813,79532628,354139,f9b0e5162be9fde4333c6b785c5b4083,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,675c2f85-b23e-49d6-9c1c-d5ffc6cedcd9,syn26001061,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5a3fafa2-e265-451f-92ed-a66f9a7fd620,1.65E+12,3434950,MN-1-MIC-combos_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001062,1,syn26001062,Mirdametinib_MN1_210512_combo.csv,3D microtissue viability,3418059,file,1,syn26001052,syn21984813,syn21984813,79532630,546155,165b38da388443218bd7cfc626ea156b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,87c172ba-a3c3-4dde-8269-79a26f254af5,syn26001062,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,af688421-5a19-4a4c-877c-bcfe7ee6fec9,1.65E+12,3434950,MN-1-MIC-combos_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001063,1,syn26001063,Olaparib_MN1_210512_combo.csv,3D microtissue viability,3418059,file,1,syn26001052,syn21984813,syn21984813,79532632,644960,3f25e8338d41636b1d25e8a1b5c19110,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,81dca65f-5d3c-49f5-8e36-9ecbdc8632b3,syn26001063,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,68708619-9b6d-4ff2-9a42-b5d0396a2b42,1.65E+12,3434950,MN-1-MIC-combos_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001064,1,syn26001064,Ribociclib_MN1_210512_combo.csv,3D microtissue viability,3418059,file,1,syn26001052,syn21984813,syn21984813,79532634,388722,eb3b558ad6d739ea9c1ce67c650f888d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,ea33fcd3-a1fd-47e5-9213-28678f4d752a,syn26001064,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2ae2912f-c950-4b6c-abff-b37a7392f774,1.65E+12,3434950,MN-1-MIC-combos_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001065,1,syn26001065,Selumetinib_MN1_210512_combo.csv,3D microtissue viability,3418059,file,1,syn26001052,syn21984813,syn21984813,79532636,567440,e9d6ada479b29b0380fc58978ac60193,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,e6b65b86-5114-4429-a4fb-e5fac4089f2c,syn26001065,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1e615fc5-bd6f-4ca5-98dd-865a764f3504,1.65E+12,3434950,MN-1-MIC-combos_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001070,1,syn26001070,Trabectedin_MN3_001_210519_combo.csv,3D microtissue viability,3418059,file,1,syn26001067,syn21984813,syn21984813,79532653,590908,431f65ee99444addfd023fd47a7dfde2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,d1017324-9a91-40a8-848d-bcb5cbdb9732,syn26001070,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ef6d4f55-af9f-4fad-be0d-b16e3b0da9af,1.65E+12,3434950,MN-3-001-MIC-combos_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001072,1,syn26001072,Trametinib_MN3_001_210519_combo.csv,3D microtissue viability,3418059,file,1,syn26001067,syn21984813,syn21984813,79532657,335528,b248f9168b664ad36e01842200ea2efe,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,4876191a-7609-43a1-ba39-27deb49c259c,syn26001072,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,20a169a0-314c-4508-9a4a-4423699facb7,1.65E+12,3434950,MN-3-001-MIC-combos_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001074,1,syn26001074,Vorinostat_MN3_001_210519_combo.csv,3D microtissue viability,3418059,file,1,syn26001067,syn21984813,syn21984813,79532661,273608,4e2313d63a48a9711c77e1a3cd52477b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,18415e19-da89-4fcf-9c9f-b0a45b81fa4d,syn26001074,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,bfa64b09-2c1f-4f63-9cd2-9cf33f9aa8aa,1.65E+12,3434950,MN-3-001-MIC-combos_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001075,1,syn26001075,Mirdametinib_MN3_001_210519_combo.csv,3D microtissue viability,3418059,file,1,syn26001067,syn21984813,syn21984813,79532664,399843,a431fb086f26f5001d097bcada21ca93,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,302c54ce-3a34-4ab8-8b39-2944e03e645a,syn26001075,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1c8baff3-c5e7-4c7c-aab7-42fbc9f2812c,1.65E+12,3434950,MN-3-001-MIC-combos_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001076,1,syn26001076,Olaparib_MN3_001_210519_combo.csv,3D microtissue viability,3418059,file,1,syn26001067,syn21984813,syn21984813,79532665,431224,be165e4f4fa6fc0ea0c9dd9a9464a253,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,4ce91d2d-bfb6-4a4f-9828-dbb46ff5febb,syn26001076,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c9d74dcb-5f6a-4acc-9b6d-90e20dfeff4a,1.65E+12,3434950,MN-3-001-MIC-combos_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001077,1,syn26001077,Ribociclib_MN3_001_210519_combo.csv,3D microtissue viability,3418059,file,1,syn26001067,syn21984813,syn21984813,79532668,328643,f1c3e11484d4af46e92f4d4cb90e067f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,11e761fb-0d5c-4edc-970e-4f64a07f3c16,syn26001077,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5ed1ad16-5eef-4bf5-9eea-142482d1dae8,1.65E+12,3434950,MN-3-001-MIC-combos_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001078,1,syn26001078,Selumetinib_MN3_001_210519_combo.csv,3D microtissue viability,3418059,file,1,syn26001067,syn21984813,syn21984813,79532670,347028,3f7e06a3fb977bcaf89d510f330f61e0,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,ebe1fc04-7e66-47ac-8b69-24876c0cd22d,syn26001078,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,efc37756-7c95-477e-a10c-c896c99ee545,1.65E+12,3434950,MN-3-001-MIC-combos_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001080,1,syn26001080,SHP099_MN3_001_210519_combo.csv,3D microtissue viability,3418059,file,1,syn26001067,syn21984813,syn21984813,79532674,342467,a6e1db0cc81dac74b75f172d53256103,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,28642b40-0b83-42c3-adce-9e887f524231,syn26001080,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9641207b-8e60-45e8-a08c-c11dcc0ece83,1.65E+12,3434950,MN-3-001-MIC-combos_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001083,1,syn26001083,Trabectedin_MN2_210526_combo.csv,3D microtissue viability,3418059,file,1,syn26001082,syn21984813,syn21984813,79532678,1232901,b57d39d1416921991e04cd86e01dc477,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,7f06ab1c-83b5-40a1-aa0b-c9acbc7f19a8,syn26001083,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d611708b-f445-4fec-82de-f1a98586189b,1.65E+12,3434950,MN-2-MIC-combos_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001085,1,syn26001085,Trametinib_MN2_210526_combo.csv,3D microtissue viability,3418059,file,1,syn26001082,syn21984813,syn21984813,79532684,973221,38447fb2db8c4f53eb0ddd2dea0894d9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,72737713-5211-40a1-b9ad-44f19e34dd48,syn26001085,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,448b3ab2-3001-4006-bc0e-3b2b9b3044e1,1.65E+12,3434950,MN-2-MIC-combos_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001087,1,syn26001087,Vorinostat_MN2_210526_combo.csv,3D microtissue viability,3418059,file,1,syn26001082,syn21984813,syn21984813,79532687,681943,4fc54584e331de5476e45f18a35b1e14,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,a880f707-d58c-410d-99ed-649586ca4caa,syn26001087,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a7a2b293-04df-4aed-84ff-5e81ab56c063,1.65E+12,3434950,MN-2-MIC-combos_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001088,1,syn26001088,Mirdametinib_MN2_210526_combo.csv,3D microtissue viability,3418059,file,1,syn26001082,syn21984813,syn21984813,79532690,770692,0442ab3c0ba63ad480f96dab26dff9e8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,d0d4ed7f-fe6d-47b0-abe3-cfdbf6e2e463,syn26001088,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5e352cb6-4c84-4cd5-a6c0-f0db20281e20,1.65E+12,3434950,MN-2-MIC-combos_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001089,1,syn26001089,Olaparib_MN2_210526_combo.csv,3D microtissue viability,3418059,file,1,syn26001082,syn21984813,syn21984813,79532692,906952,271aaa1e877424d3b3c9fb290abdd313,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,34aa72ac-2ac9-4997-9f98-b24ab8e6bf6c,syn26001089,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2054dce2-2e90-45fb-8acc-4d30f6d395a9,1.65E+12,3434950,MN-2-MIC-combos_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001090,1,syn26001090,Ribociclib_MN2_210526_combo.csv,3D microtissue viability,3418059,file,1,syn26001082,syn21984813,syn21984813,79532695,827214,0dc94f40e0da57c9829cba3fe140a342,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,0654150c-8dd0-4324-8f00-969d3674e884,syn26001090,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,291db422-9d5e-428b-9011-2387fc16afdc,1.65E+12,3434950,MN-2-MIC-combos_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001091,1,syn26001091,Selumetinib_MN2_210526_combo.csv,3D microtissue viability,3418059,file,1,syn26001082,syn21984813,syn21984813,79532698,846378,7096f7d3b90428fd89a0443a8002cccd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,697649d6-57c5-43b4-91e7-b15f02d996c4,syn26001091,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,cfdc5a27-165a-4b47-a980-f769966ed09b,1.65E+12,3434950,MN-2-MIC-combos_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001093,1,syn26001093,SHP099_MN2_210526_combo.csv,3D microtissue viability,3418059,file,1,syn26001082,syn21984813,syn21984813,79532702,454271,5bd8e1eadae4676438c0051cfdeaecaa,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,1e177830-bdcb-4952-a09e-d0a915c6fbdb,syn26001093,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,14a0843e-1b39-47b8-ac3e-b90081cb1945,1.65E+12,3434950,MN-2-MIC-combos_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001100,1,syn26001100,SHP099_WU_225_210602_combo.csv,3D microtissue viability,3418059,file,1,syn26001097,syn21984813,syn21984813,79532724,444186,30bc8a8b7a13055842421513f7b9ff67,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,9c09620a-08bb-4be5-9226-45560ceb5e49,syn26001100,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6c02afef-6a86-4a05-bdd3-ceb53bec8b7f,1.65E+12,3434950,WU-225-MIC-combos_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001103,1,syn26001103,Trabectedin_WU_225_210602_combo.csv,3D microtissue viability,3418059,file,1,syn26001097,syn21984813,syn21984813,79532730,707610,37b4f8677f9f4800def49894840f47d4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,f36f75f5-ec76-47d8-92a1-32468c499ccf,syn26001103,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f4910d0f-ed36-4c1e-8cac-d54f10275ea5,1.65E+12,3434950,WU-225-MIC-combos_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001105,1,syn26001105,Trametinib_WU_225_210602_combo.csv,3D microtissue viability,3418059,file,1,syn26001097,syn21984813,syn21984813,79532736,684552,9e54ea5f0c4a372c90f3f33ba205cf18,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,43485519-9357-426a-af1a-be60696d9cb4,syn26001105,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f1c44802-bea7-4333-9f8a-31a4d25342b4,1.65E+12,3434950,WU-225-MIC-combos_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001106,1,syn26001106,Vorinostat_WU_225_210602_combo.csv,3D microtissue viability,3418059,file,1,syn26001097,syn21984813,syn21984813,79532738,521123,620bd011d21acf5c3cead6d0d284c9f5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,cfe8146f-dd30-41a0-9ed9-f73be2b575bf,syn26001106,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6e089071-f585-4c86-b80e-3390b0f68309,1.65E+12,3434950,WU-225-MIC-combos_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001107,1,syn26001107,Mirdametinib_WU_225_210602_combo.csv,3D microtissue viability,3418059,file,1,syn26001097,syn21984813,syn21984813,79532740,539590,d7df12cb327951ca7240ff7e5ecda7e3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,ab9055b1-502b-4553-8544-f62e86dc36f1,syn26001107,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,82108dc1-795b-4a8a-9f7c-e115e2588831,1.65E+12,3434950,WU-225-MIC-combos_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001108,1,syn26001108,Olaparib_WU_225_210602_combo.csv,3D microtissue viability,3418059,file,1,syn26001097,syn21984813,syn21984813,79532742,501569,663d83080675cf3cd4d65731e0154517,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,53ab3b03-6753-426f-bfc4-4f7cfa77efdb,syn26001108,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ab7bd2e4-5bc4-4c69-8155-82c0918a09be,1.65E+12,3434950,WU-225-MIC-combos_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001109,1,syn26001109,Ribociclib_WU_225_210602_combo.csv,3D microtissue viability,3418059,file,1,syn26001097,syn21984813,syn21984813,79532744,601633,de7b69c442ef436152422e32a0f4b617,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,99fd4d9b-e3dd-4a0d-97ff-becf18c2bcca,syn26001109,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,73a2edef-e14c-4da9-8174-7a4e00ec6ebf,1.65E+12,3434950,WU-225-MIC-combos_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001111,1,syn26001111,Selumetinib_WU_225_210602_combo.csv,3D microtissue viability,3418059,file,1,syn26001097,syn21984813,syn21984813,79532747,446174,a9c8e3220cce473c857830bd8046ff0b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,1d4848a5-2a41-4b9f-87b1-0e17f2a191f5,syn26001111,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ad3efa82-c904-4a13-942b-73d57d2f4a0c,1.65E+12,3434950,WU-225-MIC-combos_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001113,1,syn26001113,SHP099_JHU_2_002_CL_210609_combo.csv,3D microtissue viability,3418059,file,1,syn26001112,syn21984813,syn21984813,79532752,434677,f36adceb6370063e2979ada89cd08f31,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,SHP099,JH-2-002-CL,,,1.63E+12,,,3479e1e4-751b-4b2a-8d72-322afe43cadc,syn26001113,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,d2048711-4302-4a49-b450-defca8e76ff5,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001116,1,syn26001116,Trabectedin_JHU_2_002_CL_210609_combo.csv,3D microtissue viability,3418059,file,1,syn26001112,syn21984813,syn21984813,79532758,558268,c2276ae5a3bbba692dd2a349a7de79a9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Trabectedin,JH-2-002-CL,,,1.63E+12,,,84fc1a79-9466-4f33-9f66-eaffacb49b53,syn26001116,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,5aaec15f-813f-493c-a00a-1969b91857fd,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001118,1,syn26001118,Trametinib_JHU_2_002_CL_210609_combo.csv,3D microtissue viability,3418059,file,1,syn26001112,syn21984813,syn21984813,79532762,523467,fc8ec123c74c9e63dbdbd711fdfa5aaa,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Trametinib,JH-2-002-CL,,,1.63E+12,,,f8da5789-c6e3-429b-9bbc-46dbe86764a6,syn26001118,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,6490e115-af72-42d1-90fd-bca9e8364680,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001120,1,syn26001120,Vorinostat_JHU_2_002_CL_210609_combo.csv,3D microtissue viability,3418059,file,1,syn26001112,syn21984813,syn21984813,79532765,441736,9981d54b29dc411ce982d7203fb42ae4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Vorinostat,JH-2-002-CL,,,1.63E+12,,,86496e0f-2a45-4b74-83ae-17aa3aabe2a7,syn26001120,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,33693ebc-28e4-4609-b9f9-29dc40c48a57,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001121,1,syn26001121,Olaparib_JHU_2_002_CL_210609_combo.csv,3D microtissue viability,3418059,file,1,syn26001112,syn21984813,syn21984813,79532768,573185,9fc2b00113bbbbc8cf874fc3dd4d7943,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Olaparib,JH-2-002-CL,,,1.63E+12,,,ab50e9dd-ed7e-4be0-99db-a4480bface65,syn26001121,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,18fc6bae-9b6b-406d-a6cc-9f822edcef8a,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001122,1,syn26001122,Ribociclib_JHU_2_002_CL_210609_combo.csv,3D microtissue viability,3418059,file,1,syn26001112,syn21984813,syn21984813,79532770,539258,78ef0d7e934219fd4e5972de91dd8402,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Ribociclib,JH-2-002-CL,,,1.63E+12,,,929b43e4-c956-43e9-b6f6-c3d8f9b5abab,syn26001122,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,e756eac6-7147-4e78-a00a-6153395edb35,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001123,1,syn26001123,Selumetinib_JHU_2_002_CL_210609_combo.csv,3D microtissue viability,3418059,file,1,syn26001112,syn21984813,syn21984813,79532772,396967,69af31f3b996ac43de9db176d50db188,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,Selumetinib,JH-2-002-CL,,,1.63E+12,,,64213d3c-dd69-487c-a879-3e196cca7aad,syn26001123,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,5d4ce1d1-e9e5-440f-86f3-ee5b0d1a992a,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001126,1,syn26001126,Olaparib_JHU_2_002_210616_combo.csv,3D microtissue viability,3418059,file,1,syn26001125,syn21984813,syn21984813,79532778,760602,cf7fc2fad5c0ed39ca3f70327cdbc965,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,2dd6a045-0dfc-438f-83ad-08db81299342,syn26001126,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,aeee64fa-b5a6-41f5-bccf-8366332d000d,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001128,1,syn26001128,Ribociclib_JHU_2_002_210616_combo.csv,3D microtissue viability,3418059,file,1,syn26001125,syn21984813,syn21984813,79532782,703810,dfcc1a4e55987d0d04a81d70bb6a3aa8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,d912251a-3a09-489a-844f-004ea62b3af4,syn26001128,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a4a245c0-cac8-40e7-bc1a-23411f4fbb3b,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001131,1,syn26001131,Selumetinib_JHU_2_002_210616_combo.csv,3D microtissue viability,3418059,file,1,syn26001125,syn21984813,syn21984813,79532788,642124,9df22320c197c8f915a8ee30366e1990,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,fcfdfc87-0b64-49a1-852a-a4cbd399a6c0,syn26001131,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5819250a-597d-447b-9403-308045a7828d,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001133,1,syn26001133,SHP099_JHU_2_002_210616_combo.csv,3D microtissue viability,3418059,file,1,syn26001125,syn21984813,syn21984813,79532791,541109,88d61e372f9f9db844841bcdb9f5e4d1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,207764f6-32cf-47b2-8f9c-614d35a0bcad,syn26001133,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2f550d57-56dc-4085-92c3-92b46cfa827c,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001136,1,syn26001136,Trabectedin_JHU_2_002_210616_combo.csv,3D microtissue viability,3418059,file,1,syn26001125,syn21984813,syn21984813,79532798,955143,de7c47816dbc40c218c25b177602a590,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,9d8c0288-a922-4496-a588-5f8b5f69ef0f,syn26001136,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f1f291a8-b2c8-478a-81b8-faaf0654b665,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001137,1,syn26001137,Trametinib_JHU_2_002_210616_combo.csv,3D microtissue viability,3418059,file,1,syn26001125,syn21984813,syn21984813,79532800,677354,bd88256f1b9085f8d61f9dc1c463b6ae,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,788bda92-a3a7-411c-80c6-4399addcf63b,syn26001137,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7911e950-1f75-4bfd-966f-62119b52ab69,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001138,1,syn26001138,Vorinostat_JHU_2_002_210616_combo.csv,3D microtissue viability,3418059,file,1,syn26001125,syn21984813,syn21984813,79532801,475149,e129c643fe126ce6e7818bec6b16c279,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,7ddf455b-5cf2-404a-948d-195548bb934a,syn26001138,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0a0cca98-43eb-4297-8119-c24d9e5de74c,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001139,1,syn26001139,Digoxin_JHU_2_002_210616_combo.csv,3D microtissue viability,3418059,file,1,syn26001125,syn21984813,syn21984813,79532804,958370,27de7ada6f738808c8d32757e26f8291,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,08f5cd3e-5252-41a5-bfc2-1df30cec240f,syn26001139,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3e14a609-30dd-4c9b-af12-8dd279a809ca,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001140,1,syn26001140,Mirdametinib_JHU_2_002_210616_combo.csv,3D microtissue viability,3418059,file,1,syn26001125,syn21984813,syn21984813,79532806,652653,3159aec731b99acbfe1a6ee09d806d5e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,64d27a23-51cb-49b5-afcb-0493b9f54dc7,syn26001140,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8708516c-e27d-4579-92c7-09dbcc191bc8,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001151,1,syn26001151,Selumetinib_JHU_2_031_210629_combo.csv,3D microtissue viability,3418059,file,1,syn26001142,syn21984813,syn21984813,79532812,654616,ccd6d930c9de2ff18819ae5843414dde,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,343d356d-9b99-4553-9e1f-a7b6bad095e7,syn26001151,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b1f4c1a4-c3c0-4ee1-9b52-b1c12e7bc19b,1.65E+12,3434950,JH-2-031-MIC-combos_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001153,1,syn26001153,SHP099_JHU_2_031_210629_combo.csv,3D microtissue viability,3418059,file,1,syn26001142,syn21984813,syn21984813,79532816,551566,f6ab017af67633a35042f0aadbd02023,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,19ff58fd-c37d-40a5-9512-45f95aacb27e,syn26001153,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b98a8823-fdfa-4f34-8f75-a8b3782c8149,1.65E+12,3434950,JH-2-031-MIC-combos_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001156,1,syn26001156,Trabectedin_JHU_2_031_210629_combo.csv,3D microtissue viability,3418059,file,1,syn26001142,syn21984813,syn21984813,79532822,925926,cd0036702f8a385467ec10b3c2dfacc3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,090c92d5-0f3a-4401-b0db-dabb8b12b0dd,syn26001156,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,92bc2a8c-8bd5-4baf-8f05-d5fd774051f9,1.65E+12,3434950,JH-2-031-MIC-combos_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001157,1,syn26001157,Trametinib_JHU_2_031_210629_combo.csv,3D microtissue viability,3418059,file,1,syn26001142,syn21984813,syn21984813,79532824,1018595,745286d3ae0f1b59bbd7e5757a310c07,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,e055fd37-f26f-4809-bd3e-9d9ef54199bb,syn26001157,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c3aa55b1-49ac-497e-a017-f20a150e6ceb,1.65E+12,3434950,JH-2-031-MIC-combos_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001158,1,syn26001158,Vorinostat_JHU_2_031_210629_combo.csv,3D microtissue viability,3418059,file,1,syn26001142,syn21984813,syn21984813,79532825,715260,40390dbc90d5750889868af2c6fb67e8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,25117af9-a818-40ae-9b60-a9947da585b2,syn26001158,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e961a9ad-09c6-449a-b024-b7522904765d,1.65E+12,3434950,JH-2-031-MIC-combos_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001159,1,syn26001159,Digoxin_JHU_2_031_210629_combo.csv,3D microtissue viability,3418059,file,1,syn26001142,syn21984813,syn21984813,79532828,1505838,132ae2c1c3304ba5098118ef705e562c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,8bfa431f-489f-4430-be23-9dfd40bec2e7,syn26001159,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ffe53d46-6704-4faa-aea3-15e283c3d6de,1.65E+12,3434950,JH-2-031-MIC-combos_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001160,1,syn26001160,Mirdametinib_JHU_2_031_210629_combo.csv,3D microtissue viability,3418059,file,1,syn26001142,syn21984813,syn21984813,79532829,776805,41aff64123679657261d65ffb1985d84,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,b0eefd6b-7162-48e9-bf41-b222c0cb7912,syn26001160,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,cbd8bb43-8a30-44dc-ab96-61b8b7421a3b,1.65E+12,3434950,JH-2-031-MIC-combos_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001162,1,syn26001162,Olaparib_JHU_2_031_210629_combo.csv,3D microtissue viability,3418059,file,1,syn26001142,syn21984813,syn21984813,79532834,714599,df324405635c3b5b5dd5f9e28cff4cc9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,0184df8c-703b-4cfc-90b0-319ed814685c,syn26001162,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3ed45bc7-187e-4cb8-a8ee-08524b2a677e,1.65E+12,3434950,JH-2-031-MIC-combos_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001164,1,syn26001164,Ribociclib_JHU_2_031_210629_combo.csv,3D microtissue viability,3418059,file,1,syn26001142,syn21984813,syn21984813,79532838,920008,34c5f3d73b8d1ad6ea4abe4e714a93b3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,a0f8a656-f74a-4432-afff-486c01ad7bcf,syn26001164,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,147cc4b9-2fd0-4c29-ad14-708c3602878e,1.65E+12,3434950,JH-2-031-MIC-combos_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001178,1,syn26001178,CerdulatinibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532871,921715,d5af7998e4b90025461e7534a8017657,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Cerdulatinib,,,,1.63E+12,,,e59e2c51-9f91-45f2-96ec-0b8fc85dfbb9,syn26001178,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2715b984-0134-4e28-8a1a-f6fb6b75a023,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001179,1,syn26001179,CUDC907JHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532872,1107289,02b6cde0a4f7cd8596581ee508ba432c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,CUDC907,,,,1.63E+12,,,3bf2a7d1-4f4e-4a1f-9494-bb9e4958cda2,syn26001179,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5a4c0b8b-a8ae-44e4-a062-9667f237ad26,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001180,1,syn26001180,DacarbazineJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532875,628555,389e281083fd65b48937550e9a7bb9cd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Dacarbazine,,,,1.63E+12,,,10545d8e-8c96-4ad7-8d36-28e08e4e722e,syn26001180,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a3a17dfe-9f38-4073-83a6-3b67e01a9ad4,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001181,1,syn26001181,DigoxinJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532878,1505838,132ae2c1c3304ba5098118ef705e562c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,8126125e-0359-4a33-9831-6e0a3bcaa4f8,syn26001181,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b1fad4b5-167e-4936-b552-36a8a8ab3358,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001182,1,syn26001182,DoxorubicinJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532881,1046856,965213665b8ba8c3bcc58a8edf905853,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Doxorubicin,,,,1.63E+12,,,7086b520-f573-4332-822c-447a7c5393c6,syn26001182,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,caa64822-f3fd-45d1-9127-a0e511c72581,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001183,1,syn26001183,EpirubicinJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532883,931985,4d2e1207e1d6ef3824dd78514d465cb8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Epirubicin,,,,1.63E+12,,,302e4fd6-686c-41fb-9632-f535fcb67c7c,syn26001183,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d676227b-3459-4065-a855-d598fe3e41bc,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001184,1,syn26001184,EribulinJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532885,1038397,b11c375e7e7eadfb57ddff2bd3936d29,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Eribulin,,,,1.63E+12,,,2892ca07-d243-437f-847b-391453cdf7b0,syn26001184,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b7ff502a-9345-4fd9-8f2f-4f0e636fc978,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001185,1,syn26001185,ErlotinibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532886,890845,4772afc9b2eba73347b0881a00ffd80f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Erlotinib,,,,1.63E+12,,,a0714457-6458-40ad-afce-05f8101ccb5a,syn26001185,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1d7cd190-e45b-486f-9577-acd90d7be934,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001186,1,syn26001186,EtoposideJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532889,867645,57cfc11295755ad7a21407816aab8b9a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Etoposide,,,,1.63E+12,,,349521c0-ab0e-4be5-8463-f90731404f8d,syn26001186,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f83ed031-dfc6-4c36-a4ea-caabb12e436f,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001187,1,syn26001187,IfosfamideJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532891,608893,0324aa2124e0c8dded59c3be854eadb7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Ifosfamide,,,,1.63E+12,,,9e37b5a3-130d-4922-9130-bffa1d7be33e,syn26001187,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5c500c4b-2837-44f6-8535-e9441ec48a14,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001188,1,syn26001188,IrinotecanJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532893,789964,57375daf35d05fc0d0b0f5a41d183b5f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Irinotecan,,,,1.63E+12,,,5e55663c-d7bc-4698-86d1-62866012e0f4,syn26001188,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,16d8c105-7bd4-435d-be03-14c84b91618a,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001189,1,syn26001189,MirdametinibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532895,776805,41aff64123679657261d65ffb1985d84,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,b66bc433-0b3a-4378-bc41-245fbdc43cfb,syn26001189,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,41f82f3b-f7c0-452b-b706-f4d1be00f690,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001190,1,syn26001190,OlaparibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532897,714599,df324405635c3b5b5dd5f9e28cff4cc9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,23b14a79-e3bb-402c-96bd-207e70c63527,syn26001190,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,03ab2f6c-2ddf-4b81-a753-9af16101a359,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001191,1,syn26001191,RibociclibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532899,920008,34c5f3d73b8d1ad6ea4abe4e714a93b3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,26c555ee-febf-4fae-8c3b-21dd37eade06,syn26001191,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c00e69f3-7a40-49c8-8878-2f90e5639470,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001192,1,syn26001192,RipretinibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532901,484957,88167e8c626a9936e3f6a24f2dd25cc8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Ripretinib,,,,1.63E+12,,,c6d23dc9-be0c-45f1-921b-9e846ff07ac7,syn26001192,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f25184a8-c0b6-4153-bc32-48f663802c87,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001193,1,syn26001193,SapanisertibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532903,693375,a5ebbdf9e48f86d1e2690081201923a9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Sapanisertib,,,,1.63E+12,,,6d5874f8-eb4a-4232-ae05-0e6a84b29890,syn26001193,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e47518f0-ba81-4f00-bf1d-c3ab8be8e377,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001194,1,syn26001194,SelumetinibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532905,654616,ccd6d930c9de2ff18819ae5843414dde,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,ef7d1e81-8420-4841-a9ec-377e002c84f2,syn26001194,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,78936f1f-a0c3-491c-9d5b-b264a1f2fb68,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001195,1,syn26001195,SHP099JHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532907,551566,f6ab017af67633a35042f0aadbd02023,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,SHP099,,,,1.63E+12,,,43cc773c-cd21-46e4-86ae-d331aae1c599,syn26001195,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ed72ec00-f6ea-4b1e-a878-244273535769,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001196,1,syn26001196,SirolimusJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532909,1291293,e8e2e5ea956e0fc10598f7feee809119,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Sirolimus,,,,1.63E+12,,,b7733d55-22e3-4f8e-8a10-2258173a74f5,syn26001196,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,62b883fc-7b95-4643-a16f-28f2c38385c0,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001197,1,syn26001197,TrabectedinJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532911,925926,cd0036702f8a385467ec10b3c2dfacc3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,30e214b6-7ff8-4ac4-a21b-9f26d61b8a64,syn26001197,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,eaec25fc-884d-4ded-b068-a43553d3f1db,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001198,1,syn26001198,TrametinibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532913,1018595,745286d3ae0f1b59bbd7e5757a310c07,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,80d1b1ff-b115-409b-bcfb-f124a1d8a8a9,syn26001198,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,71b7563a-3e98-4ecb-a6e3-21105b5f545d,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001199,1,syn26001199,VerteporfinJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532915,1426134,9b5a2331e27984ec08dc86e8704073a5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Verteporfin,,,,1.63E+12,,,7d1acfbc-2bdb-47cf-a757-0d9d92ee2c3d,syn26001199,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,87027ba4-53f3-4da9-aeee-3964dbb23a43,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001200,1,syn26001200,VorinostatJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532916,715260,40390dbc90d5750889868af2c6fb67e8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,79e717ad-2355-43d1-9f09-fd124dbbb0b7,syn26001200,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d119f840-8238-433a-8381-b1bafd3d7ed8,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001201,1,syn26001201,BortezomibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532919,498272,0318871839db84c2a28279a6f1119655,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Bortezomib,,,,1.63E+12,,,428ee152-a32a-435c-b76e-f9940f39526c,syn26001201,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5c24c0e0-27fe-4db7-8e20-fddef2925758,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001202,1,syn26001202,BrigatinibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532921,677792,27385bf22845c223d961ace03c375f8e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Brigatinib,,,,1.63E+12,,,8daf5f16-7ce5-4f53-8e25-a49736fbd1b3,syn26001202,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5574c652-a885-4cd3-bf18-0d66cb409c03,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001203,1,syn26001203,CabozantinibJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532923,975557,d7e7b704b6c86409989cac70372f6b9f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Cabozantinib,,,,1.63E+12,,,5d1e4970-70dc-4170-8bc6-bd8454289eb9,syn26001203,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,97764ea2-d4c0-435e-b00d-3efc4d2ade69,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26001204,1,syn26001204,CarboplatinJHU_2_031_210629.csv,3D microtissue viability,3418059,file,1,syn26001177,syn21984813,syn21984813,79532925,747832,15ed4d87338f46e7bb0b8e4eb65807fe,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,unknown,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,Carboplatin,,,,1.63E+12,,,f14ab796-5447-4b74-9c6c-f560f1b13d42,syn26001204,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d5702980-abe1-4730-a76d-71cf62220a3a,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379549,1,syn26379549,RibociclibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562965,500680,863b0c71c5b40c8171b24224920db1b6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,,syn26379549,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,cae43538-4158-4418-8b88-8768a24a7b7c,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379550,1,syn26379550,RipretinibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562966,588965,01214e3f3a0b64c5f0fc01a538117264,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Ripretinib,,,,1.63E+12,,,,syn26379550,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,516a4a1f-bb68-4f3c-a48c-01616354a9d1,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379551,1,syn26379551,SapanisertibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562967,447752,572a18183510231a252eb378b1b6c692,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Sapanisertib,,,,1.63E+12,,,,syn26379551,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,219b9aa9-f3e5-468a-8b92-7d4d486da06d,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379552,1,syn26379552,SelumetinibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562968,460103,a3b62d63ccd419593c6a93439a5ffdd3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,,syn26379552,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,64f1cfae-4e18-4b1c-9984-bbada7defb83,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379553,1,syn26379553,SirolimusWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562972,812730,d00d6e5531fd58de30f0cbc95c52a5df,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Sirolimus,,,,1.63E+12,,,,syn26379553,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e61c499f-6b5f-4eaa-bdc1-540bf02206c8,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379554,1,syn26379554,TNO155WU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562974,515351,cd60949eb2e7880f758d976a4b6678c0,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,TNO155,,,,1.63E+12,,,,syn26379554,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,bb55a660-890b-4678-ac2c-1e2aabd9cb6a,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379555,1,syn26379555,TrabectedinWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562977,840430,046f5013d3f0b559c22cf8227ad2e1fb,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,,syn26379555,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e6196961-3ed1-4bdd-a55c-b7ca7d070d68,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379556,1,syn26379556,TrametinibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562978,471276,25187d82f332e198f5e61a34ad0169f5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,,syn26379556,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e1c83550-9719-4aff-a983-f88fb29bf251,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379558,1,syn26379558,VerteporfinWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562981,735544,4f9e78f1802816a4a338556eb8a8d33a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Verteporfin,,,,1.63E+12,,,,syn26379558,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,03e1e4bd-08fd-42be-99f2-5a35af13244f,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379559,1,syn26379559,VorinostatWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562982,450501,d8030dc27a14a19b0483a3a049fc7c3b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,,syn26379559,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b4173b0d-75fc-4192-bcc5-9f6f443a0cad,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379560,1,syn26379560,BortezomibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562985,522481,193a329507899bbdb759be27e18b1e1d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Bortezomib,,,,1.63E+12,,,,syn26379560,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8e564be7-aab9-4e94-915a-56fe31049bea,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379561,1,syn26379561,BrigatinibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562987,587331,e756cd6a0a717300dfdd163e499ccdbb,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Brigatinib,,,,1.63E+12,,,,syn26379561,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,309dea99-5945-4d43-b843-a1daadd8ac4b,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379562,1,syn26379562,CabozantinibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562989,505085,51dc3e5c7f0ed716377d3c36472dc227,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Cabozantinib,,,,1.63E+12,,,,syn26379562,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f3134134-1422-4b27-b7f2-2e071889c021,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379563,1,syn26379563,CarboplatinWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562991,376464,3d70fa1da82aa07b5900697e8735e7a5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Carboplatin,,,,1.63E+12,,,,syn26379563,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ee4631ad-b741-47f2-8019-6ae2b7834acb,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379564,1,syn26379564,CerdulatinibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562993,559732,ace44737770826f1de426cf975885658,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Cerdulatinib,,,,1.63E+12,,,,syn26379564,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e8a009a7-c891-44e8-b635-2ca85cdfd575,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379565,1,syn26379565,CUDC907WU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562995,565627,31a3e81ab42735bbdb50cac859ddea6d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,CUDC907,,,,1.63E+12,,,,syn26379565,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,360226e0-57b5-4856-a3d9-d7601c55b29a,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379566,1,syn26379566,DacarbazineWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562996,360391,76b5fa9b4b1898811c13aa5dec59912c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Dacarbazine,,,,1.63E+12,,,,syn26379566,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e8da98b0-e001-4790-8e75-93f18d98ab54,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379567,1,syn26379567,DigoxinWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83562997,845533,ea9fb1de756644edc6053b526c81f8ce,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,,syn26379567,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,689a42c9-d733-4b5b-b4f8-ce4af9c677e5,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379568,1,syn26379568,DoxorubicinWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83563000,672720,4b3ea1e430a8bacb896400df438c28b4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Doxorubicin,,,,1.63E+12,,,,syn26379568,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,aba689ce-5375-40bc-8004-1518e7566bdc,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379569,1,syn26379569,EpirubicinWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83563002,578285,d620bb1f6dacd74872fd1b9cc4777e05,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Epirubicin,,,,1.63E+12,,,,syn26379569,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7d53e746-84f4-400b-aacc-e2925bee3be7,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379570,1,syn26379570,EribulinWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83563004,840334,b7c1f14c4d644d3f7d06a9c1af325b92,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Eribulin,,,,1.63E+12,,,,syn26379570,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,09be955d-1039-44ac-b1c3-9910450907d5,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379571,1,syn26379571,ErlotinibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83563006,421913,73641425293be459e3cebc973fd4ad91,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Erlotinib,,,,1.63E+12,,,,syn26379571,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2552762b-5e2a-43dd-8ccc-2e3a8ea8d378,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379572,1,syn26379572,EtoposideWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83563009,607694,a63aaa5c765f25b3a686e3dc6ca47a8d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Etoposide,,,,1.63E+12,,,,syn26379572,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,de54e9cd-01cf-41e5-9967-bddbff196217,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379573,1,syn26379573,IfosfamideWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83563010,347078,d73978e7e6186f696de14b0fee4affc1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Ifosfamide,,,,1.63E+12,,,,syn26379573,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,89af3c4e-3ac3-479c-b92c-ffbafc95c4cf,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379574,1,syn26379574,IrinotecanWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83563013,640355,68ba644168b25eaa043353267d5f026d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Irinotecan,,,,1.63E+12,,,,syn26379574,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ce619ee9-4dae-4667-89be-b5e57d1581f1,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379575,1,syn26379575,MirdametinibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83563015,477499,ff318ce44a0c796be16cfe77da38ed3a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,,syn26379575,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,34cc25aa-c4fc-491a-8657-2d7b830496ee,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379576,1,syn26379576,OlaparibWU-225_210901.csv,3D microtissue viability,3418059,file,1,syn26379548,syn21984813,syn21984813,83563017,608234,a3979a74b2f272c7f8641d5a083eb396,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,,syn26379576,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,bdfa0049-8f91-4bdb-881d-9dba36efe118,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379581,1,syn26379581,CabozantinibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563023,327661,a19636069f5406905693fdd06327d9ff,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Cabozantinib,,,,1.63E+12,,,,syn26379581,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b2b7ae59-a674-4310-8fb7-193eaf22a40a,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379582,1,syn26379582,CarboplatinJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563025,247691,197d67dcc4ebc8df79a08e33b29d5c02,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Carboplatin,,,,1.63E+12,,,,syn26379582,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5a50c45a-b4dd-4b1a-a38a-a5639685a5ea,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379583,1,syn26379583,CerdulatinibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563027,313815,195295329e7aacb9f0ddf2e1c89897e3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Cerdulatinib,,,,1.63E+12,,,,syn26379583,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,353b6bd9-4dfd-4e0e-960d-1474b3c5ad32,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379584,1,syn26379584,CUDC907JHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563028,293448,73fd51c9548eb50a5f6658d9271a6806,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,CUDC907,,,,1.63E+12,,,,syn26379584,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3946e781-652b-4666-b320-81390f3e1271,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379585,1,syn26379585,DacarbazineJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563030,138001,ca4d7da548cc47c29ad01fd32385ae7b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Dacarbazine,,,,1.63E+12,,,,syn26379585,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a8df77f7-5ad0-4381-af40-18b8ea79b57a,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379586,1,syn26379586,DigoxinJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563032,440631,c59157cb3a2b8faea60f4745d672b3b1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,,syn26379586,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,58e0ffc9-d4c0-4215-9c06-92b97ed7f5f5,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379587,1,syn26379587,DoxorubicinJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563034,406193,5ede154c4934a3730a16f8ad86880f83,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Doxorubicin,,,,1.63E+12,,,,syn26379587,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,871d6c4c-ca43-431c-8bb2-c0b6fdf38ab2,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379588,1,syn26379588,EpirubicinJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563036,222963,d0d5876532650f66d18d56a167eccc48,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Epirubicin,,,,1.63E+12,,,,syn26379588,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ed2b62f8-732a-48ff-8a30-c34cb88dfc47,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379589,1,syn26379589,EribulinJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563039,349993,df6fbbd6aa783a27303e91883e228fef,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Eribulin,,,,1.63E+12,,,,syn26379589,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,552f395b-39be-44b5-ba6d-fb913a47f5ff,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379590,1,syn26379590,ErlotinibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563040,323809,dd5065a89347d977fcf6f74ecb226fa8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Erlotinib,,,,1.63E+12,,,,syn26379590,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d83f1a05-431c-4be7-8f9e-5c247874172d,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379591,1,syn26379591,EtoposideJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563043,220299,2fdba975c07243fd82362768e0eee553,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Etoposide,,,,1.63E+12,,,,syn26379591,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,cbda4a13-bc1f-459b-86e0-6e2337ea6d5f,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379592,1,syn26379592,IfosfamideJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563045,148238,57e0901d6d516d5e9ab9dd016cb69c84,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Ifosfamide,,,,1.63E+12,,,,syn26379592,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,27ffea4d-83d4-42b5-9851-cf12f6b166cb,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379593,1,syn26379593,IrinotecanJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563047,209830,ddf23358a6fdf5983635ebd46746444a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Irinotecan,,,,1.63E+12,,,,syn26379593,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6c0f6fad-3de6-460b-acbe-6e7c7b8efa29,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379594,1,syn26379594,MirdametinibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563049,192371,86766208ecc1b86a5ccf1ec90244cefd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,,syn26379594,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,137811d2-6909-458f-b6c0-5f51484413d7,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379595,1,syn26379595,OlaparibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563051,199570,064033e196776b403de2c8c8a11ff5b1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,,syn26379595,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ac9cf525-b98a-4586-9b14-5c43187481b8,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379596,1,syn26379596,RibociclibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563052,303498,c72642991d418319ad153ac9638bbeb1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,,syn26379596,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1fa2258d-6774-4544-87a5-c13eb51f460d,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379597,1,syn26379597,RipretinibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563055,208610,17c6f48434c99d5cd4bd1c470b112cf7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,,syn26379597,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,beeb65e5-7627-4acf-a9be-e07cfaf7e1e6,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379598,1,syn26379598,SapanisertibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563056,250868,08afb36246dcf374d95de46cd3898aaf,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Sapanisertib,,,,1.63E+12,,,,syn26379598,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1766a5aa-80a0-495b-9a56-a5d3d761c179,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379599,1,syn26379599,SelumetinibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563058,184180,77592d9a5927f94aa6b8d5445ba338c3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,,syn26379599,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,82358908-9893-49af-92c9-2e1ae3ccb7a6,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379600,1,syn26379600,SirolimusJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563061,333564,b72cc3d5539fa9c79d37efbf7104e01f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Sirolimus,,,,1.63E+12,,,,syn26379600,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3848ef4d-f0bf-43f9-94c8-2bd84d7a632f,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379601,1,syn26379601,TNO155JHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563063,246200,139e9e8dbfb4528fa8cf7ef01a49e90a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,TNO155,,,,1.63E+12,,,,syn26379601,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,531d1248-b50a-4b69-b7ed-3fa89deb2c1f,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379602,1,syn26379602,TrabectedinJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563065,285212,3e9bc6929cda4d42f8ae6139ca3e4c9f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,,syn26379602,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,37ebb851-0a25-40f9-b59c-96426e452f1c,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379603,1,syn26379603,TrametinibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563067,286360,b5c2791c06cf7778578bcb720c30d143,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,,syn26379603,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8b150697-e330-41c2-b8a6-c153f064b1f7,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379604,1,syn26379604,VerteporfinJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563069,409783,8fe37f3a0232267e0f4287497cbafc7f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Verteporfin,,,,1.63E+12,,,,syn26379604,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ea7c3e68-b112-41b6-a997-04f4a9ba745a,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379605,1,syn26379605,VorinostatJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563071,219167,03c13187ca9ddbf1e339158da3e03407,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,,syn26379605,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f9d186c1-b9b3-401b-a06a-858d7c41b68b,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379606,1,syn26379606,BortezomibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563073,259050,50d4769d9da7d6c8df29bf2a50e576f4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Bortezomib,,,,1.63E+12,,,,syn26379606,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e13dca28-f9bf-4d43-b588-172c8fceac93,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379607,1,syn26379607,BrigatinibJHU2079_210930.csv,3D microtissue viability,3418059,file,1,syn26379580,syn21984813,syn21984813,83563075,263900,b1fd0d90a196c86ae18eb4c2aaff07c4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Brigatinib,,,,1.63E+12,,,,syn26379607,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4327bc7d-94d7-4300-9677-def47f17b6bb,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379639,1,syn26379639,Selumetinib_JHU2079_210930_combo.csv,3D microtissue viability,3418059,file,1,syn26379638,syn21984813,syn21984813,83563135,184180,77592d9a5927f94aa6b8d5445ba338c3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,,syn26379639,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b7ec9717-1efc-46e5-85fb-5f0e92f75b0d,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379640,1,syn26379640,Selumetinib_Vorinostat_JHU2079_210930_combo.csv,3D microtissue viability,3418059,file,1,syn26379638,syn21984813,syn21984813,83563137,308128,ce24802cc21d4922b2fba93327aa812b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,,syn26379640,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,bae5d526-887d-441c-a909-a8dab37ad5e5,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379641,1,syn26379641,TNO155_JHU2079_210930_combo.csv,3D microtissue viability,3418059,file,1,syn26379638,syn21984813,syn21984813,83563139,246200,139e9e8dbfb4528fa8cf7ef01a49e90a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,TNO155,,,,1.63E+12,,,,syn26379641,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,dfb7c3d3-4737-433e-bc91-18b1916b9669,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379644,1,syn26379644,Trabectedin_JHU2079_210930_combo.csv,3D microtissue viability,3418059,file,1,syn26379638,syn21984813,syn21984813,83563144,285212,3e9bc6929cda4d42f8ae6139ca3e4c9f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,,syn26379644,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,aa599a42-9a04-4eb7-9461-f898b7c7613d,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379645,1,syn26379645,Trametinib_JHU2079_210930_combo.csv,3D microtissue viability,3418059,file,1,syn26379638,syn21984813,syn21984813,83563147,286360,b5c2791c06cf7778578bcb720c30d143,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,,syn26379645,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5e18adfd-a950-4f3a-b41c-bddebe3e14d4,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379646,1,syn26379646,Vorinostat_JHU2079_210930_combo.csv,3D microtissue viability,3418059,file,1,syn26379638,syn21984813,syn21984813,83563148,218312,d54a70ac1c697f1626fba4ba2d0508cd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,,syn26379646,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1f821b07-192b-4169-9c64-026e408daf1e,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379647,1,syn26379647,Digoxin_JHU2079_210930_combo.csv,3D microtissue viability,3418059,file,1,syn26379638,syn21984813,syn21984813,83563151,440631,c59157cb3a2b8faea60f4745d672b3b1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,,syn26379647,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,55f472a8-cfee-49bc-b591-19a53945e7ef,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379648,1,syn26379648,Mirdametinib_JHU2079_210930_combo.csv,3D microtissue viability,3418059,file,1,syn26379638,syn21984813,syn21984813,83563152,192371,86766208ecc1b86a5ccf1ec90244cefd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,,syn26379648,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a0aa6431-d3fb-425b-a4aa-e5b69680afe0,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379650,1,syn26379650,Olaparib_JHU2079_210930_combo.csv,3D microtissue viability,3418059,file,1,syn26379638,syn21984813,syn21984813,83563157,199570,064033e196776b403de2c8c8a11ff5b1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,,syn26379650,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,357208a0-5df2-439c-8285-d19650a2ce59,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379652,1,syn26379652,Ribociclib_JHU2079_210930_combo.csv,3D microtissue viability,3418059,file,1,syn26379638,syn21984813,syn21984813,83563161,303498,c72642991d418319ad153ac9638bbeb1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,,syn26379652,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,433be408-65af-4c53-97fe-309a95301359,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379661,1,syn26379661,Ribociclib_WU_225_210901_combo.csv,3D microtissue viability,3418059,file,1,syn26379660,syn21984813,syn21984813,83563173,500680,863b0c71c5b40c8171b24224920db1b6,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Ribociclib,,,,1.63E+12,,,,syn26379661,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4431db0b-066b-4cca-a98d-7d6dfeb43d4a,1.65E+12,3434950,WU-225-MIC-combos_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379664,1,syn26379664,Selumetinib_WU_225_210901_combo.csv,3D microtissue viability,3418059,file,1,syn26379660,syn21984813,syn21984813,83563179,460103,a3b62d63ccd419593c6a93439a5ffdd3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Selumetinib,,,,1.63E+12,,,,syn26379664,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c0e00758-8a39-42be-8159-a5dfead061c0,1.65E+12,3434950,WU-225-MIC-combos_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379667,1,syn26379667,TNO155_WU_225_210901_combo.csv,3D microtissue viability,3418059,file,1,syn26379660,syn21984813,syn21984813,83563185,515351,cd60949eb2e7880f758d976a4b6678c0,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,TNO155,,,,1.63E+12,,,,syn26379667,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8a32e816-7241-4e2d-b3ff-92fc1e53d537,1.65E+12,3434950,WU-225-MIC-combos_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379668,1,syn26379668,Trabectedin_WU_225_210901_combo.csv,3D microtissue viability,3418059,file,1,syn26379660,syn21984813,syn21984813,83563186,840430,046f5013d3f0b559c22cf8227ad2e1fb,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Trabectedin,,,,1.63E+12,,,,syn26379668,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c1c422ad-429d-41a0-9a7d-84a88f3546f5,1.65E+12,3434950,WU-225-MIC-combos_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379669,1,syn26379669,Trametinib_WU_225_210901_combo.csv,3D microtissue viability,3418059,file,1,syn26379660,syn21984813,syn21984813,83563188,471276,25187d82f332e198f5e61a34ad0169f5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Trametinib,,,,1.63E+12,,,,syn26379669,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3e03d0f4-5a47-476a-a2a5-3c6cce62cda0,1.65E+12,3434950,WU-225-MIC-combos_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379670,1,syn26379670,Vorinostat_WU_225_210901_combo.csv,3D microtissue viability,3418059,file,1,syn26379660,syn21984813,syn21984813,83563190,448721,c0704c7fa209ac2f910e6141fc863bae,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Vorinostat,,,,1.63E+12,,,,syn26379670,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6fc4d136-c81f-45ef-9b96-038e8782eb91,1.65E+12,3434950,WU-225-MIC-combos_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379671,1,syn26379671,Digoxin_WU_225_210901_combo.csv,3D microtissue viability,3418059,file,1,syn26379660,syn21984813,syn21984813,83563192,845533,ea9fb1de756644edc6053b526c81f8ce,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Digoxin,,,,1.63E+12,,,,syn26379671,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4da81763-d549-43bc-a2fe-3c379a96aea4,1.65E+12,3434950,WU-225-MIC-combos_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379673,1,syn26379673,Mirdametinib_WU_225_210901_combo.csv,3D microtissue viability,3418059,file,1,syn26379660,syn21984813,syn21984813,83563197,477499,ff318ce44a0c796be16cfe77da38ed3a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Mirdametinib,,,,1.63E+12,,,,syn26379673,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,dccb4bb6-c5a7-4eb4-a7ec-44cde2034ec1,1.65E+12,3434950,WU-225-MIC-combos_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26379675,1,syn26379675,Olaparib_WU_225_210901_combo.csv,3D microtissue viability,3418059,file,1,syn26379660,syn21984813,syn21984813,83563201,608234,a3979a74b2f272c7f8641d5a083eb396,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,Olaparib,,,,1.63E+12,,,,syn26379675,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,ced6c186-c4b4-4ded-be6f-38359e7164db,1.65E+12,3434950,WU-225-MIC-combos_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454489,2,syn26454489,DMSO_JHU2079CL_210428.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196672,156067,7d9f73f1d0b4bb36eee1657b109a3fcd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,,,,,,microtissue,,,DMSO,JH-2-079-CL,,,1.64E+12,,,,syn26454489,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,PDX tissue,,,,6b6fff11-1d5f-4787-8876-2e826023ad4e,1.65E+12,3434950,JH-2-079-CL-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454490,2,syn26454490,DMSO_JHU2079CL_210505.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196674,204514,dba54acce5d22ceee3f6868425e35da8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,,,,,,microtissue,,,DMSO,JH-2-079-CL,,,1.64E+12,,,,syn26454490,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,PDX tissue,,,,893d1c1e-1244-4fdb-b700-1cd92ea4872d,1.65E+12,3434950,JH-2-079-CL-MIC_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454491,2,syn26454491,DMSO_JHU2103CL_210406.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196678,1138587,19c784f59ee5ef534561e762039cdd6f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-103,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-103-CL-MIC,Male,,,,,,microtissue,,,DMSO,JH-2-103-CL,,,1.64E+12,,,,syn26454491,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,PDX tissue,,,,1ae6faf4-eb4e-4b3a-952d-1d292a812f0f,1.65E+12,3434950,JH-2-103-CL_210406,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454492,2,syn26454492,DMSO_MN1_210512.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196680,174469,584c372be1b32968bbc12cd4521ba664,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454492,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,ba0ed4fe-7950-4657-995d-5a9296f18a0c,1.65E+12,3434950,MN-1-MIC_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454493,2,syn26454493,DMSO_MN2_210121.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196684,152349,7d016b4cd31f9cadebe8d5ae904c8285,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454493,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,4122b396-c442-44ce-841d-52453c4b5c64,1.65E+12,3434950,MN-2-MIC_210121,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454494,2,syn26454494,DMSO_MN2_210316.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196686,705549,5e880a9e1241fbdd0d4d864590b3a0a2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454494,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,54668cc1-9339-4104-9820-c4c1ac59525e,1.65E+12,3434950,MN-2-MIC_210316,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454495,2,syn26454495,DMSO_MN2_2105266.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196688,87554,dedd5bc473bb44a6d4f57f04de9de443,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454495,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,67d49327-2a3f-49fa-a686-58c74a9a5944,1.65E+12,3434950,MN-2-MIC_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454496,2,syn26454496,DMSO_MN3001_210519.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196700,166815,d51a989c8caf776f546704e0a8aa86de,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,MN-3-100-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454496,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,c5a5c9e1-2269-4996-b4aa-98a064ee90c7,1.65E+12,3434950,MN-3-100-MIC_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454497,2,syn26454497,DMSO_MN3002_210420.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196718,157962,54d2263aeaf886e3ca59892523ef95dc,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,MN-3-200-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454497,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,20b18923-6630-4336-ac1d-586fecfee7b6,1.65E+12,3434950,MN-3-200-MIC_210420,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454500,2,syn26454500,DMSO_WU225_210602.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196748,216541,cbdc074183c12087f96e2a6e461039ba,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454500,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,6314c194-482e-48e2-89f8-599f8b4aeafb,1.65E+12,3434950,WU-225-MIC_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454501,2,syn26454501,DMSO_WU225_210901.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196756,237570,7e460ac08bb31058769144350a396fab,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454501,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,cbf7da7c-817d-4be3-96b6-b74d1de91707,1.65E+12,3434950,WU-225-MIC_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454502,2,syn26454502,DMSO_WU356_210428.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196762,220051,cc463d65418be0b712cc35968588ca1f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454502,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,b55278ae-9bab-4d3d-bfc5-a2dc872fce4d,1.65E+12,3434950,WU-356-MIC_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454503,2,syn26454503,DMSO_WU368_210609.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196766,214471,8728b479451e907f9212e4ee7af5b1f9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU368-003,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,WU-368-MIC,Female,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454503,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,d9a222d4-127d-49af-a7a4-41efa8386958,1.65E+12,3434950,WU-368-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454504,3,syn26454504,DMSO_JHU2002_210616.csv,3D microtissue viability,3418059,file,3,syn26454488,syn21984813,syn21984813,85196652,332407,395b0ea39297d1635c1fc489c3b8ee41,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454504,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,d34ef30b-24fa-434f-a694-f84be1eccf7a,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454505,2,syn26454505,DMSO_JHU2002CL_210413.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196656,379491,249cb47b30d148b5083e4f5ae467024e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,DMSO,JH-2-002-CL,,,1.64E+12,,,,syn26454505,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,PDX tissue,,,,ee59ef49-b1db-4aec-967f-ab1e9e61ae40,1.65E+12,3434950,JH-2-002-CL-MIC_210413,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454506,2,syn26454506,DMSO_JHU2002CL_210609.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196658,119357,a6edf5e60860e9aab197175a0f917415,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,DMSO,JH-2-002-CL,,,1.64E+12,,,,syn26454506,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,PDX tissue,,,,55dce1c5-976f-4620-bb9a-5ec643b8f7f7,1.65E+12,3434950,JH-2-002-CL-MIC_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454507,2,syn26454507,DMSO_JHU2031_210205.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196662,54810,abf76356ae46980522877a9b48b70c7e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454507,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,c21691fa-78ba-4533-816d-37d6b8ee4c09,1.65E+12,3434950,JH-2-031-MIC_210205,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454508,2,syn26454508,DMSO_JHU2031_210629.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196664,395246,0154e16c5b3128f4c478be1688c3e081,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454508,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,51a48475-a163-4b68-a454-c1c4aeaea4da,1.65E+12,3434950,JH-2-031-MIC_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454509,2,syn26454509,DMSO_JHU2079_210930.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196668,135644,c25562a56d3a1766444638c4e4ebf7e2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-MIC,Female,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454509,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,dde52306-4ce5-4bd4-b57f-0f4030e717ae,1.65E+12,3434950,JH-2-079-MIC_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454510,2,syn26454510,DMSO_JHU2079CL_combos_210505.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196676,204514,dba54acce5d22ceee3f6868425e35da8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-CL-MIC,Female,,,,,,microtissue,,,DMSO,JH-2-079-CL,,,1.64E+12,,,,syn26454510,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,PDX tissue,,,,facf92ee-68a2-4858-a3f3-f70bd79d8bd4,1.65E+12,3434950,JH-2-079-CL-MIC -combos_210505,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454511,2,syn26454511,DMSO_MN1_combos_210512.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196682,174469,584c372be1b32968bbc12cd4521ba664,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn1,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,MN-1-MIC,Female,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454511,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,9d9a3f7e-acac-4bdc-b246-2ed888afea0e,1.65E+12,3434950,MN-1-MIC-combos_210512,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454512,2,syn26454512,DMSO_MN2_combos_210526.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196691,87554,dedd5bc473bb44a6d4f57f04de9de443,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,MN-2-MIC,Female,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454512,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,23d5cba1-8948-4c5b-a5e2-b30e3bc031df,1.65E+12,3434950,MN-2-MIC-combos_210526,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454514,2,syn26454514,DMSO_WU225_combos_210602.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196758,216541,cbdc074183c12087f96e2a6e461039ba,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454514,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,61e17f59-e974-435b-90d7-1efeacdef41b,1.65E+12,3434950,WU-225-MIC-combos_210602,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454515,2,syn26454515,DMSO_WU225_combos_210901.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196760,237570,7e460ac08bb31058769144350a396fab,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU225-001,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,WU-225-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454515,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,322dbd18-3e0b-443c-80da-4a0d23e12674,1.65E+12,3434950,WU-225-MIC-combos_210901,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454516,2,syn26454516,DMSO_WU356_combos_210428.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196764,220051,cc463d65418be0b712cc35968588ca1f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU356-002,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454516,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,f5b49bfe-c7ea-4338-81ed-cef92cda978c,1.65E+12,3434950,WU-356-MIC-combos_210428,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454517,2,syn26454517,DMSO_JHU2002_combos_210616.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196654,334690,946de53aeaf1c0ed475300773b304626,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JHU-2-002-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454517,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,798179e8-9947-41ef-abbb-767e5bbcbe00,1.65E+12,3434950,JH-2-002_210616,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454518,2,syn26454518,DMSO_JHU2002CL_combos_210609.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196660,120260,bd148a1d198d999eb89837004f311e09,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-002-CL-MIC,Male,,,,,,microtissue,,,DMSO,JH-2-002-CL,,,1.64E+12,,,,syn26454518,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,PDX tissue,,,,d5782b2f-1e83-4d97-b2f5-e56fb56ed828,1.65E+12,3434950,JH-2-002-CL-MIC-combos_210609,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454519,2,syn26454519,DMSO_JHU2031_combos_210629.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196666,395246,0154e16c5b3128f4c478be1688c3e081,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU031-030,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-031-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454519,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,2cd4c07d-c0c6-42d3-9e23-5b4c312936e8,1.65E+12,3434950,JH-2-031-MIC-combos_210629,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454520,2,syn26454520,DMSO_JHU2079_combos_210930.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196670,135644,c25562a56d3a1766444638c4e4ebf7e2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,JH-2-079-MIC,Female,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454520,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,ae87d3fe-7eee-47a1-b32f-4ff34bdc91bf,1.65E+12,3434950,JH-2-079-MIC-combos_210930,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26454521,2,syn26454521,DMSO_MN3001_combos_210519.csv,3D microtissue viability,3418059,file,2,syn26454488,syn21984813,syn21984813,85196709,166815,d51a989c8caf776f546704e0a8aa86de,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn3_pdx_rpt,-/-,+/+,Homo sapiens,experimentalData,,,syn21984813,MN-3-001-MIC,Male,,,,,,microtissue,,,DMSO,,,,1.64E+12,,,,syn26454521,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,PDX tissue,,,,dca08bdc-79de-43b0-95ed-46f6d40a4672,1.65E+12,3434950,MN-3-001-MIC-combos_210519,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997054,1,syn26997054,DMSOMN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943541,52690,f1fc7de8f6a4b94a5d591fc9f1e2e828,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,DMSO,,,,1.64E+12,,,,syn26997054,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,550dceda-f0fd-4cfe-9e70-01855d38c3f8,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997056,1,syn26997056,MirdametinibMN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943543,185274,524de8e12babc42cae8689155e325ae3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Mirdametinib,,,,1.64E+12,,,,syn26997056,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,5d0ee7da-de4b-4277-b891-3aba911e0c37,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997057,1,syn26997057,OlaparibMN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943544,172832,8fdcd868565fcc6e01149186c6c5984b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Olaparib,,,,1.64E+12,,,,syn26997057,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,05fda919-99d9-479e-a81d-0f1f308f4550,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997058,1,syn26997058,RibociclibMN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943548,232708,75502d0d0aad3f19e1de7c8d4b019fde,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Ribociclib,,,,1.64E+12,,,,syn26997058,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7a9e63af-50fc-4144-a914-3d48e9af3eba,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997059,1,syn26997059,SelumetinibMN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943550,187661,f4106383af08997e040288697faaa9c1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Selumetinib,,,,1.64E+12,,,,syn26997059,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e1be0ff8-3d6c-4a41-a61d-6981af7e876a,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997060,1,syn26997060,TNO155MN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943551,225969,c88dbccb6e9a626c399121ea9949f70f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,TNO155,,,,1.64E+12,,,,syn26997060,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,c04ec7ee-6b12-4c62-a728-0dacd9e7d486,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997061,1,syn26997061,TrabectedinMN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943553,53707,97c25677366cb66773b4dc012a7b566b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Trabectedin,,,,1.64E+12,,,,syn26997061,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,fa735481-abaa-4d6b-8472-b17f9359d2ca,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997062,1,syn26997062,TrametinibMN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943555,216528,83ef23588ce7509e22410d9e1612fa93,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Trametinib,,,,1.64E+12,,,,syn26997062,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,349642e4-24df-4ed1-af68-9b3e040aac43,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997064,1,syn26997064,VorinostatMN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943558,165594,6cfafde2711e8c5f1ac995de39024f06,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Vorinostat,,,,1.64E+12,,,,syn26997064,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a213d688-1d82-466d-ba10-aff404b19bb4,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997065,1,syn26997065,CUDC907MN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943561,172583,2ab3b945c99899bba6c632245411874a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,CUDC907,,,,1.64E+12,,,,syn26997065,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,07c61817-06c7-4ee7-a46f-b2c3272f85c6,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997066,1,syn26997066,DigoxinMN2_48hr_211102.csv,3D microtissue viability,3418059,file,1,syn26997051,syn21984813,syn21984813,87943562,337484,4764012059bd0cb91ac6ffd9157a0266,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Digoxin,,,,1.64E+12,,,,syn26997066,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,fb2f3a7c-8d20-42ec-be45-482c22a47dde,1.65E+12,3434950,MN-2_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997076,1,syn26997076,MirdametinibJH2002_CL_48hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997073,syn21984813,syn21984813,87943573,135179,0a7836ef81efa37aa23196660a462161,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Mirdametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997076,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,9a720f51-9db2-4041-9065-17401975baa6,1.65E+12,3434950,JH-2-002-CL_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997077,1,syn26997077,OlaparibJH2002_CL_48hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997073,syn21984813,syn21984813,87943575,168102,c2d2743d27f1918a4bac3efe0dde0d27,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Olaparib,JH-2-002-CL,,,1.64E+12,,,,syn26997077,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,cc9c33ca-36fe-4f53-bd50-0ba9cc6a1850,1.65E+12,3434950,JH-2-002-CL_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997078,1,syn26997078,RibociclibJH2002_CL_48hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997073,syn21984813,syn21984813,87943576,174747,d8690b10e73f938e1f90d1ce236550cb,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Ribociclib,JH-2-002-CL,,,1.64E+12,,,,syn26997078,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,e3e74e6a-096d-4663-951e-a01fc269df07,1.65E+12,3434950,JH-2-002-CL_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997079,1,syn26997079,SelumetinibJH2002_CL_48hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997073,syn21984813,syn21984813,87943578,133326,f8d278c75899adf307043cdce2dca16f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Selumetinib,JH-2-002-CL,,,1.64E+12,,,,syn26997079,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,c9bd5a48-1291-47e9-81d1-c97eb81e9e57,1.65E+12,3434950,JH-2-002-CL_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997080,1,syn26997080,TrabectedinJH2002_CL_48hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997073,syn21984813,syn21984813,87943581,52574,c0903a8fbc234701af924c414ae41dd3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trabectedin,JH-2-002-CL,,,1.64E+12,,,,syn26997080,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,e843b7d1-01ff-48d8-af88-4f5d39d854ca,1.65E+12,3434950,JH-2-002-CL_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997081,1,syn26997081,TrametinibJH2002_CL_48hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997073,syn21984813,syn21984813,87943583,156543,6cff0f88a650add457ae9ed370bf2d52,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997081,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,275d95f4-c681-4418-a974-fa9f641c385f,1.65E+12,3434950,JH-2-002-CL_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997083,1,syn26997083,VorinostatJH2002_CL_48hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997073,syn21984813,syn21984813,87943586,138737,2fdc858171f6810b0d18f9a3e738c8c8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Vorinostat,JH-2-002-CL,,,1.64E+12,,,,syn26997083,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,326996b2-519c-4816-af8b-5b5ff1da6b76,1.65E+12,3434950,JH-2-002-CL_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997084,1,syn26997084,DigoxinJH2002_CL_48hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997073,syn21984813,syn21984813,87943588,242358,f04a3ae19204f93a8870fc65c1048fd7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Digoxin,JH-2-002-CL,,,1.64E+12,,,,syn26997084,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,234bd558-fe51-4fc0-89c7-bc624919c6e8,1.65E+12,3434950,JH-2-002-CL_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997085,1,syn26997085,DMSOJH2002_CL_48hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997073,syn21984813,syn21984813,87943590,55370,52dbc17c2fe39e18cce535da5ffd41db,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,DMSO,JH-2-002-CL,,,1.64E+12,,,,syn26997085,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,7ccc30b5-1e84-4dd4-a44d-f47d2fa16fc0,1.65E+12,3434950,JH-2-002-CL_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997103,1,syn26997103,MirdametinibJH2002_CL_72hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997097,syn21984813,syn21984813,87943609,193344,7c24e77abe9dbec081347f5c2b49c9b2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Mirdametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997103,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,950586c0-7ba7-4bbd-bffa-9c9c1d3df469,1.65E+12,3434950,JH-2-002-CL_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997105,1,syn26997105,OlaparibJH2002_CL_72hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997097,syn21984813,syn21984813,87943612,174878,225bda0e44e73b9fa7221cbdefe48078,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Olaparib,JH-2-002-CL,,,1.64E+12,,,,syn26997105,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,dcf039d8-2c00-4d51-9143-91c529fef0b0,1.65E+12,3434950,JH-2-002-CL_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997106,1,syn26997106,RibociclibJH2002_CL_72hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997097,syn21984813,syn21984813,87943613,262870,f0de2fa74406a1724b0f508581bcc438,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Ribociclib,JH-2-002-CL,,,1.64E+12,,,,syn26997106,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,85156b43-ffa9-4eb1-b1db-acc0357caa25,1.65E+12,3434950,JH-2-002-CL_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997107,1,syn26997107,SelumetinibJH2002_CL_72hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997097,syn21984813,syn21984813,87943617,191759,dc95810a9d3f8f15dd5220b953aa6504,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Selumetinib,JH-2-002-CL,,,1.64E+12,,,,syn26997107,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,aab1b164-f7de-4d84-b5d5-2a27699d3c2b,1.65E+12,3434950,JH-2-002-CL_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997108,1,syn26997108,TrabectedinJH2002_CL_72hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997097,syn21984813,syn21984813,87943618,58887,acdf0c15d6ba929a17d57ed4f215e2ee,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trabectedin,JH-2-002-CL,,,1.64E+12,,,,syn26997108,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,7e64e2b9-91b8-445f-b03b-fd633ca4dfcc,1.65E+12,3434950,JH-2-002-CL_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997109,1,syn26997109,TrametinibJH2002_CL_72hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997097,syn21984813,syn21984813,87943620,186843,96ee4421a6cbe3f43192eb94762ee94c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997109,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,f4a296be-e725-423a-af5c-a417078a472a,1.65E+12,3434950,JH-2-002-CL_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997111,1,syn26997111,VorinostatJH2002_CL_72hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997097,syn21984813,syn21984813,87943624,181323,07d193e4956392998c64020378460819,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Vorinostat,JH-2-002-CL,,,1.64E+12,,,,syn26997111,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,68a1df97-96eb-42db-9a52-d36baa59fff7,1.65E+12,3434950,JH-2-002-CL_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997112,1,syn26997112,CUDC907JH2002_CL_72hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997097,syn21984813,syn21984813,87943625,254012,357ff5c87f39c11db9d3721aaa55c58b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,CUDC907,JH-2-002-CL,,,1.64E+12,,,,syn26997112,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,985b01f3-8c7b-4218-bce8-00915fa872f7,1.65E+12,3434950,JH-2-002-CL_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997113,1,syn26997113,DigoxinJH2002_CL_72hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997097,syn21984813,syn21984813,87943627,323527,6e235b448f6978833c00970fad07cc5a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Digoxin,JH-2-002-CL,,,1.64E+12,,,,syn26997113,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,615ccf9d-7847-4ca4-b72e-a80dab9869ff,1.65E+12,3434950,JH-2-002-CL_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997114,1,syn26997114,DMSOJH2002_CL_72hr_211116.csv,3D microtissue viability,3418059,file,1,syn26997097,syn21984813,syn21984813,87943629,44881,f9d97b6434a2120a0f32dbbbd159dc58,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,DMSO,JH-2-002-CL,,,1.64E+12,,,,syn26997114,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,6135f89b-b4e0-4d47-9499-7ffdda49849a,1.65E+12,3434950,JH-2-002-CL_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997131,1,syn26997131,Mirdametinib_211102_48hr_MN2_combos.csv,3D microtissue viability,3418059,file,1,syn26997128,syn21984813,syn21984813,87943647,185274,524de8e12babc42cae8689155e325ae3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Mirdametinib,,,,1.64E+12,,,,syn26997131,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,215c8c4a-02c1-4e70-98c3-97c5b1bb5a6a,1.65E+12,3434950,MN-2_combos_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997133,1,syn26997133,Olaparib_211102_48hr_MN2_combos.csv,3D microtissue viability,3418059,file,1,syn26997128,syn21984813,syn21984813,87943650,172832,8fdcd868565fcc6e01149186c6c5984b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Olaparib,,,,1.64E+12,,,,syn26997133,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4740b94c-f106-49e0-acf3-ada2d30cb91c,1.65E+12,3434950,MN-2_combos_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997135,1,syn26997135,Ribociclib_211102_48hr_MN2_combos.csv,3D microtissue viability,3418059,file,1,syn26997128,syn21984813,syn21984813,87943655,232708,75502d0d0aad3f19e1de7c8d4b019fde,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Ribociclib,,,,1.64E+12,,,,syn26997135,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,f25a7ead-29a0-4e81-8e96-99fa6a2a9d53,1.65E+12,3434950,MN-2_combos_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997137,1,syn26997137,Selumetinib_211102_48hr_MN2_combos.csv,3D microtissue viability,3418059,file,1,syn26997128,syn21984813,syn21984813,87943658,187661,f4106383af08997e040288697faaa9c1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Selumetinib,,,,1.64E+12,,,,syn26997137,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,780be203-94bb-457e-910b-91667405efa2,1.65E+12,3434950,MN-2_combos_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997141,1,syn26997141,TNO155_211102_48hr_MN2_combos.csv,3D microtissue viability,3418059,file,1,syn26997128,syn21984813,syn21984813,87943666,225969,c88dbccb6e9a626c399121ea9949f70f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,TNO155,,,,1.64E+12,,,,syn26997141,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,850bdc1f-f85a-432f-8afb-5cd1f66d5a6c,1.65E+12,3434950,MN-2_combos_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997144,1,syn26997144,Trabectedin_211102_48hr_MN2_combos.csv,3D microtissue viability,3418059,file,1,syn26997128,syn21984813,syn21984813,87943672,53707,97c25677366cb66773b4dc012a7b566b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Trabectedin,,,,1.64E+12,,,,syn26997144,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,91463582-86c9-4985-bd0f-8bc247b96456,1.65E+12,3434950,MN-2_combos_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997145,1,syn26997145,Trametinib_211102_48hr_MN2_combos.csv,3D microtissue viability,3418059,file,1,syn26997128,syn21984813,syn21984813,87943674,216528,83ef23588ce7509e22410d9e1612fa93,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Trametinib,,,,1.64E+12,,,,syn26997145,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,437d0680-4031-4942-8c5e-f5905a7975f9,1.65E+12,3434950,MN-2_combos_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997146,1,syn26997146,Vorinostat_211102_48hr_MN2_combos.csv,3D microtissue viability,3418059,file,1,syn26997128,syn21984813,syn21984813,87943676,165594,6cfafde2711e8c5f1ac995de39024f06,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Vorinostat,,,,1.64E+12,,,,syn26997146,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,930604c6-4ece-41df-9988-9b3fa9f66669,1.65E+12,3434950,MN-2_combos_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997148,1,syn26997148,Digoxin_211102_48hr_MN2_combos.csv,3D microtissue viability,3418059,file,1,syn26997128,syn21984813,syn21984813,87943679,337484,4764012059bd0cb91ac6ffd9157a0266,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,Digoxin,,,,1.64E+12,,,,syn26997148,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,fad0d994-104a-40f5-a6f7-ddef8b332e49,1.65E+12,3434950,MN-2_combos_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997149,1,syn26997149,DMSO_211102_48hr_MN2_combos.csv,3D microtissue viability,3418059,file,1,syn26997128,syn21984813,syn21984813,87943680,52690,f1fc7de8f6a4b94a5d591fc9f1e2e828,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",mn2_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,MN-2-MIC,Female,,,,,,,,,DMSO,,,,1.64E+12,,,,syn26997149,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e3b8d62c-87e2-4187-833d-bdae52aaa206,1.65E+12,3434950,MN-2_combos_211102_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997154,1,syn26997154,DMSO_211116_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997152,syn21984813,syn21984813,87943692,55370,52dbc17c2fe39e18cce535da5ffd41db,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,DMSO,JH-2-002-CL,,,1.64E+12,,,,syn26997154,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,bfffdd1a-c1cd-4679-966b-a72b5712e9a0,1.65E+12,3434950,JH-2-002-CL_combos_211116_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997155,1,syn26997155,Mirdametinib_211116_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997152,syn21984813,syn21984813,87943694,135179,0a7836ef81efa37aa23196660a462161,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Mirdametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997155,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,c2e4c541-7ec4-4a3e-8005-720fa8b47dcf,1.65E+12,3434950,JH-2-002-CL_combos_211116_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997158,1,syn26997158,Olaparib_211116_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997152,syn21984813,syn21984813,87943700,168102,c2d2743d27f1918a4bac3efe0dde0d27,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Olaparib,JH-2-002-CL,,,1.64E+12,,,,syn26997158,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,443755ed-28f2-4a5d-aa64-53b99c44c7bd,1.65E+12,3434950,JH-2-002-CL_combos_211116_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997161,1,syn26997161,Ribociclib_211116_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997152,syn21984813,syn21984813,87943705,174747,d8690b10e73f938e1f90d1ce236550cb,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Ribociclib,JH-2-002-CL,,,1.64E+12,,,,syn26997161,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,d91484ad-cd2e-492f-8904-ceeeb2506701,1.65E+12,3434950,JH-2-002-CL_combos_211116_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997163,1,syn26997163,Selumetinib_211116_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997152,syn21984813,syn21984813,87943708,133326,f8d278c75899adf307043cdce2dca16f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Selumetinib,JH-2-002-CL,,,1.64E+12,,,,syn26997163,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,8abad12d-5888-46c3-98dd-8a42ea6f630a,1.65E+12,3434950,JH-2-002-CL_combos_211116_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997166,1,syn26997166,Trabectedin_211116_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997152,syn21984813,syn21984813,87943715,52574,c0903a8fbc234701af924c414ae41dd3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trabectedin,JH-2-002-CL,,,1.64E+12,,,,syn26997166,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,59573f15-4d70-48ac-8bbd-90378a7ef71f,1.65E+12,3434950,JH-2-002-CL_combos_211116_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997167,1,syn26997167,Trametinib_211116_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997152,syn21984813,syn21984813,87943717,156543,6cff0f88a650add457ae9ed370bf2d52,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997167,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,0da46262-4a3b-4fe9-800a-750dfe32dad5,1.65E+12,3434950,JH-2-002-CL_combos_211116_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997168,1,syn26997168,Vorinostat_211116_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997152,syn21984813,syn21984813,87943719,138737,2fdc858171f6810b0d18f9a3e738c8c8,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Vorinostat,JH-2-002-CL,,,1.64E+12,,,,syn26997168,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,6d8947e5-887e-41f9-9620-2bb251e39069,1.65E+12,3434950,JH-2-002-CL_combos_211116_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997169,1,syn26997169,Digoxin_211116_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997152,syn21984813,syn21984813,87943720,242358,f04a3ae19204f93a8870fc65c1048fd7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Digoxin,JH-2-002-CL,,,1.64E+12,,,,syn26997169,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,ca52b4cb-f2f9-4a0e-b203-429a49218107,1.65E+12,3434950,JH-2-002-CL_combos_211116_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997175,1,syn26997175,Mirdametinib_211116_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997173,syn21984813,syn21984813,87943727,193344,7c24e77abe9dbec081347f5c2b49c9b2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Mirdametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997175,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,68c4a945-02f8-491e-a322-f396f286afaa,1.65E+12,3434950,JH-2-002-CL_combos_211116_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997178,1,syn26997178,Olaparib_211116_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997173,syn21984813,syn21984813,87943732,174878,225bda0e44e73b9fa7221cbdefe48078,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Olaparib,JH-2-002-CL,,,1.64E+12,,,,syn26997178,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,708d3c27-8f8b-4a33-b3ac-97d581c6a150,1.65E+12,3434950,JH-2-002-CL_combos_211116_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997180,1,syn26997180,Ribociclib_211116_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997173,syn21984813,syn21984813,87943737,262870,f0de2fa74406a1724b0f508581bcc438,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Ribociclib,JH-2-002-CL,,,1.64E+12,,,,syn26997180,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,1b813036-107c-4a92-9b2a-a11abe8b29fd,1.65E+12,3434950,JH-2-002-CL_combos_211116_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997183,1,syn26997183,Selumetinib_211116_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997173,syn21984813,syn21984813,87943741,191759,dc95810a9d3f8f15dd5220b953aa6504,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Selumetinib,JH-2-002-CL,,,1.64E+12,,,,syn26997183,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,197297c9-6c9f-4630-8b25-d565be9b0ca9,1.65E+12,3434950,JH-2-002-CL_combos_211116_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997186,1,syn26997186,Trabectedin_211116_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997173,syn21984813,syn21984813,87943747,58887,acdf0c15d6ba929a17d57ed4f215e2ee,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trabectedin,JH-2-002-CL,,,1.64E+12,,,,syn26997186,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,e6488f66-cf4f-400b-9033-69101c108fc9,1.65E+12,3434950,JH-2-002-CL_combos_211116_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997187,1,syn26997187,Trametinib_211116_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997173,syn21984813,syn21984813,87943750,186843,96ee4421a6cbe3f43192eb94762ee94c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997187,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,72875973-314d-414b-9f69-c183efe098d5,1.65E+12,3434950,JH-2-002-CL_combos_211116_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997191,1,syn26997191,Vorinostat_211116_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997173,syn21984813,syn21984813,87943754,181323,07d193e4956392998c64020378460819,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Vorinostat,JH-2-002-CL,,,1.64E+12,,,,syn26997191,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,e00bd366-293b-4493-92fa-450b8d9da03c,1.65E+12,3434950,JH-2-002-CL_combos_211116_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997193,1,syn26997193,Digoxin_211116_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997173,syn21984813,syn21984813,87943758,323527,6e235b448f6978833c00970fad07cc5a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Digoxin,JH-2-002-CL,,,1.64E+12,,,,syn26997193,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,ba5a9325-b589-40e6-aede-75549c7a6a47,1.65E+12,3434950,JH-2-002-CL_combos_211116_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997194,1,syn26997194,DMSO_211116_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997173,syn21984813,syn21984813,87943760,44881,f9d97b6434a2120a0f32dbbbd159dc58,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,DMSO,JH-2-002-CL,,,1.64E+12,,,,syn26997194,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,19dbdc79-1e2d-4217-8e71-2bb083c524f4,1.65E+12,3434950,JH-2-002-CL_combos_211116_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997202,1,syn26997202,Mirdametinib_211130_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997198,syn21984813,syn21984813,87943777,116537,30f14afff5c2fbff8bc258b0bea62c29,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Mirdametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997202,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,a48eff6c-b0ad-4057-97fd-42d148f30d0b,1.65E+12,3434950,JH-2-002-CL_combos_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997205,1,syn26997205,Olaparib_211130_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997198,syn21984813,syn21984813,87943783,87960,72994c5df43228fb2c3af39b02918230,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Olaparib,JH-2-002-CL,,,1.64E+12,,,,syn26997205,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,7d1dd1c1-620f-4013-bd12-a2259ad49510,1.65E+12,3434950,JH-2-002-CL_combos_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997207,1,syn26997207,Selumetinib_211130_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997198,syn21984813,syn21984813,87943789,143419,cc32f04d7877715e9d899f08a21cde1e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Selumetinib,JH-2-002-CL,,,1.64E+12,,,,syn26997207,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,c88dc34c-62e7-4108-93f8-9421e5f60573,1.65E+12,3434950,JH-2-002-CL_combos_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997209,1,syn26997209,Trabectedin_211130_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997198,syn21984813,syn21984813,87943794,22621,9f929dca96bd775ba188d4d47bd070fa,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trabectedin,JH-2-002-CL,,,1.64E+12,,,,syn26997209,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,d13fef66-2e5d-4476-9e15-888c930b342b,1.65E+12,3434950,JH-2-002-CL_combos_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997211,1,syn26997211,Digoxin_211130_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997198,syn21984813,syn21984813,87943796,183616,4a9e35b32be8931d4f22845f6b258bb5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Digoxin,JH-2-002-CL,,,1.64E+12,,,,syn26997211,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,03a90af0-5e0a-48b0-b499-7f7cf18b24f0,1.65E+12,3434950,JH-2-002-CL_combos_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997212,1,syn26997212,DMSO_211130_48hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997198,syn21984813,syn21984813,87943799,60743,0690d12a8b76a37ec4f3876f0a04f975,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,DMSO,JH-2-002-CL,,,1.64E+12,,,,syn26997212,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,daa25afd-d3c2-472a-b5f1-3ffb71a72c94,1.65E+12,3434950,JH-2-002-CL_combos_211130_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997222,1,syn26997222,Olaparib_211130_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997217,syn21984813,syn21984813,87943830,177181,07192c969324b885e457c87df32bbef2,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Olaparib,JH-2-002-CL,,,1.64E+12,,,,syn26997222,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,942583b0-c1eb-4512-b9c4-fd7888d0de61,1.65E+12,3434950,JH-2-002-CL_combos_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997224,1,syn26997224,Selumetinib_211130_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997217,syn21984813,syn21984813,87943833,158761,30220d6a0481f9b38aef1416ab37b0d9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Selumetinib,JH-2-002-CL,,,1.64E+12,,,,syn26997224,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,ba56fead-cb10-45e1-9407-2827044b704e,1.65E+12,3434950,JH-2-002-CL_combos_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997226,1,syn26997226,Trabectedin_211130_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997217,syn21984813,syn21984813,87943838,24006,ae76ec5acfa958917c4e94b70cf44f9d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trabectedin,JH-2-002-CL,,,1.64E+12,,,,syn26997226,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,ee222630-eff5-4af4-962a-910b13352e01,1.65E+12,3434950,JH-2-002-CL_combos_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997227,1,syn26997227,Digoxin_211130_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997217,syn21984813,syn21984813,87943841,295602,5b1b6b9b4e2b3b1bab4ce28f4071fd0b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Digoxin,JH-2-002-CL,,,1.64E+12,,,,syn26997227,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,e42d572e-336b-4c68-9792-db3896825f04,1.65E+12,3434950,JH-2-002-CL_combos_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997228,1,syn26997228,DMSO_211130_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997217,syn21984813,syn21984813,87943842,66295,a442eca7edf69fbb0c128c25f43a0c9c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,DMSO,JH-2-002-CL,,,1.64E+12,,,,syn26997228,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,314c0766-b7af-4d3c-a310-b9c08c360479,1.65E+12,3434950,JH-2-002-CL_combos_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997229,1,syn26997229,Mirdametinib_211130_72hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997217,syn21984813,syn21984813,87943844,119771,d2a4ef228417320297106f64b79d462a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Mirdametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997229,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,24fdc1a3-4b9f-44bb-9971-ae4f600cd293,1.65E+12,3434950,JH-2-002-CL_combos_211130_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997243,1,syn26997243,Selumetinib_211130_125hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997235,syn21984813,syn21984813,87943859,84100,aeb506a4a05e6386c702bd125b1f4826,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Selumetinib,JH-2-002-CL,,,1.64E+12,,,,syn26997243,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,a70eec2e-ab09-4024-9d3b-1cb4f31afa2d,1.65E+12,3434950,JH-2-002-CL_combos_211130_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997245,1,syn26997245,Trabectedin_211130_125hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997235,syn21984813,syn21984813,87943862,37645,0679a1851f3059f98f44218bf90afc2e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Trabectedin,JH-2-002-CL,,,1.64E+12,,,,syn26997245,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,f919ccbf-2944-4cbd-a608-ee8d3d18d379,1.65E+12,3434950,JH-2-002-CL_combos_211130_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997246,1,syn26997246,Digoxin_211130_125hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997235,syn21984813,syn21984813,87943865,162317,db419f9b5d7a0916b7572cdad244cb7c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Digoxin,JH-2-002-CL,,,1.64E+12,,,,syn26997246,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,98e4f9f2-d9f2-4799-b3a0-4f9987567619,1.65E+12,3434950,JH-2-002-CL_combos_211130_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997247,1,syn26997247,DMSO_211130_125hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997235,syn21984813,syn21984813,87943866,53925,cbf2442ff6be6d6311591e763a8ed299,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,DMSO,JH-2-002-CL,,,1.64E+12,,,,syn26997247,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,1f4bd251-e8b2-473c-8fe8-f8ce401d7218,1.65E+12,3434950,JH-2-002-CL_combos_211130_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997248,1,syn26997248,Mirdametinib_211130_125hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997235,syn21984813,syn21984813,87943869,72182,b7f84164f5ac809194ac79f4ab4f093e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Mirdametinib,JH-2-002-CL,,,1.64E+12,,,,syn26997248,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,3240684b-c20d-4460-a6d3-a948cbbafc02,1.65E+12,3434950,JH-2-002-CL_combos_211130_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997252,1,syn26997252,Olaparib_211130_125hr_JH2002_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997235,syn21984813,syn21984813,87943875,97223,56a678e6e31b67a111db920141e8937b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JHU002-033,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-002-CL,Male,,,,,,,,,Olaparib,JH-2-002-CL,,,1.64E+12,,,,syn26997252,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,39dbc004-ec91-4101-ad1e-99b29d6c834f,1.65E+12,3434950,JH-2-002-CL_combos_211130_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997262,1,syn26997262,Olaparib_211213_48hr_JH2079_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997259,syn21984813,syn21984813,87943887,121226,cb5fe967211950d192d22ab14fb1d1a9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-CL,Male,,,,,,,,,Olaparib,JH-2-079-CL,,,1.64E+12,,,,syn26997262,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,fadbe43b-c639-4095-8f98-74e2bd18df01,1.65E+12,3434950,JH-2-079-CL_combos_211213_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997264,1,syn26997264,Selumetinib_211213_48hr_JH2079_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997259,syn21984813,syn21984813,87943891,114704,4404d0833dc1719126d150bc3e8a8e35,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-CL,Male,,,,,,,,,Selumetinib,JH-2-079-CL,,,1.64E+12,,,,syn26997264,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,cdf4a8bf-836f-4acc-a416-788d5de6fe25,1.65E+12,3434950,JH-2-079-CL_combos_211213_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997266,1,syn26997266,Trabectedin_211213_48hr_JH2079_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997259,syn21984813,syn21984813,87943894,41533,a930716dfbd5f48ffff5c05193f732ec,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-CL,Male,,,,,,,,,Trabectedin,JH-2-079-CL,,,1.64E+12,,,,syn26997266,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,9979bee9-5635-4d1c-9d6f-8236696d0638,1.65E+12,3434950,JH-2-079-CL_combos_211213_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997268,1,syn26997268,Digoxin_211213_48hr_JH2079_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997259,syn21984813,syn21984813,87943898,243279,571ce9e1a34204223472210686ec779b,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-CL,Male,,,,,,,,,Digoxin,JH-2-079-CL,,,1.64E+12,,,,syn26997268,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,08152549-5b7c-4a2c-b4c4-82270313b435,1.65E+12,3434950,JH-2-079-CL_combos_211213_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997269,1,syn26997269,DMSO_211213_48hr_JH2079_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997259,syn21984813,syn21984813,87943899,23038,03773b8efce04988b69e756e671fb26c,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-CL,Male,,,,,,,,,DMSO,JH-2-079-CL,,,1.64E+12,,,,syn26997269,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,00fcd400-68c9-4026-9b3a-4a162efc14d1,1.65E+12,3434950,JH-2-079-CL_combos_211213_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997270,1,syn26997270,Mirdametinib_211213_48hr_JH2079_CL_combos.csv,3D microtissue viability,3418059,file,1,syn26997259,syn21984813,syn21984813,87943902,93057,b8980f8f3649a4a2f29a6a79a3f24636,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-CL,Male,,,,,,,,,Mirdametinib,JH-2-079-CL,,,1.64E+12,,,,syn26997270,MPNST Patient-Derived Model Centers,Yes,,,,,nerves,,,,,hours,primary tumor,,,,e29fd150-e698-48a9-9800-01b1b6e65092,1.65E+12,3434950,JH-2-079-CL_combos_211213_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997325,1,syn26997325,Olaparib_211217_48hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997322,syn21984813,syn21984813,87943959,158007,a7b7266f739c992250b2546f0f3e07c5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Olaparib,,,,1.64E+12,,,,syn26997325,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d7159e37-71db-45c1-8847-c2bf42802917,1.65E+12,3434950,JH-2-079_combos_211217_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997327,1,syn26997327,Selumetinib_211217_48hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997322,syn21984813,syn21984813,87943963,227642,593c3ef572c3a4f23d9341568fdbcbd7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Selumetinib,,,,1.64E+12,,,,syn26997327,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,aec13b79-c045-464d-ac4a-a879193809ae,1.65E+12,3434950,JH-2-079_combos_211217_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997330,1,syn26997330,Trabectedin_211217_48hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997322,syn21984813,syn21984813,87943967,89189,b82809cb8678c5f3d2fd62642c8c57a9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Trabectedin,,,,1.64E+12,,,,syn26997330,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0f613f80-02f8-49a6-acff-474ac7d4ce37,1.65E+12,3434950,JH-2-079_combos_211217_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997331,1,syn26997331,Digoxin_211217_48hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997322,syn21984813,syn21984813,87943969,337542,cfc204974b3c58416bcf7c74808eaf35,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Digoxin,,,,1.64E+12,,,,syn26997331,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,6bad89d3-c183-4772-aa16-5b40f8c340ce,1.65E+12,3434950,JH-2-079_combos_211217_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997332,1,syn26997332,DMSO_211217_48hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997322,syn21984813,syn21984813,87943972,45387,db71ae279a0d234094cb5961093227dd,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,DMSO,,,,1.64E+12,,,,syn26997332,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2c58a9b0-5f8b-4281-b571-11200b6843d1,1.65E+12,3434950,JH-2-079_combos_211217_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997333,1,syn26997333,Mirdametinib_211217_48hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997322,syn21984813,syn21984813,87943974,167494,7027be9a35679c976f8ba9a7ec92c752,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Mirdametinib,,,,1.64E+12,,,,syn26997333,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,da70e169-5ca6-49d9-9c81-32918a7459cb,1.65E+12,3434950,JH-2-079_combos_211217_48,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997351,1,syn26997351,Selumetinib_211217_72hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997347,syn21984813,syn21984813,87943993,184002,a93e8a781f44212c40fe4c1d557d82c7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Selumetinib,,,,1.64E+12,,,,syn26997351,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,a23d0f98-a29c-4834-a182-10f3f930b49f,1.65E+12,3434950,JH-2-079_combos_211217_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997353,1,syn26997353,Trabectedin_211217_72hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997347,syn21984813,syn21984813,87943998,103352,c41176a061c4dbb057feb551387d793e,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Trabectedin,,,,1.64E+12,,,,syn26997353,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d0af59e5-7952-4261-9c57-b7e36142536b,1.65E+12,3434950,JH-2-079_combos_211217_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997354,1,syn26997354,Digoxin_211217_72hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997347,syn21984813,syn21984813,87944000,263023,b2c2d719d138f7356ae8834feeb5825d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Digoxin,,,,1.64E+12,,,,syn26997354,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,44835b97-5c0a-498a-863f-c3175769a6b8,1.65E+12,3434950,JH-2-079_combos_211217_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997355,1,syn26997355,DMSO_211217_72hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997347,syn21984813,syn21984813,87944001,65245,2cc3e9d7085aef3ac93d2b90cf6040d7,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,DMSO,,,,1.64E+12,,,,syn26997355,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,33620eb6-7550-4a43-9273-9efe82f1631e,1.65E+12,3434950,JH-2-079_combos_211217_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997356,1,syn26997356,Mirdametinib_211217_72hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997347,syn21984813,syn21984813,87944003,156557,c4c4fb14b0d5344ccff07e7ed7edc12a,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Mirdametinib,,,,1.64E+12,,,,syn26997356,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,89a0997a-27c8-4518-8899-f8abb250f363,1.65E+12,3434950,JH-2-079_combos_211217_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997360,1,syn26997360,Olaparib_211217_72hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997347,syn21984813,syn21984813,87944010,174693,b5e805d960a8c67f20c71ff3576a1aa5,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Olaparib,,,,1.64E+12,,,,syn26997360,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,aeaff1c9-bce1-41d1-a6a1-f09f016e1f52,1.65E+12,3434950,JH-2-079_combos_211217_72,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997367,1,syn26997367,Olaparib_211217_125hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997364,syn21984813,syn21984813,87944018,220523,c07ec3b15263248827bf5a9dc6ae09b3,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Olaparib,,,,1.64E+12,,,,syn26997367,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4108c53e-968f-4dfb-b2e0-b9e8111524a3,1.65E+12,3434950,JH-2-079_combos_211217_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997369,1,syn26997369,Selumetinib_211217_125hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997364,syn21984813,syn21984813,87944021,182852,c29ee9944ad74b087f1dc8c6fec33191,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Selumetinib,,,,1.64E+12,,,,syn26997369,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,57859cef-6619-497c-a77a-bd1db6d2f069,1.65E+12,3434950,JH-2-079_combos_211217_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997372,1,syn26997372,Trabectedin_211217_125hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997364,syn21984813,syn21984813,87944024,90406,d63c5b4f1b0019db990b95c2952a5e48,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Trabectedin,,,,1.64E+12,,,,syn26997372,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,52fd0196-35b2-4f6d-a2cb-ff10f296c06c,1.65E+12,3434950,JH-2-079_combos_211217_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997373,1,syn26997373,Digoxin_211217_125hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997364,syn21984813,syn21984813,87944027,345347,d836a17b5707f783a176a8c7aad6aeb9,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Digoxin,,,,1.64E+12,,,,syn26997373,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7f479b67-9d07-413f-b2cd-a9e3bcef61c4,1.65E+12,3434950,JH-2-079_combos_211217_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997374,1,syn26997374,DMSO_211217_125hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997364,syn21984813,syn21984813,87944030,52786,381eec2fae48c35eaa3e2c2211313852,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,DMSO,,,,1.64E+12,,,,syn26997374,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,37235380-b525-42bd-8054-5077e58cc2cb,1.65E+12,3434950,JH-2-079_combos_211217_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
26997375,1,syn26997375,Mirdametinib_211217_125hr_JH2079_combos.csv,3D microtissue viability,3418059,file,1,syn26997364,syn21984813,syn21984813,87944033,206349,7d06e3fa04ba02272108b6426e9ce0ca,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",JH-2-079c_pdx,-/-,+/+,Homo sapiens,experimentalData,No,No,syn21984813,JH-2-079-MIC,Male,,,,,,,,,Mirdametinib,,,,1.64E+12,,,,syn26997375,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0f102520-2731-4c15-8d46-b37f9b7b0770,1.65E+12,3434950,JH-2-079_combos_211217_125,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538166,1,syn27538166,Selumetinib_220209_48hr_WU536_combos.csv,3D microtissue viability,3418059,file,1,syn27538159,syn21984813,syn21984813,89639527,564540,87c43ae9bd29244b7d10a9efbc597080,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Selumetinib,nan,,,1.65E+12,220209 WU536 combos/Selumetinib_220209_48hr_WU536_combos.csv,,c1f44c4b-a101-4009-a5c5-9475b6847260,syn27538166,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e636b73f-0a68-48f5-a139-27acea5bacb9,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538171,1,syn27538171,TNO155_220209_48hr_WU536_combos.csv,3D microtissue viability,3418059,file,1,syn27538159,syn21984813,syn21984813,89639534,643190,f234d77c760da1fdeb2789b82ca49e9d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,nan,,,TNO155,nan,,,1.65E+12,220209 WU536 combos/TNO155_220209_48hr_WU536_combos.csv,,9a6c8492-90eb-4e9b-a21d-bb94ab18a377,syn27538171,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,3eeef138-e61e-4e04-b6b8-b3b2e27df093,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538174,1,syn27538174,Trabectedin_220209_48hr_WU536_combos.csv,3D microtissue viability,3418059,file,1,syn27538159,syn21984813,syn21984813,89639540,647213,fa2070cb30c10164193b39b2e5717b76,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Trabectedin,nan,,,1.65E+12,220209 WU536 combos/Trabectedin_220209_48hr_WU536_combos.csv,,16edda6a-feeb-46bb-b52b-598e353ff012,syn27538174,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,83d22576-1c2d-4aa6-a58b-6c4e460038d8,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538175,1,syn27538175,Trametinib_220209_48hr_WU536_combos.csv,3D microtissue viability,3418059,file,1,syn27538159,syn21984813,syn21984813,89639543,535716,9f36ba5d364170457f6c15339528e0ab,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Trametinib,nan,,,1.65E+12,220209 WU536 combos/Trametinib_220209_48hr_WU536_combos.csv,,ab661c5c-ce94-4e61-9083-29781384a4e7,syn27538175,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,8125d162-9967-4f98-93e8-5ba30bfccd88,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538176,1,syn27538176,Vorinostat_220209_48hr_WU536_combos.csv,3D microtissue viability,3418059,file,1,syn27538159,syn21984813,syn21984813,89639545,473081,bfe9125c4117497f61515e903f88aff1,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Vorinostat,nan,,,1.65E+12,220209 WU536 combos/Vorinostat_220209_48hr_WU536_combos.csv,,757c4d5c-bd84-4e05-a821-4301562faa75,syn27538176,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0e80998c-a5ef-4b99-80cf-9a4e9f38bda4,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538177,1,syn27538177,Digoxin_220209_48hr_WU536_combos.csv,3D microtissue viability,3418059,file,1,syn27538159,syn21984813,syn21984813,89639547,825192,2f015782dbdaf3a21298a964722026ef,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Digoxin,nan,,,1.65E+12,220209 WU536 combos/Digoxin_220209_48hr_WU536_combos.csv,,35c5dbcb-d5e5-42e4-8701-be683742efba,syn27538177,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,e336f4e2-40b1-4adc-9551-4445ef0a609f,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538178,1,syn27538178,DMSO_220209_48hr_WU536_combos.csv,3D microtissue viability,3418059,file,1,syn27538159,syn21984813,syn21984813,89639549,81090,666e4e43400572cdea0600fc661c77d4,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,nan,,,DMSO,nan,,,1.65E+12,220209 WU536 combos/DMSO_220209_48hr_WU536_combos.csv,,bf700618-ef38-4788-9cd5-1f47aacbee9c,syn27538178,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,d396815f-c94c-428e-91ce-1c69fcd63ec6,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538179,1,syn27538179,Mirdametinib_220209_48hr_WU536_combos.csv,3D microtissue viability,3418059,file,1,syn27538159,syn21984813,syn21984813,89639551,465689,f8450b7dc2f4813ed47b7e89ab57c379,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Mirdametinib,nan,,,1.65E+12,220209 WU536 combos/Mirdametinib_220209_48hr_WU536_combos.csv,,f85be40f-6b81-4894-9bad-73e4ffadb1b8,syn27538179,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,85466c44-0017-418f-bd4b-45b568325fa8,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538185,1,syn27538185,Olaparib_220209_48hr_WU536_combos.csv,3D microtissue viability,3418059,file,1,syn27538159,syn21984813,syn21984813,89639559,517840,6fca2daca87a2ebcf5152bcf7caa736f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Olaparib,nan,,,1.65E+12,220209 WU536 combos/Olaparib_220209_48hr_WU536_combos.csv,,9749bcf9-29cd-436e-bde5-9f1149de43f1,syn27538185,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,fe2deedb-985e-4872-ae65-16572d5f4e15,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538189,1,syn27538189,Ribociclib_220209_48hr_WU536_combos.csv,3D microtissue viability,3418059,file,1,syn27538159,syn21984813,syn21984813,89639563,561239,051ff38bf99283820f3d8756f0f00f93,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,,,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Ribociclib,nan,,,1.65E+12,220209 WU536 combos/Ribociclib_220209_48hr_WU536_combos.csv,,9a012e60-f462-4535-aae8-f82994cb6833,syn27538189,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,9d408c96-b47c-4068-84c9-ad8ff414ee56,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538197,1,syn27538197,MirdametinibWU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639574,465689,f8450b7dc2f4813ed47b7e89ab57c379,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Mirdametinib,nan,,,1.65E+12,220209 WU536/MirdametinibWU536_48hr_220209.csv,,9eeaa875-9703-4f4c-a1fc-2e51086c4b6d,syn27538197,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,15cffbf4-e4f1-415c-a608-1310b643422e,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538198,1,syn27538198,OlaparibWU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639575,517840,6fca2daca87a2ebcf5152bcf7caa736f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Olaparib,nan,,,1.65E+12,220209 WU536/OlaparibWU536_48hr_220209.csv,,325e7ebb-fcf0-4e63-a953-fb6995bba4ab,syn27538198,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,1d66b6db-e337-4c6b-94cc-d4e561a53fbb,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538199,1,syn27538199,RibociclibWU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639577,561239,051ff38bf99283820f3d8756f0f00f93,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Ribociclib,nan,,,1.65E+12,220209 WU536/RibociclibWU536_48hr_220209.csv,,7151b0cb-8c1b-4890-b591-6d6bafd3a5d5,syn27538199,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,de33c7df-4b62-47c9-9171-2ec5198f35e1,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538201,1,syn27538201,SelumetinibWU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639581,564540,87c43ae9bd29244b7d10a9efbc597080,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Selumetinib,nan,,,1.65E+12,220209 WU536/SelumetinibWU536_48hr_220209.csv,,13a5f43a-201b-4502-8d18-2675a97c54b9,syn27538201,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,b0eacecb-ef59-4399-b4b1-2c132160725d,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538202,1,syn27538202,TNO155WU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639583,643190,f234d77c760da1fdeb2789b82ca49e9d,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,TNO155,nan,,,1.65E+12,220209 WU536/TNO155WU536_48hr_220209.csv,,0000fd97-39fd-4f81-9f49-eeffe473e062,syn27538202,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,7d9d46a0-56fc-47fb-98d0-924f3e497cb0,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538203,1,syn27538203,TrabectedinWU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639584,647213,fa2070cb30c10164193b39b2e5717b76,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Trabectedin,nan,,,1.65E+12,220209 WU536/TrabectedinWU536_48hr_220209.csv,,50a7368f-acac-4f74-9e5c-37a6e71b368e,syn27538203,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,85c68eb6-3683-42f9-a924-7002a2c95e7a,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538204,1,syn27538204,TrametinibWU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639587,535716,9f36ba5d364170457f6c15339528e0ab,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Trametinib,nan,,,1.65E+12,220209 WU536/TrametinibWU536_48hr_220209.csv,,dfa815f5-280a-47f1-a4ca-c6cd4ce6aae9,syn27538204,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,052b8d54-83cf-4a7b-98c2-452f2c5a9c84,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538205,1,syn27538205,VorinostatWU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639589,473082,3d2aeb1cada5100aebf29e5ccf45a69f,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Vorinostat,nan,,,1.65E+12,220209 WU536/VorinostatWU536_48hr_220209.csv,,7c2ff9d2-ca8d-49f0-b022-bc4a61ddeccc,syn27538205,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,0898e29e-867c-43cb-a01b-facb4a7971b8,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538206,1,syn27538206,CUDC907WU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639591,518263,9476a0676cfde3fce8bb73ce9d3f4596,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,CUDC907,nan,,,1.65E+12,220209 WU536/CUDC907WU536_48hr_220209.csv,,828594aa-a49c-4252-b217-cf76aee8022b,syn27538206,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,05658ca7-c4d7-427a-be4f-1ecc9daa7b29,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538207,1,syn27538207,DigoxinWU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639593,825192,2f015782dbdaf3a21298a964722026ef,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,Digoxin,nan,,,1.65E+12,220209 WU536/DigoxinWU536_48hr_220209.csv,,d9ae577d-b6f7-40ca-9f3e-e4f412114e34,syn27538207,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,4410ae60-ac3f-4a35-b15f-47fe8486d1e2,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",
27538208,1,syn27538208,DMSOWU536_48hr_220209.csv,3D microtissue viability,3418059,file,1,syn27538193,syn21984813,syn21984813,89639595,24184,a1d3e3ecd6fa3d3355d3e0ed27316399,,processed,drugScreen,Neurofibromatosis type 1,csv,"NFRI,NIH-NCI",WU-536_pdx,-/-,Unknown,Homo sapiens,experimentalData,No,None,syn21984813,WU-356-MIC,Male,,,,,,nan,,,DMSO,nan,,,1.65E+12,220209 WU536/DMSOWU536_48hr_220209.csv,,26917861-5296-4531-9c31-49231d6b791f,syn27538208,MPNST Patient-Derived Model Centers,No,,,,,nerves,,,,,hours,primary tumor,,,,2f0c693c-5cad-49ee-9486-89b107ed911f,1.65E+12,3434950,WU-536_220209,"[""Malignant Peripheral Nerve Sheath Tumor""]",

